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Abstract 
The PrP prion protein (PrPC)  is a glycoprotein believed to be present in all vertebrates. In 
mammals, a protease-resistant isoform of the prion protein (PrPSC),  produced by 
posttranslational modifications of PrPC,  is believed to be the agent or a component of the 
agent causing transmissible spongiform encephalopathies (TSEs). PrPC  and  PrPSC  are 
encoded by the same gene (PRNP) and variation within this locus has been associated with 
disease development and modulation in a number of species. The selective forces acting on 
the PrP gene have now been investigated in a number of TSE affected species and although 
PRNP appears to have been under strong selective constraint throughout the mammalian 
evolutionary history, species-specific selective patterns seem to exist. The current lack of 
knowledge concerning the functional role of the PrP protein, and its exact role in disease, 
have made the interpretation of these different evolutionary scenarios very challenging; 
however, the potential for disease to shape the genetic variability of the PrP gene has been 
demonstrated in the human gene. 
Variation at codon 132 of the Cervus canadensis (wapiti) PRNP has been claimed to 
modulate Chronic Wasting Disease (CWD), a relatively new TSE affecting cervid species 
and currently the only TSE naturally affecting both captive and free-ranging populations. 
Codon 132 corresponds to the human codon 129 and variation at this position has been 
associated with TSE-related balancing selection in humans. 
This thesis investigated the genetic variability and selective patterns of coding and 
non-coding regions of PRNP in free-ranging populations of C. canadensis and C. elaphus 
(CWD-free species closely related to wapiti) to gain a better understanding of the possible 
functional or disease-related forces shaping PrP genetics. 
The study of codon 132 genotypic patterns in CWD +vi and CWD vE wapiti provided 
no evidence for genetic modulation of CWD susceptibility, challenging previously published 
data. Despite this, a modulatory role of this residue in CWD incubation time, as suggested by 
many, is still possible. 
The analysis of the variability patterns in the PrP gene of the two cervid species 
suggested the presence of purifying selection. This was also supported by analyses aimed at 
identifying positively selected sites, which showed that codon 100 was the only site under 
positive selection throughout mammalian evolution, while the rest of the protein was under 
strong purifying selection. These data provide further support for the hypothesis suggesting a 
key cellular role for the PrP protein. The adaptive pressures driving selection at codon 100 
are unknown, although they are most likely to be related to PrP function. A role for variation 
at this position in the interactions of the PrP protein with cell membrane translocation factors 
is proposed. 
The study provided an insight into the possible forces shaping PrP genetics and 
revaluated the role of variation at codon 132 in the wapiti PRNP gene in relation to CWD 
susceptibility; as well as contributing to our knowledge of the level and pattern of DNA 
sequence variability in natural populations of mammals. 
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Chapter I: Introduction 
1.1 Transmissible Spongiform Encephalopathies 
Transmissible Spongiform Encephalopathies (TSEs), or prion diseases, are a group of 
incurable and infectious neurodegenerative diseases that affect both humans and animals. 
Animal TSEs include scrapie in sheep and goats (Parry 1962), Chronic Wasting Disease 
(CWD) in deer, wapiti and moose in North America (Williams and Young 1980; Kreeger et 
al. 2006; Baeten et al. 2007), Bovine Spongiform Encephalopathy (BSE) in cattle (Wells et 
al. 1987), Feline Spongiform Encephalopathy in captive wild and domestic felines (Wyatt et 
al. 1991; Peet and Curran 1992; Willoughby et al. 1992) and Transmissible Mink 
Encephalopathy in captive mink (zu Rhein, Eckroade, and Marsh 1971). BSE-like 
spongiform encephalopathies have also been identified in a number of captive wild 
ungulates. These BSE-like disorders are thought to be the result of exposure to BSE 
contaminated feed (Jeffrey and Wells 1988; Wilesmith 1988; Fleetwood and Furley 1990; 
Kirkwood et al. 1990). Human TSEs can be inherited, sporadic or iatrogenic; they include 
Creutzfeldt Jakob Disease (CJD) (Creutzfeldt 1920; Jakob 1921), variant CJD (vCJD) (Will 
et al. 1996), Gerstmann-Sträussler-Scheinker syndrome (GSS) (Gerstmann 1928), Fatal 
Familial Insomnia (FF1) (Rossi et al. 1998) and Kuru (Zigas and Gajdusek 1957). TSEs are 
characterised by long incubation periods and often, but not always, by the spongiform 
vacuolation of the brain and deposition of a protease-resistant form (PrP, also called PrP') 
of a host encoded protein (PrPC)  in the central nervous system (CNS) and in the lympho-
reticular system of the affected individual. Levels and patterns of deposition and vacuolation 
depend on factors such as the strain of the infectious agent and the host (DeArmond et al. 
1993; Lasmezas etal. 1997; Nitrini etal. 1997; Manson etal. 1999; Foster etal. 2001). 
TSEs have been the focus of much media and public attention since the late 1990s 
when the first case of BSE was identified in the UK (Wells et al. 1987). This was the 
beginning of an epidemic which affected over 180,000 cattle (Bradley 2002) and which 
raised serious concerns for human health, when it became known that consumption of 
infected meat was probably associated with the emergence of a new human TSE, in the form 
of vCJD (Will et al. 1996; Bruce et al. 1997; Hill et al. 1997; Scott et al. 1999). The BSE 
epidemic originated from the use of TSE infected meat and bone meal (MBM) in cattle feed 
(Wilesmith 1988; Bradley and Matthews 1992) and for this reason, a number of bans on the 
feeding of MBM to any food animal species were introduced between 1988 and 1996 
(Bradley and Wilesmith 1993; Bradley 2002). These bans are believed to have reduced the 
spread of the disease so that to date, only 158 people have died of vCJD in the UK (Ghani et 
al. 1998); http://www.cjd.ed.ac.uklfigures.htm ). The origin of the BSE agent is still 
unknown; it has been hypothesised that the epidemic could have started with the introduction 
of cattle infected by a "sporadic" form of BSE or scrapie affected sheep in the MBM 
production process (Anil etal. 1999). 
A relatively new TSE epidemic is currently affecting cervid species across the US 
and Canada; causing serious economic problems and sparking fears that the CWD agent may 
cross the species barrier and result in a BSE-like scenario in humans. 
1.2 Nature of the TSE Agent 
Due to the characteristic long incubation periods, the infectious agent was initially believed 
to be a slow virus (Sigurdsson 1954). However, infectivity was shown to be highly resistant 
to ionising radiation and nucleases, which would inactivate conventional viruses (Alper et al. 
1967; Latarjet et al. 1970; Millson, Hunter, and Kimberlin 1976). These data, together with 
the ability of phenol, proteases and urea to affect infectivity (Hunter and Millson 1967; 
Hunter et al. 1969) suggested that the agent lacked a genetic component and that it was a 
self-replicating protein (Griffith 1967). There are two major hypotheses on the nature of the 
infectious agent; the prion hypothesis and the virino hypothesis. However, to date, neither of 
the two hypotheses has been proved or disproved to the satisfaction of the research 
community, and the exact nature of the TSE agent is still a matter of intense research and 
debate. 
1.3 Prion Hypothesis 
The prion hypothesis states that the prion (proteinaceous infectious agent) is a novel 
infectious particle devoid of a nucleic acid component (Prusiner 1982). An abnormal 
protease resistant protein was isolated from scrapie-infected hamster brain. This protein, 
termed P02730 , is the protease-resistant core of PrPS  (Section 1.8) (Bolton, McKinley, and 
Prusiner 1982; Prusiner et al. 1984). PrPS  is believed to be the infectious agent or a 
component of it and its accumulation in TSE affected organisms is considered a hallmark of 
disease. However, detection of the disease isoform is not always related to disease as both 
TSE infectivity in the absence of PrPSC  and PrPSC  in the absence of infectivity have been 
reported (Prusiner et al. 1990; Lasmezas et al. 1997; Manson et al. 1999; Piccardo et al. 
2007). This lack of an absolute link between the disease isoform and neurological disease is 
one of the arguments put forward against the prion hypothesis (Section 1.3). While the 
presence of PrPSC  is not necessary, the expression of PrPC  is essential for the development of 
TSEs, as shown by the inability of PrP null mice to develop disease (Bueler et al. 1992; 
Bueler et al. 1993; Manson et al. 1994; Sakaguchi et al. 1995). The infectivity of prions is 
explained by the suggestion that PrP sc can convert PrPC  into PrP. Two models of this 
conversion process have been proposed: the conformational conversion model (Jarrett and 
Lansbury 1993) and the nucleated polymerisation model (Prusiner 1991). The ability of 
PrPS to alter the biochemical characteristics of the normal PrP isoform have been shown in a 
cell free system by the conversion of cellular or even bacterial recombinant PrPC  to protease-
resistant forms by PrPSC  (Kocisko et al. 1994). The existence of sporadic and familial TSEs 
(Section 1.3) is explained in the prion hypothesis by the ability of changes in the primary 
structure of the protein to enable the spontaneous formation of PrP. The identification of 
single nucleotide polymorphisms (SNPs) capable of modulating TSEs in human and animals 
provides further support for the link between PrP and TSEs (Sections 1.13, 1.14, 1.15 and 
1.27). The prion hypothesis explains the existence of different TSE strains by suggesting that 
different conformations of PrPSC  and the way in which they interact with PrPC  determine 
strain characteristics (Bessen and Marsh 1992). Variation in the glycosylation of PrP has also 
been proposed as a possible way to account for biological diversity between TSE strains 
(Collinge etal. 1996). 
Despite widespread support for the prion hypothesis and the development of 
methods which appear to have been able to generate infectivity in vitro (Legname et al. 
2004; Legname et al. 2005), direct confirmation that PrPSC  is the infectious agent has yet to 
be provided. 
1.4 Virino Hypothesis 
The resistance of the TSE agent to ionising radiation (Alper, Haig, and Clarke 1966) has 
been used to advocate a TSE agent devoid of nucleic acid. However, resistance to UV light 
has been shown for viroids; plant pathogens that consist of a short stretch of single-stranded 
RNA without any polypeptide component (Diener 1972). This does hold true if more 
penetrating radiation is used (e.g. X-rays). Despite this, through the comparison of data from 
X-ray inactivation studies of the TSE agent and data obtained from viruses with known 
genomes, a genome size of 2-4 kb could not be excluded for the TSE agent (Chesebro 
1999). This is equivalent to the genome of a small virus and is about ten times larger than the 
one of a viroid (Diener 1972; Chesebro 1999). The size of this genome could even be 
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increased if the TSE agent was able to repair damaged nucleic acid during replication as 
done by retroviruses (Chesebro 1999). These data provide support for the virino hypothesis, 
which proposes that the TSE agent is a novel infectious species composed of nucleic acid 
(encoding strain characteristics) and a host-encoded protein coat (Dickinson and Outram 
1988; Farquhar, Somerville, and Bruce 1998). Despite all effort, no TSE specific nucleic 
acid has been identified. 
1.5 Strains, Transmission and Species Barrier 
The TSE agent, like conventional pathogens, exhibits strain variation (Bruce 1993; Bruce et 
al. 2003), indicating its ability to carry information. Traditionally, TSE strains have been 
differentiated through strain typing in mice, a method based on simple observations of 
disease characteristics and their variation between different strains of mice and agent. The 
traditional discriminatory parameters are: incubation period and brain pathology (Fraser and 
Dickinson 1968; Dickinson and Meikle 1971; Bruce et al. 1991). Additional strain typing 
parameters include clinical signs, efficiency of inter-species transmission and susceptibility 
to inactivation by heat and chemicals (Bruce et al. 2003). Although strain typing has 
conventionally been performed through mice bioassay, this procedure is slow and expensive, 
which makes it unsuitable to large scale investigations. In recent years, faster and cheaper 
biochemical strain typing approaches have also been developed; these include the analysis of 
patterns of PrP glycosylation and variation in the conformation of PrPSC  (Collinge et al. 
1996; Telling et al. 1996; Somerville et al. 1997; Safar et al. 1998). However, biochemical 
strain typing methods, in contrast with bioassay, do not prove the infectious nature of the 
investigated TSE agents and are not 100% strain specific. 
Transmission of TSE strains between different host species usually results in 
prolonged incubation times and/or inefficient transmission (survivors). Nonetheless, if the 
disease is then passaged within the second host, the incubation times shorten and stabilise 
while the efficiency of transmission increases (Pattison 1965). This effect has been termed 
the "species barrier". 
1.6 The Mammalian Prion Protein 
PrPSC is the protease-resistant isoform of PrPC,  a host encoded glycoprotein (Bolton, 
McKinley, and Prusiner 1982; Prusiner 1982; Oesch et al. 1985) PrP' and PrPSC  are encoded 
by the same gene and the disease isoform is produced by a posttranslational modification of 
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PrPC (Prusiner 1991; Jarrett and Lansbury 1993). 
Mature mammalian PrPC  is a glycoprotein of around 210 amino acids, which is 
encoded from a single open reading frame (ORF) of typically 254-256 codons. PrPC  is a 
membrane protein and it is synthesized in the rough endoplasmic reticulum (ER); it then 
transits through the Golgi before reaching the cell surface (Hegde and Lingappa 1999). The 
maturation of the protein involves a number of posttranslational modifications, most of 
which occur in the ER. The 22-24 amino acid long (species dependent) signal peptide is 
cleaved off to generate the N-terminus Lys-Lys-Arg found in the mature PrPC;  a 
hydrophobic peptide of around 20 amino acids is also removed at the C-terminus while a 
glycosyl-phosphatidyl-inositol (GPO anchor is attached. The C-terminal domain is folded 
into a largely a-helical conformation and is stabilised by a single disuiphide bond, while the 
N-terminal region is unstructured and flexible (Stahl et al. 1987; Turk et al. 1988; Haraguchi 
et al. 1989; Rick et al. 1996). This N-terminal region contains a number of histidine-glycine-
proline rich octapeptide repeats. The number of these can vary between and within species 
(Schatzl et al. 1995; Wopther et al. 1999). The size and structure of the repeat region are 
highly variable across vertebrate classes and a study of its structural evolution proposed an 
alternative configuration for the repeat region (Rivera-Milla et al. 2006): the study identified 
two types of repeats (A and B) which are present at unequal ratios in all vertebrate PrPs 
(Rivera-Milla et al. 2006). 
Mammalian PrPC  can have N-linked glycans attached at two sites on the C-terminus 
giving rise to different glycotypes as individual polypeptides can be di-, mono- or un-
glycosylated. The molecular weight of the mature PrPC  protein in vivo ranges from 33 to 35 
kDa (Oesch et al. 1985) depending on the level of glycosylation. In all the cervid species 
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1.7 PrPC  Function 
The prion protein is expressed in most adult tissues (Bendheim et al. 1992; Manson et aL 
1992; McBride et al. 1992; Ford et al. 2002) but it is found at the highest level in the central 
nervous system and lympho-reticular system (Dodelet and Cashman 1998). The high degree 
of conservation between species suggests a key role in cellular metabolism (Seabury et al. 
2004). Prnp°'° mice do not display obvious developmental or anatomical defects and have a 
normal lifespan. This suggests the possible presence of backup systems that compensate for 
the lack of PrPC  (Caughey and Baron 2006). However, more careful analyses revealed 
alterations in hippocampal neuronal function (Collinge et al. 1994; Tobler et al. 1996; 
Tobler, Deboer, and Fischer 1997), circadian rhythms (Tobler et al. 1996), brain copper 
levels, superoxide dismutase (SOD) activity, cuproenzyme levels (Brown et al. 1997), 
oxidative tissue damage (Shyu et al. 2005), phagocytosis and inflammatory response (de 
Almeida et al. 2005), haematopoietic-stem-cell renewal (Zhang et al. 2006), neural stem cell 
differentiation (Steele et al. 2006), stress responses (Nico et al. 2005), spatial learning, 
memory, and sleep patterns (Nishida et al. 1997; Criado et al. 2005). 
To date, a number of possible functions have been proposed for PrPC;  however, none 
of them has been confirmed and the function of this protein is still subject of intense 
research. PrPC  has been shown to bind suiphated glycosaminoglycans (GAGs) (Hundt et al. 
2001; Gonzalez-Iglesias et al. 2002) and variety of other molecules including laminins 
(Graner et al. 2000), laminin receptor (Hundt et al. 2001), stress-inducible protein 1 (STI-1) 
(Zanata et al. 2002; Lopes et al. 2005), neural cell adhesion molecule (NCAM) (Santuccione 
et al. 2005) and proteins of the Bcl-2 family (Caughey and Baron 2006; Liang et al. 2006). 
These interactions provide potential support for the involvement of PrPC  in cellular processes 
such as cell adhesion, signalling (Schneider et al. 2003; Santuccione et al. 2005), synapse 
formation (Kanaani et al. 2005) and neuronal survival (Chen et al. 2003; Solforosi et al. 
2004). PrPC  has also been shown to bind copper through copper binding domains; this 
interaction is, however, complex and the role of PrP in copper metabolism, if any, remains 
unknown. A number of possible functions have been proposed, including copper endocytosis 
(Taylor et al. 2005), and copper homeostasis (Vassallo and Herms 2003; Cerpa et al. 2005). 
When compared with other copper-binding proteins, the affinity of PrPC  for this metal is low 
(Caughey and Baron 2006). However, it has been shown that its affinity can be increased by 
the presence of GAGs (Gonzalez-Iglesias et al. 2002). Structural analysis of vertebrate PrP 
and PrP-like molecules suggest a structural conservation of the C-terminus while the N-
terminus is highly heterogeneous and most non-mammalian repeats lack the copper binding 
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sites, which could question the role of PrP in copper metabolism (Rivera-Milla etal. 2006). 
PrPC was also believed to neutralise superoxide radicals in a way similar to 
superoxide dismutase, thus preventing cellular damage (Brown, Clive, and Haswell 2001). 
However, in vivo tests of the copper/zinc and manganese SOD activity of PrPC  failed to 
detect any significant contribution of the prion protein to total SOD activity (Hutter, 
Heppner, and Aguzzi 2003). PrPC  has also been shown to modulate phagocytosis in vitro and 
in vivo and alter leukocyte recruitment to the site of inflammation (de Almeida et al. 2005). 
1.8 PrPSC 
Despite having the same primary amino acid sequence, PrPC  and  PrPSC  have different 
secondary structures; while the disease associated isoform has a secondary structure 
comprised predominantly of f-sheets PrPC  is mainly a-helical (Bolton, McKinley, and 
Prusiner 1982; Oesch et al. 1985; Pan et al. 1993; Rick et al. 1996). These conformational 
differences are believed to be the result of post-translational events and can plausibly be seen 
as the cause of the unusual biochemical properties of PrPSc,  including partial resistance to 
proteinase-K digestion, insolubility in detergents and tendency to form insoluble aggregates 
(Oesch et al. 1985; Caughey et al. 1990; Safar et al. 1998). To date, it has not been possible 
to accurately resolve the tertiary structure of PrPSC  due to its tendency to form large and 
heterogeneous aggregates (Lee and Eisenberg 2003; Govaerts et al. 2004). 
1.9 The Prion Protein Gene 
PrPC is encoded by a single copy gene, which in mammals is composed of two or three exons 
(depending on the species), a continuous open reading frame and a cytosine/guanine rich 
promoter (Goldmann 1993). The gene has been located on human chromosome 20, on mouse 
chromosome 2 (Liao et al. 1986; Sparkes et al. 1986) and on bovine and ovine chromosome 
13 (Castiglioni et al. 1998; Comincini et al. 2000). The chromosomal location in the deer 
genome is unknown. The prion gene is highly conserved between mammalian species and is 
thought to be present in all the species of this class (Schatzl etal. 1995; Wopfner etal. 1999; 
Van Rheede et al. 2003). To date, PrP homologs have also been identified in birds (chicken, 
duck, quail, condor, petrel, owl and pigeon) (Harris et al. 1991; Gabriel et al. 1992; Asante 
et al. 2002; Zhang et aL 2002; Rivera-Milla, Stuermer, and Malaga-Trillo 2003; Rivera-
Milla et al. 2006), reptiles (turtle) (Simonic et al. 2000), fish (zebrafish, carp, stickleback, 
salmon and pufferfish) (Suzuki et al. 2002; Oidtmann et al. 2003; Rivera-Milla, Stuermer, 
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and Malaga-Trillo 2003) and amphibians (African clawed frog) (Strumbo et al. 2001). 
The number of exons of the prion gene differs slightly between different mammalian 
species. Sheep, cattle, mouse and hamster have three exons while the human PrP gene lacks 
the non-coding exon II and has therefore only two exons. Exon III (human exon II) contains 
the open reading frame and the entire 3' untranslated region (3'UTR) (Horiuchi et al. 1998; 
Lee et al. 1998). 
The size of the two PrP introns varies depending on the species. In the human PrP 
gene both introns are merged into one. Intron I has a length of approximately 2.2-2.4 kb 
(Westaway et al. 1994a; Lee et al. 1998) and it has been shown to contain elements capable 
of regulating the activity of the PrP promoter in a tissue-specific manner (Baybutt and 
Manson 1997; Inoue et al. 1997; McCormack et al. 2002). The length of Intron II is much 
more heterogeneous and it varies from 7.7 kb in hamster to 18kb in mouse (Westaway et al. 
1994a; Lee et al. 1998); a tissue-specific regulatory function of this region has been 
suggested for mouse PrP (Fischer et al. 1996). 
The PrP promoter region has been shown to be variable between the different 
mammalian species examined to date, except for four conserved sequence motifs, which 
might function in the regulation of PrP expression (Westaway et al. 1 994a; Westaway et al. 
1994b). The transcription start site appears to be controlled by SP1 transcription factor 
binding-sites rather than a TATA box element (Saeki et al. 1996; Inoue et al. 1997; Funke-
Kaiser et al. 2001; Mahal etal. 2001). 
1.10 The PrP Pseudogene (PRNPqJ) 
White-tailed deer (Odocoileus virginianus), mule deer (Odocoileus hemionus) and black-
tailed deer (Odocoileus hemionus columbianus) have all been shown to carry one copy of a 
PRNP pseudogene with the classic characteristics of retrotransposed genes: the absence of 
introns, lack of expressed mRNA and, presence of a 3' poly(A) tract and flanking repeats (5' 
[AA]GAAAATTCCTGAGA 3'). PRNPu is 4223bp (not including the poly (A) tract and the 
direct repeats) and is truncated at the 5' end of exon 1 by 25bp. The main difference 
between the coding sequence (CDS) of PRNP and PRNPW is the presence of asparagine at 
codon 138 of PRNPW, while all the functional gene alleles encode serine (Brayton et al. 
2004; O'Rourke et al. 2004). However, functional alleles encoding N 138 are found in other 
species of the Bovidae: fallow deer (Dama dama), caribou (Rangfer tarandus) (O'Rourke et 
al. 2004), Pere David's deer (Elaphurus davidianus), Nilgai (Boselaphus tragocamelus) (Dr. 
W. Goldmann, 2006. Personal communications) and sheep (Ovis aries) (Thorgeirsdottir et 
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al. 1999; Tranulis etal. 1999). 
The mule deer pseudogene is polymorphic at codon 65 (G -p E), codon 151 (R -+ 
C) and codon 253 (L -* F) (Brayton et al. 2004). It also carries three insertions and three 
deletions, all within the 3 'UTR and both tag and taa can be found as stop signals at the end 
of the open reading frame (Jewell et al. 2004). The pseudogene of white-tailed deer is less 
variable and the only variant detected to date is in the octapeptide repeat number, which has 
between five and six repeats (O'Rourke et al. 2004; Johnson et al. 2006). 
This lack of variation, together with the low frequency at which PRNPu is present in 
white-tailed deer, suggest that the pseudogene appeared in mule deer and black-tailed deer 
(where the pseudogene is present at higher frequencies) after they diverged from white-tailed 
deer and subsequently entered the 0. virginianus genome through hybridization of ancestral 
sympatric populations (O'Rourke et al. 2004). There is as yet no evidence that the presence 
of the pseudogene affects disease development (O'Rourke et al. 2004; Johnson et al. 2006). 
The only other species which has been shown to carry a PRNP pseudogene is the 
silky anteater (Cyc!opes didaclylus); this appears to be an older pseudogene and it contains 
two frame shift mutations, three stop codons and many nonsynonymous substitutions (Van 
Rheede et al. 2003). 
1.11 Doppel and PrP-Iike Genes 
The prion gene has a paralog, PRND, which encodes a protein named Doppel (dpl). This 
locus is thought to have arisen by duplication of PRNP (Moore et al. 1999; Mastrangelo and 
Westaway 2001). This gene is localized 12 to 20 kb (depending on the species) downstream 
of the prion gene and it is only present in eutherian mammals (Moore et al. 1999; Tranulis et 
al. 1999; Mead et al. 2000; Comincini et al. 2001) although a PRND-like gene has been 
identified in Xenopus tropicalis (western clawed frog) (Premzt and Gamulin 2007). This 179 
amino acid protein is similar to the C-terminal globular domain of the prion protein. DpI 
lacks the octarepeats region of PrP as well as the highly conserved hydrophobic region 
(Schatzl et al. 1995; Luhrs et al. 2003; Oidtmann et al. 2003). Dpl niRNA is present at low 
levels in the adult central nervous system while it is present at high levels in the testis 
(Moore et al. 1999; Peoc!h  et al. 2000; Silverman et al. 2000; Tranulis et al. 2001). The 
level of doppel expression in the CNS of TSE infected mice does not seem to influence the 
pathology or pathogenesis of natural TSEs (Mead et al. 2000; Peoc'h et al. 2000; Tuzi et al. 
2002). Another gene, designated PRNT, which appears to be specific to primates, is located 3 
kb downstream of PRND (Makrinou, Collinge, and Antoniou 2002; Premzl and Gamulin 
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2007). This gene is believed to encode an intracellular testis-specific protein called Prt 
(Premzl and Gamulin 2007). Another paralog of PRNP identified by genome scanning was 
named SPRN and like PRI%JP is believed to be present in all vertebrates (Premzl et al. 2003; 
Uboldi et al. 2006; Premzl and Gamulin 2007). This gene encodes the Shadoo (Sho) protein. 
Recently, a duplicate of SPRN has also been found in a number of fish species. This gene 
was called SPRNB and it encodes the Shadoo2 (Sho2) protein (Premzl et al. 2004; Premzl 
and Gamulin 2007). Shadoo has been shown to be a GPI-anchored glycoprotein and like PrP 
is believed to be expressed in most tissues (Premzl and Gamulin 2007). With the exception 
of the hippocampus and the cerebellum, Shadoo is mainly expressed in neurons which lack 
PrP, suggesting a PrP-like activity of Shadoo (Watts, Balachandran, and Westaway 2006). 
Compared to tetrapod PrPs, a variety of PrP like proteins have been detected in fish species. 
Three PrP homologues, PrP- 1, PrP-2A and PrP-2B have been identified in a number, but not 
all, studied fish species as well as two other proteins which are believed to be duplicates of 
fish PrP-1 and PrP-2A (Suzuki et al. 2002; Rivera-Milla, Stuermer, and Malaga-Trillo 2003; 
Premzl et al. 2004; Cotto et al. 2005; Premzl and Gamulin 2007). PrP-1 and PrP-2A show 
high levels of expression in fish brain (Suzuki et al. 2002); thus suggesting a possible 
evolutionary conserved role of vertebrate PrPs in the CNS (Oidtmann et al. 2003; Rivera-
Milla et al. 2006). 
1.12 PrP and Selection 
The PrP gene has been subjected to a limited number of evolutionary studies which focused 
mainly on the genetic variability of the ORF in a number of mammalian species: humans 
(Mead et al. 2003; Seabury etal. 2004; Soldevila etal. 2005; Soldevila etal. 2006; Zan etal. 
2006a), cattle (Seabury et al. 2004) and sheep (Slate 2005). 
In one of these studies, the genetic variability of the prion gene in Kuru affected and 
non-affected individuals was analysed and endocannibalism-related TSE epidemics in 
prehistoric human populations were proposed as the cause of heterozygote advantage at 
codon 129 (Mead et al. 2003). Although investigators agree that balancing selection is most 
likely to have acted on human PRNP in Kuru affected populations, the theory of a worldwide 
signature of balancing selection in humans, due to cannibalism, is controversial and a 
number of additional studies were published to challenge this theory. The supplementary 
studies contradict the original conclusions, which are believed to be the result of 
ascertainment bias, and describe a complex history of selection dominated mainly by 
positive selection, although temporally and spatially localized balancing selection (Hardy et 
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al. 2006) and/or weak purifying selection could not be excluded (Kreitman and Di Rienzo 
2004; Soldevila et al. 2005; Sot devila et al. 2006; Zan et al. 2006a). 
Evaluation of the genetic variability patterns present within and between a number 
of species of the subfamily Bovinae indicated the presence of strong purifying selection 
throughout the evolution of this subfamily (Seabury et al. 2004). Evidence for purifying 
selection was also found throughout ruminant evolution, with the exception of sheep and 
goats. The sheep PRPNP gene was shown to be under balancing selection while a relaxation 
of purifying selection was detected in goats (Slate 2005). 
The evolutionary history of the mammalian PrP gene seems to be controlled by 
purifying selection (Krakauer, Zanotto, and Pagel 1998), although the presence of other 
species-specific evolutionary processes has been demonstrated. The driving forces behind 
these alternative evolutionary scenarios, whether functional or disease-related, are still 
unknown. 
1.13 Scrapie and Disease Modulation 
Scrapie is the prion disease of sheep and goats; it is the most common of TSEs in terms of 
number of outbreaks and worldwide distribution. The disease is considered to occur 
worldwide and Australia and New Zealand are the only two countries which are officially 
classified as scrapie-free. It was also the first one to be recognised in veterinary medicine. Its 
occurrence has been linked to changes in sheep husbandry and breeding that were put into 
practice in the 18 th century. In 1936, researchers showed the transmissibility of scrapie to 
healthy sheep by intraocular administration of a homogenate of scrapie-infected sheep brain 
(Cuille and Chelle 1936). Since 2002, an obligatory active surveillance program based on 
large-scale testing of both slaughtered and fallen small ruminants has been implemented in 
the EU. This, together with the development of better PrP sc detection techniques, has 
resulted in the discovery of so-called atypical scrapie cases, which present unusual 
pathological and PrP sc molecular features. This has lead to the reclassification of scrapie 
cases into classical and atypical (Le Dur et al. 2005). 
The clinical symptoms of classical scrapie include nervousness, social withdrawal of 
the animal from the flock, uncoordinated movements, tremors and loss of wool and skin 
abrasions caused by scraping against inanimate objects as a result of pruritus. The disease 
has incubation periods on average ranging from two to five years and a clinical stage which 
usually lasts between 1 and 6 months (Parry 1962; Dickinson and Fraser 1972). Like other 
TSEs, scrapie is characterised by the deposition of PrPSC  in the central nervous and 
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lymphoreticular systems, by spongiosis of the grey matter neuropil and by the formation of 
intraneuronal vacuoles (Hadiow 1961). Despite sharing many of the features of CWD 
(described in detail in Sections 1.17 to 1.27), one of the unique features of scrapie is the 
substantial strain variation that has been identified by sub-passaging the infectious agent in 
mice and recording its effects on disease phenotypes (Bruce etal. 1991; Bruce etal. 2003). 
Variation in the scrapie incubation periods was first linked to different alleles of the 
Sip gene: sA and pA (Dickinson 1976). Studies of genetic linkage in mouse indicated that 
the prion gene could be congruent with the Sinc gene, which is the equivalent of the ovine 
Sip gene (Westaway et al. 1994a). Sheep scrapie resistance and susceptibility have been 
associated with polymorphisms, A136V, R154H and Q17IRIH, within the coding region of 
the prion gene (Goldmann et al. 1990; Goldmann et al. 1991a; Laplanche et al. 1993) (The 
polymorphisms are described by giving the ovine codon number flanked by the two amino 
acid variants, using the single letter code). A number of other SNPs are suspected of having 
some effect on disease: H143R, RI5IC, P168L, QI71K and N176K. However, their low 
frequencies make the investigation of possible modulatory effects difficult (Baylis and 
Goldmann 2004; Goldmann et al. 2006a). 
The first description of an association of SNPs with scrapie was shown in the 
Neuropathogenesis (NPU) Cheviot flock. NPU-Cheviot sheep homozygous or heterozygous 
for V136  are susceptible to peripheral challenge with SSBP/1 scrapie, while animals of the 
same flock homozygous for A 136 are highly resistant to this challenge (Goldmann et al. 
1991a). A similar genotype-disease association has been described for experimental and 
classical scrapie in American Cheviot (Maciulis et al. 1992), Swaledale (Hunter et al. 1993), 
lie de France, Romanov (Laplanche et al. 1993) Shetland, Halfbred and Bleu du Maine 
sheep (Hunter et al. 1994). However, disease modulation also appears to depend on allelic 
frequency and breed. For example, in the Suffolk breed, the V 136 variant is very rare and 
scrapie is associated with alanine homozygosity (Westaway et al. 1994c). However, not all 
Suffolk sheep homozygous for alanine are susceptible to disease: in the US, Suffolk sheep 
carrying the AA 136 QR171 and the AA 136 RR171 genotypes are not affected by the disease, 
which seems to be restricted to the AA 136 QQin  genotype (Westaway et al. 1994c). A similar 
modulatory effect was described in Lacaune sheep (Clouscard et al. 1995). Higher 
susceptibility to scrapie has also been described in QQI7I  sheep of the Cheviot, Flemish and 
Swifter breeds (Bossers et al. 1996); however in these animals homozygosity for glutamine 
was associated with the VA 136 genotype. Some breeds carry the 11171 allele and in this case 
too the modulatory effect of the allele is dependent on the breed and allelic frequency (Belt 
et al. 1995; Clouscard etal. 1995). 
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Seven of the twelve possible haplotypes obtainable from the SNPs at codon 136, 154 
and 171 have been observed: ARR, ARQ, VRQ, AHQ, ARH, AHR and VRR (Belt et al. 
1995; Kutzer, Pfeiffer, and Brenig 2002; Tkacikova et al. 2003). Here, the genotypes are 
described by giving the amino acid for each codon (136, 154 and 171) in turn, for each allele 
in turn. Of the identified genotypes, the most resistant is ARR/ARR (Baylis and Goldmann 
2004) and to date only one case of classical scrapie case has been detected in this particular 
genotype (Ikeda et al. 1995). In addition to this, a number of cases of atypical scrapie have 
been reported in ARR/ARR sheep (Buschmann et al. 2004; Orge et al. 2004; Le Dur et al. 
2005). Sheep with the ARR/ARR genotype can also be experimentally infected with BSE 
(Houston et al. 2003). The three most susceptible genotypes to classical scrapie are 
VRQIVRQ, ARHIVRQ and ARQ/VRQ (Belt etal. 1995; Clouscard et al. 1995; Hunter etal. 
1997b; Baylis et al. 2002; Baylis and Goldmann 2004). 
Goat scrapie is rare in the UK but relative common in countries like Cyprus, France 
and Italy. A number of goat polymorphisms have also been associated with scrapie 
modulation: 1142M, R143H and R154H (Goldmann et al. 1996; Billinis et al. 2002; Agrimi 
et al. 2003). 
Despite the strong association of PrP polymorphisms with the incidence of scrapie in 
sheep and goats (Goldmann et al. 1991 b; Baylis and Goldmann 2004), scrapie has been 
shown not to be a genetic TSE, as is found in humans: scrapie-associated PrP alleles are 
commonly found in sheep from Australia and New Zealand, which are scrapie-free countries 
(Hunter et al. 1997a; Hunter and Cairns 1998). This indicates that an additional factor is 
needed for scrapie development. This exogenous factor, presumably an infectious agent, is 
absent from unaffected flocks and from scrapie-free countries (Hunter et al. 1997a; Hunter 
and Cairns 1998). 
The National Scrapie Plan (NSP) in the UK aims at increasing the classical scrapie 
resistance by the selective breeding of sheep carrying scrapie-resistance genotypes (Atkinson 
2001). Analogous programs are currently being implemented in most EU countries as well as 
in the USA. However, the observation that genotypes resistant to classical scrapie are 
susceptible to the atypical form, challenges the effectiveness of these breeding programs (Le 
Dur et al. 2005). 
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1.14 BSE and PrP Genetics 
In contrast to the ovine and caprine genes, the FRNP gene of domestic cattle (Bos taurus) 
has been shown to be highly conserved and only two nonsynonymous polymorphisms have 
been identified to date (S154N and E21 1K) (Wopfner et al. 1999) (Richt J. A. unpublished 
observation). Despite the fact that these SNPs are not believed to have a modulatory role in 
disease, the identification of E21 1K in an American cattle diagnosed with the atypical H-
type BSE raises the possibility of the existence of genetic forms of atypical BSE: this SNP 
corresponds to the human E200K polymorphism, the most common cause of inherited 
human prion disease worldwide (Goldfarb et al. 1991; Mead 2006) (Richt J. A. unpublished 
observation). 
In addition to this, a strong association between two indel polymorphisms in the 
regulatory region of the bovine PR/VP gene and BSE have been detected. The alleles with 
deletions at both polymorphic sites were overrepresented in diseased animals (Sander et al. 
2004; Juling et al. 2006). These polymorphisms are believed to modulate PRNP expression 
and thus affect BSE incubation time and/or BSE susceptibility (Sander et al. 2004; 
Kashkevich et al. 2007). However, in US cattle, both indels lie within a high linkage 
disequilibrium region of 6.7 kb; due to this their alleles are strongly correlated with the 
alleles of 43 other polymorphisms raising the possibility that the two indels may not be 
directly involved in BSE susceptibility but that they may simply be linked to a modulatory 
polymorphism (Clawson et al. 2006). Despite the latter study, these data seem to indicate a 
genetic component, although marginal, in the host response to BSE. 
1.15 Human TSEs and PrP Genetics 
The familial forms of human TSEs, approximately 10-15% of all human prion diseases, are 
caused by specific mutations of the PR/VP gene (Prusiner 1998). Over 30 of these mutations 
have now been described and they include premature stop codons, nonsynonymous SNPs 
and insertions of octapeptide repeats (Mead 2006). Two non-synonymous polymorphisms 
have also been shown to have a modulatory effect on disease: M129V and E219K (Palmer et 
al. 1991; Shibuya et al. 1998). 
Codon 129 has disease susceptibility and phenotype modifying effects mall human 
prion diseases (Mead 2006). Homozygosity at this position predisposes to iatrogenic and 
sporadic CJD, (Collinge, Palmer, and Dryden 1991; Palmer etal. 1991) while heterozygosity 
seems to delay disease onset (Zeidler et al. 1997). Similar effects have been shown in 
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relation to the Kuru epidemic: as a result of high disease incidence and the protective effect 
of heterozygosity, survivors carry a strong signature of balancing selection linked to this 
position (Cervenakova et al. 1999; Lee et al. 2001; Mead et al. 2003) (Section 1.12). To 
date, all primary vCJD cases have occurred in individuals homozygous for methionine 
(Collinge et al. 1996; Ironside et a1 2006); despite this, studies in transgenic mice suggest 
that MV 129 and VV129 genotypes may simply result in prolonged incubation periods rather 
than resistance (Bishop et al. 2006). A genetic study of three probable cases of person to 
person vCJD transmission by blood transfusion revealed that one of the infected patients was 
heterozygous at codon 129 (Peden et al. 2004). Valine homozygous individuals have also 
been shown to be susceptible to vCJD: codon 129 analysis in DNA extracted from UK 
appendix samples that had tested positive for PrPSC  (Hilton et al. 2004) identified two of the 
samples as VV129 (Ironside etal. 2006). 
The modulatory effects of codon 219 have been described in Japan, where the 
M129V SNP has a low frequency (Furukawa et al. 1995; Shibuya et al. 1998); this SNP has 
also been detected in other populations of East Asia and of the Indian subcontinent, which 
share similar M129V frequency patterns with the Japanese population (Mead etal. 2003). 
Polymorphisms outside the coding region have also been associated with disease, 
indicating that mechanisms other than variation of the primary sequence can control disease 
susceptibility in humans (Mead et al. 2001; McCormack et al. 2002; Vollmert et al. 2006). 
1.16 Transgenic mouse models of TSEs 
Mice, like other members of the order Rodentia, are not naturally affected by TSEs. 
However, relatively low costs of maintenance, a short reproductive cycle and shorter disease 
incubation times have made mouse the leading model system for these diseases and mouse 
models have underpinned many of the major breakthroughs in the field of TSEs (Moore and 
Melton 1997; Prusiner 1999). 
A variety of transgenic models, have been developed over the years to study 
different aspects of TSEs and to try to unravel the nature of the infectious agent. Knockout 
studies led to the recognition of the essential role of PR/S/P in TSE development (Bueler et 
al. 1992) (Section 1.7 and 1.16) and the effects of PRNP dosage (Manson et al. 1994). 
Animals devoid of the PrP gene have been generated utilising different knockout strategies 
(Bueler et al. 1992; Manson et al. 1994; Sakaguchi et al. 1995). Several transgenic mouse 
lines encoding truncated or mutated forms of the PrP protein have been developed and used 
to analyse the role of PrP structure and SNPs on disease mechanisms and protein function 
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(Fischer et al. 1996; Muramoto et al. 1996; Manson et al. 1999; Flechsig et al. 2000; Bishop 
et al. 2006). Transgenic mice expressing PrP genes from other species have also been used 
for the investigation of species barrier (Scott etal. 1989; Telling et al. 1995). 
1.17 Chronic Wasting Disease 
Chronic wasting disease is a naturally occurring animal TSE that has been identified in four 
species of the family Cervidae: mule deer (Odocoileus hemionus) (Williams and Young 
1980), white-tailed deer (Odocoi!eus virginianus), wapiti (Cervus canadensis) (Williams and 
Young 1982) and Moose (A ices alces) (Baeten etal. 2007). Hybrid animals of mule deer and 
white-tailed deer have also been affected (Salman 2003). 
The first detected CWD case was in a subspecies of mule deer: black tailed deer 
(Odocoileus hemionus co!umbianus) (Williams and Young 1980). It was detected as a 
clinical syndrome of unknown aetiology at a wildlife research facility in Colorado in 1967 
and in 1978 it was finally diagnosed as a spongiform encephalopathy (Williams and Young 
1980). In the following years the disease was diagnosed in captive mule deer in Wyoming 
and soon after in wapiti. CWD remained limited to captive cervids until 1981, when it was 
detected in free-ranging wapiti in Colorado (Spraker et al. 1997). This made CWD the first 
TSE known to affect both captive and free-ranging populations (Table 2) (Williams and 
Young 1982). Since the 1980s the disease has been identified in two additional cervid 
species, white-tailed deer and moose. Table 1 provides a detailed timeline of the epidemic. 
To date, CWD has been detected in 14 American states, three Canadian provinces and in a 
number of imported wapiti in South Korea (Sohn et al. 2002; Kim et al. 2005). 
This disease, like all other TSEs, has received much more scientific, public and 
political attention after the BSE epidemic in cattle and the discovery of a possible link 
between BSE and human vCJID. 
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Table I - Timeline of the CWD Epidemic 
The data utilised for the table were obtained from the websites of the following organisations: 
Chronic Wasting Disease Alliance, Alberta Fish and Wildlife Division, Saskatchewan 
Environment and Resources, Colorado Division of Wildlife, Illinois Department of Natural 
Resources, Kansas Wildlife Department, Minnesota Department of Natural Resources, 
Montana Department of Fish, Wildlife and Parks, Nebraska Game and Parks Commission, 
New Mexico Department of Game and Fish, New York Division of Fish Wildlife and Marine 
Resources, Oklahoma Department of Wildlife Conservation, South Dakota Department of 
Game Fish and Parks, Utah Division of Wildlife Resources, West Virginia Division of Natural 





Detection of a clinical syndrome of unknown aetiology named Chronic Wasting 
Disease in a captive mule deer at a wildlife research facility in Colorado - 
1977 Diagnosis in captive mule deer in a zoo in Ontario 
1978 CWD diagnosed as a spongiform encephalopathy 
1979 Diagnosis in captive mute deer and black-tailed deer in Wyoming 
1979 Diagnosis in captive wapiti in Colorado and Wyoming 
1981 Diagnosis in a free-ranging wapiti in Colorado 
1985 Diagnosis in free-ranging mule deer and white-tailed deer in Colorado 
1986 Diagnosis in free-ranging wapiti in Wyoming 
1990 Diagnosis in free-ranging white-tailed deer and mule deer in Wyoming 
1996 Diagnosis in captive wapiti in Saskatchewan 
_1997 Diagnosis in captive wapiti in South Dakota 
_1997 Diagnosis in captive wapiti in Nebraska 
_1998 Diagnosis in captive wapiti in Oklahoma 
1999 Diagnosis in captive wapiti in Montana 
2000 Diagnosis in free-ranging mule deer in Nebraska 
2000 Diagnosis in free-ranging mute deer in Saskatchewan 
2001 Diagnosis in an wapiti exported from Canada to South Korea 
2001 Diagnosis in free-ranging white-tailed deer in South Dakota 
2001 Diagnosis in captive wapiti in Kansas 
2002 Diagnosis in a captive wapiti and white-tailed deer in Wisconsin 
2002 Diagnosis in captive white-tailed deer and wapiti in Alberta 
2002 Diagnosis in free-ranging wapiti in South Dakota 
2002 Diagnosis in free-ranging mule deer in New Mexico 
2002 Diagnosis in a captive wapiti in Minnesota 
2002 Diagnosis in a wild deer in Illinois 
2002 Diagnosis in captive mule deer and white-tailed deer in Nebraska 
2002 Diagnosis in a free-ranging white-tailed deer in Wisconsin 
2002 Diagnosis in a wild mule deer in Utah 
2002 Diagnosis in free-ranging white-tailed deer in Nebraska 
2003 Diagnosis in captive white-tailed deer in Minnesota 
2003 Diagnosis in free-ranging white-tailed deer in Saskatchewan 
2003 Diagnosis in free-ranging mule deer in South Dakota 
2005 Diagnosis in free-ranging wapiti in New Mexico 
2005 Diagnosis in captive and free-ranging white-tailed deer in New York State 
2005 Diagnosis in free-ranging mule deer in Alberta 
2005 Diagnosis in free-ranging white-tailed deer in West Virginia 
2005 Diagnosis in wapiti exported from Canada to Korea 
2006 Diagnosis in free-ranging white-tailed deer in Kansas 
2006 Diagnosis in a wild moose in Colorado 
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1.18 Origin of CWD 
The exact nature of the agent and its origin are still elusive but several hypotheses have been 
proposed. Spontaneous somatic mutations in the PrP gene could have resulted in the 
development of CWD in mule deer, with subsequent transmission to other susceptible 
cervids. Alternatively CWD could be caused by infection with an as yet unrecognised prion 
strain or it could be the result of a sheep scrapie strain that has adapted to cervids (Williams 
and Miller 2002). Similarities between the Prrsglycoform  patterns of scrapie-affected 
sheep and CWD affected cervids (Race et al. 2002), together with undistinguishable CNS 
disease patterns between scrapie challenged and naturally CWD-affected wapiti, seem to 
support the latter hypothesis. However, no PrP' was detected in the lymphoid organs of 
scrapie-infected wapiti (Hamir, Miller, and Cutlip 2004) and these two agents show 
significantly different incubation periods in challenged racoons (Hamir et al. 2003). Strain 
typing studies using wild-type inbred mice also showed distinct incubation-period and brain-
lesion profiles between the CWD, scrapie and BSE agents (Bruce et al. 1997). 
Miller and colleagues suggested, through surveillance data and epidemic modelling, 
that CWD may have been present in free-ranging cervid populations for two decades or more 
before being detected in the 1980s (Miller et al. 2000). 
1.19 Clinical Signs of CWD 
Information on clinical CWD is primarily obtained from observations of captive animals, 
mainly due to the difficulties associated with studying the disease in the wild. Consistent 
clinical signs of CWD in deer and wapiti are emaciation and behavioural changes. These 
include abnormal levels of interaction with other animals and handlers, listlessness, lowering 
of the head, drooping ears and repetitive walking in set patterns. As the disease develops, 
many animals (mainly deer) display polydipsia and polyuria. Other clinical signs, which 
occur in approximately 50-70% of affected cervids include teeth grinding and excessive 
salivation which results in drooling. The clinical disease is progressive and death is 
inevitable (Williams and Young 1982; Williams and Young 1992; Williams and Miller 
2002; Salman 2003; Williams and Miller 2003). In wapiti, the clinical stage of the disease 
tend to be more prolonged than in deer, with more subtle clinical signs (Williams and Miller 
2002). 
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Table 2 - CWD Epidemic 
The table below summarises the current state of the CWD epidemic. It gives details of the 
species and the states where the disease has been detected to date. The table also provides 
the status of the animals diagnosed with CWD: captive or free-ranging. Information was 
obtained from the same online sources described in Table 1. Wt-d = White-tailed deer. FR = 
Free ranging. 






Colorado (USA)  
Illinois (USA) 1 
Kansas (USA) 1 
Minnesota 
(USA) 
Montana (USA) I 
Nebraska 








(USA) 1 1 1 








1.20 CWD Incubation Times 
Most cases of CWD occur in adult animals, with the majority of CWD-affected animals 
being 3-5 years old. The disease usually incubates for 1.5 to 3 years before the appearance of 
clinical signs (Miller, Wild, and Williams 1998). The youngest naturally-infected animal 
showing clinical signs was approximately 17 month of age. However, late-stage disease 
(PrP °  in brainstem) has been noted in white-tailed deer at 8-10 months of age, establishing 
a minimum incubation period (O'Rourke et al. 2004). The clinical course of the disease 
varies from a few days to approximately a year, with most animals surviving from a few 
weeks to four months (Salman 2003). Maximum incubation times of naturally affected 
cervids are difficult to determine. However, the disease has been diagnosed in a wapiti older 
than 15 years of age (Williams and Miller 2002), a mule deer older than 12 years of age 
(Williams 2005) and in a white-tailed deer which was approximately 5 years old (O'Rourke 
et al. 2004). These three animals were housed in CWD endemic facilities with high 
prevalence of the disease which could indicate either late exposure to the CWD agent or 
prolonged incubation times (Williams 2005). 
1.21 CWD Prevalence 
It appears that CWD is transmitted efficiently, as high disease prevalence can be found in 
both captive and free-ranging populations in contrast to other human and animal TSEs. 
Between 1970 and 1981, approximately 90% of a captive population, which included mule 
deer and black-tailed deer, showed typical clinical features of CWD and died or were 
euthanased as a consequence of the disease (Williams and Young 1992). High disease 
prevalence has also been observed in white tailed deer: a study of 133 captive white-tailed 
deer from Nebraska detected PrP' ° in approximately 50% of the animals (O'Rourke et al. 
2004). Immunohistochemical analysis of tonsillar biopsies, which enables the identification 
of clinical and preclinical cases (Spraker et al. 2002b; Wild et al. 2002), detected PrP
cWD  in 
76% of mule deer and 80% of white-tailed deer from a CWD-endemic herd. Within 40 
months following the initial biopsies, PrPcwD was detected in the tonsils of an additional 
17% of the mule deer (Wild et al. 2002). Slightly lower levels of disease prevalence have 
been detected in wapiti. In a group of 17 wapiti slaughtered from a captive CWD-affected 
herd in 1998, 59% of the animals were found to be CWD positive by immunohistochemistry 
(Peters et al. 2000). A CWD incidence of 36% was estimated in captive wapiti from a 
wildlife research facility in Colorado between 1976 and 1985 (Miller, Wild, and Williams 
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1998). The surviving animals were subsequently culled to eradicate CWD and after a 
disinfection treatment the facility was repopulated with wapiti. However, CWD occurred 
again between 1986 and 1997 with an overall incidence of 17% (Miller, Wild, and Williams 
1998). 
CWD in free-ranging animals shows widely variable prevalence and ranges from 
less than 1% in white-tailed deer, mule deer and wapiti to approximately 30% in some local 
populations of white-tailed and mule deer (Williams 2005). 
1.22 CWD Transmission and Epidemiology 
Lateral transmission is considered the most important factor in the spread of the disease 
(Miller, Wild, and Williams 1998; Miller et al. 2000). Excessive salivation during the 
clinical phase (Williams and Young 1980) together with the identification of infectivity in 
the saliva of CWD infected deer, supports lateral transmission of the disease through 
shedding into the environment (Mathiason et al. 2006). Indirect transmission through 
environments contaminated by residual excreta or decomposed carcasses of CWD-infected 
animals has been reported experimentally for mule deer (Miller, Wild, and Williams 1998; 
Miller et al. 2004). The precise mechanisms of these indirect forms of transmission are not 
clear, but infection through foraging and soil consumption (as a source of minerals) is likely 
(Miller et al. 2004). In support of this, the ability of different soil types to absorb and retain 
PrPres, as well as infectivity, has also been reported (Johnson et al. 2006). These indirect 
transmission routes are a particular problem for captive populations although the social 
behaviour of deer and wapiti in the wild might enable these routes also to contribute to the 
spread of the disease in the free-ranging animals (Miller and Williams 2003). In addition to 
intraspecies transmission, the ability of CWD to naturally transmit between cervid species 
has been demonstrated (Williams and Miller 2002). Infectivity has also been identified in the 
blood of CWD infected deer but not in urine or faeces (Mathiason et aL 2006). On the basis 
of close taxonomic relationships, it is likely that other members of the family Cervidae could 
be susceptible to CWD if appropriately exposed (Williams 2005). 
Epidemiological studies of CWD do not support it being a feed-borne disease like 
BSE (Wilesmith 1988) and there is little evidence for the existence of maternal transmission 
(Miller, Wild, and Williams 1998; Miller and Williams 2003). In addition to this, PrPCD  has 
not been detected in placental tissues (Spraker et al. 2002a). 
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1.23 Cross-species Transmission of CWD 
The ability of CWD to infect other mammalian species has been demonstrated through 
experimental transmissions. CWD has been successfully transmitted intracerebrally from 
deer to squirrel monkeys (Marsh et al. 2005), mink, ferrets, goat, sheep (Williams and 
Young 1992; Williams 2004) mice (Bruce et al. 2003) and cattle (Hamir et al. 2005). Oral 
transmission of the CWD agent to cattle, like direct intracerebral transmission to Syrian 
golden hamster (Williams and Young 1992) and raccoon (Hamir et al. 2003), did not result 
in disease. The existence of a species barrier between cattle and cervids is also supported by 
low efficiency in vitro conversion of bovine PrPC  by cervid PrPTt)  (Raymond et al. 2000). 
Natural transmission of CWD to humans or other mammalian species has not been reported. 
This is despite direct or indirect contact of CWD-affected animals with a number of 
ruminant species: bighorn sheep, mouflon, pronghorn antelope, black-buck antelope, 
mountain and domestic goat, domestic cattle and domestic sheep (Williams and Young 1992; 
Gould et al. 2003). CWD surveillance studies have also been carried out on ruminant and 
cervid species throughout the world: cattle in Colorado (Gould et al. 2003), free-ranging 
cervids in Belgium and Germany (Schwaiger et al. 2004; Roels et al. 2005; Schettler et al. 
2006), caribou in Quebec (Lapointe et al. 2002) and Sika deer in Hokkaido (Kataoka et al. 
2005). CWD was not detected in any of these studies. 
The inability to transmit wapiti CWD to humanised transgenic mice (Kong et al. 
2005), together with the low efficiency of in vitro conversion of human PrPC  by cervid 
PrPC%\ (Raymond et al. 2000), demonstrates a substantial species barrier to the transmission 
of CWD to humans. In addition to this, zoonotic transmission of CWD has not yet been 
reported (Belay etal. 2001; Belay et al. 2004). 
1.24 CWD Pathogenesis 
The pathogenesis of CWD shares several similarities with other TSE, especially with 
scrapie. The pathogenesis of CWD consists of early accumulation of PrPCT)  in the lympho-
reticular system, including gut-associated lymphoid tissue (retropharyngeal lymph nodes, 
palatine tonsils, Peyer's patches, ileocaecal lymph nodes and mesenteric lymph nodes), 
followed by spongiform degeneration in the medulla oblongata, thalamus, hypothalamus and 
olfactory cortex (Williams and Young 1993; Sigurdson et al. 1999). PrPcWD  has been 
detected as early as 42 days p.i. in mule deer orally challenged with CWD (Sigurdson et al. 
1999). This early stage accumulation of PrP is similar to that seen in sheep infected with 
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classical scrapie (Sigurdson et al. 1999). 
The disease associated protein has also been detected in the spleen (Comoy et al. 
2002), the retina (Spraker et al. 2002a), the tongue, the kidneys, the lungs, the soft palate 
(Fox et al. 2006), the islets of Langerhans in the pancreas, the adrenal medulla and the 
pituitary gland (Sigurdson et al. 2001). CWD prions have also been detected in skeletal and 
cardiac muscles of CWD infected deer and wapiti (Angers et al. 2006; Fox et al. 2006; 
Jewell et al. 2006), thus raising the possibility of dietary exposure of carnivores and humans 
to the CWD agent through meat consumption. The presence of infectivity in skeletal muscle 
has also been demonstrated in other TSE models and natural disease. For example in mice 
experimentally infected with Me7 and Rocky Mountain Laboratory (RML) prion strains 
(Bosque et al. 2002). Deposition of disease associated prion protein has been detected in the 
muscle of experimentally and naturally scrapie-affected sheep (Andreoletti et al. 2004), as 
well as in hamster and mice experimentally infected with BSE and vCJD (Thomzig et al. 
2006) and in the striated muscle of sheep infected with BSE (Lezmi et al. 2006). Despite 
this, transmission studies to highly BSE-sensitive transgenic mice did not reveal the presence 
of infectivity in the skeletal muscle of BSE-affected cattle (Buschmann and Groschup 2005). 
1.25 Neuropathology of CWD 
The neuropathology of CWD does not differ between captive and free-ranging cervids 
(Spraker et al. 2002a), its main features are: intracytoplasmic neuronal vacuolation, 
spongiform change of the grey matter neuropil, amyloid plaques, astrocytic hypertrophy and 
hyperplasia (Bahmanyar et al. 1985; Guiroy et al. 1991; Guiroy et al. 1993a; Guiroy et al. 
1993b; Peters et al. 2000; Liberski et al. 2001). In mule deer and white-tailed deer, florid 
plaque-like structures have been detected (Guiroy et al. 1994). Florid plaques consist of an 
amyloid core surrounded by a corona of spongiform vacuoles and they are also one of the 
main characteristics of vCJD brain pathology (Ironside et al. 1996; Will et al. 1996); despite 
this similarity, vCJD and CWD differ in the patterns of PrPres  deposition (Liberski et al. 
2001; Williams 2003). 
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1.26 Cervid PrP Genetics 
The analysis of the PrP gene from the four cervid species affected by CWD is ongoing and to 
date no mutation has been linked to disease. A number of coding and non-coding 
polymorphisms have been identified. Coding polymorphisms in the CDS of mule deer 
(sequencing data have been published for over 430 animals) have been found at codons 20 
(D -* G), 96 (G - S), 116 (A -p G), and 225 (S -* F), while non-coding polymorphisms 
have been identified at codons 51 (cgc/cgt), 108 (ccalccg), 120 (gcc/gca), 128 (cttictc), 131 
(tac/tat), 139 (agg/aga), 146 (aac/aat), 156 (aac/aat), 185 (atc/att) 202 (acc/act), 206 (attlatc) 
and 247 (atc/att) (O'Rourke et al. 1998; Heaton etal. 2003; Jewell et al. 2005). 
In white-tailed deer (sequencing data have been published for over 930 animals) 
variability at the amino acid level is present at codons 20 (D -p G), 95 (Q -* H), 96 (G 
S), 116 (A -* G) and 226 (Q -+ K) (Raymond et al. 2000; Heaton et al. 2003; Johnson et al. 
2003b; Johnson et al. 2006) and silent changes were found at codons 51 (cgc/cgt), 81 
(ggtlgga), 108 (cca/ccg), 139 (agg/aga), 146 (aac/aat), 156 (aac/aat), 185 (atH), 202 (acc/act) 
(Raymond et al. 2000; Heaton etal. 2003; O'Rourke etal. 2004). 
The PrP ORF has been sequenced for three subspecies of moose for a total of 44 
animals (Alces alces shirasi, A ices alces aices and A ices alces gigas) but only low levels of 
variability have been identified: two synonymous polymorphisms at codon 63 (ccc/cct) and 
codon 246 (cta/ctc) and a nonsynonymous SNP at codon 209 (M - I) (Huson and Happ 
2006). 
The open reading frame of the wapiti (sequencing data have been published for 
approximately 400 animals) PrP gene displays low levels of polymorphism and only four 
SNPs have been identified to date: three silent polymorphisms at codons 21 (gtc/gtt), 104 
(aaa/aag) and 246 (ctc/ctg) and one coding polymorphism at codon 132 (M -* L) (O'Rourke 
etal. 1998; ORourke et al. 1999; Raymond etal. 2000). 
Although still considered CWD-free, due to its very close taxonomic relationship 
with wapiti (Section 27), the genetic variability of the European red deer CDS has also been 
investigated; sequencing data are available for just over 100 animals. Nonsynonymous 
polymorphisms have been detected at codons 59 (G -+ S), 98 (T -+ A), 208 (M -* A) and 
226 (E -+ Q) while synonymous SNPs have been found at codons 21 (gtB), 78 (cag/caa), 79 
(ccc/cct) and 136 (gcc/gct). The majority of these animals originated from free-ranging 
Italian populations (Kaluz, Kaluzova, and Flint 1997; Peletto etal. 2005). 
PRNP sequences are available for a number cervid species which are currently also 
considered CWD-free (Table 3). Several SNPs have been identified in these species: codons 
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2 (gtg/atg), 128 (ctc/ctt), 129 (0 - S), 138 (S -+ N), 146 (aac/at) and 169 (V -+ M) in 
Rangfer tarandus and codons 21 (gtB) 79 (ccc/cct), 85 (gga/ggg), 100 (S -* G), 136 
(gcc/gct) and 226 (E -+ Q) in Cervus Nippon. 
Table 3 - Cervid PrP Sequences 
PrP sequences, of cervid species currently considered TSE free, available on the NCBI 
nucleotide database. 
Common GenBank Accession no. 
Subfamily Species Subspecies Name or Reference 
Corvus dama N/A Fallow deer AY286007, AY639094 
Y09761, AY679697 





Ceivus N/A Sika deer AY679696, DQ358970, 
nippon EF057409, (Kataoka et al. 
2005) 
Ce,vus dybowskii Dybowski's sika AF1 13941 
nippon deer 
Hydropotinae Hydropotes inermis argyropus 
Korean Water 
Deer DQ358969 
Muntiacinae Muntiacus N/A Indian muntjac AF113944 
muntjak 
Capreolus N/A Western roe AY639096, AY769955 capreolus deer 
Capreolinae DQ154292, DQ154293, 
Rangifer granti Barrenground DQ154294, DQ154295, 
tarandus caribou DQ1 54296, AY639093, 
AY769956 
1.27 The role of Genetics in CWD 
Genetic susceptibility to natural disease is estimated by comparing the proportion of affected 
and unaffected animals in relation to their genotype. This model assumes uniform exposure 
of the population to the prion agent. A statistical significant difference in the frequency of 
the PrP genotypes between CWD, vE and CWfl1. white-tailed deer has been found in both 
captive (O'Rourke et al. 2004) and free-ranging populations (Johnson et al. 2006). The data 
suggested that polymorphisms at codons Q95H and 096S reduced the likelihood of 
infection: animals homozygous or heterozygous for serine at codon 96 and animals 
heterozygous at codon 95 were underrepresented in CWD +VE populations (Johnson et al. 
2003a; O'Rourke et al. 2004; Johnson et al. 2006). This was also supported by 
immunohistochemical scoring which showed that the S 96 allele is associated with slower 
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disease progression (Aiken et al. 2005; Johnson et al. 2006). In vitro conversion studies do 
not seem to support the modulatory action of codon 96 by showing that G96 and S96 PrPC  are 
converted by PrPcwD into PrPres  with similar efficiencies (Raymond et al. 2000). However, 
such studies assume that dose, strain of the agent and route of infection do not affect the 
mechanism of PrPres  formation (Johnson etal. 2006). 
Mule deer CWD was also shown to have a genetic component; heterozygosity at 
codon 225 (S -p F) was underrepresented in CWD +ve animals both in Wyoming and 
Colorado (Jewell et al. 2005; Williams 2005). The protective effect of heterozygosity was 
also supported by prolonged incubation times and slower PrP cWD  deposition in orally 
challenged 5225F captive mule deer (Jewell et al. 2005; Fox et al. 2006). 
Wapiti codon 132 (human codon 129) has been linked to CWD-susceptibility: animals 
homozygous for methionine at codon 132 have been shown to be over-represented in both 
free-ranging and farmed CWD-affected wapiti, when compared to healthy control groups, 
suggesting that homozygosity for methionine at this position predisposes wapiti to CWD 
(Table 17) (O'Rourke et al. 1999; Balachandran et al. 2002; Spraker et al. 2004a). However, 
even for codon 132, none of the genotypes seem to confer resistance to CWD (Spraker et aL 
2004a). 
1.28 Cervus elaphus and Cervus canadensis 
Deer can be divided into two distinct groups; the new world and old world deer. Old world 
deer include the subfamilies Muntiacinae and Cervinae, while new world deer include the 
subfamilies Hydropotinae and Capreolinae. The fossil record indicates that old world deer 
originated in the mid Tertiary period in Eurasia (Miyamoto, Kraus, and Ryder 1990) and 
radiated repeatedly from tropical into cold climates during the Pleistocene. 
The red deer (Cervus elaphus) is a member of the subfamily Cervinae and is 
considered to have evolved from a sika deer-like ancestor in Asia over a million years before 
present (b.p.) as suggested by remains from the Cape Deceit fauna of Alaska (Guthrie 1966). 
The fossil record indicates that C. elaphus entered Europe between 0.7 and 0.55 million 
years b.p. during the Middle Pleistocene, when cold-adapted Asian fauna replaced warm-
adapted European fauna after cold climate conditions around 700,000 years b.p. (Geist 
1999). 
In North America the red deer is called elk, which is a source of confusion as in 
Europe the name elk is used for A ices alces or what in America is defined as moose. In 1806 
the naturalist Benjamin S. Barton proposed the name wapiti for the American red deer, 
27 
which is a word from the language of the Shawnee meaning "white rump" or "white deer" 
(Geist 1999). Red deer from Eurasia colonised North America via Beringia, a land bridge 
which joined present-day Alaska and eastern Siberia at various stages of the Pleistocene and 
gave rise to wapiti. The fossil record indicates that the first wapiti appeared in the open 
steppes of Pleistocene Beringia between 0.6 and 0.4 million years b.p., during the Günz 
glacial period (Polziehn and Strobeck 2002) while it colonised North America during the 
Illinoian glacial period (0.26-0.15 million years b.p.)(Guthrie 1966). 
Currently there is still disagreement on whether red deer and wapiti should be 
considered as two independent species. Despite differing morphologically and behaviourally, 
fertile hybrids have been obtained in captivity from crosses between these two populations. 
However, hybrid populations have not been sustainable in the wild, with the exception of 
areas devoid of predators and severe climatic conditions (Geist 1999). Recently, molecular 
studies comparing allozymes and mitochondrial DNA supported the recognition of wapiti as 
a separate species: C. canadensis (Polziehn and Strobeck 1998; Polziehn and Strobeck 2002; 
Ludt et al. 2004; Pitra et al. 2004). 
1.29 Porphobilinogen Deaminase (PBGD) 
The housekeeping gene porphobilinogen deaminase was selected as a reference locus for the 
population genetics study (Chapter 5) to determine the possible effects of demography on the 
neutrality tests. 
PBGD is the third enzyme of the haem-biosynthesis pathway. This cytosolic enzyme 
catalyses the polymerization of four molecules of porphobilinogen into 
preuroporphyrinogen. Haem is synthesized in all human cells but around 85% of it is 
produced in erythroid cells for the formation of haemoglobin (Kauppinen 2005). The human 
PBGD gene is a pseudogene-free (Janssens et aL 2004) single-copy gene that comprises 15 
exons encoded within a 10 kb region of the long arm of chromosome 11; the coding region 
of this locus is 1.3 kb in size. The PBGD gene is under the control of two independent 
promoters, which results in the formation of two isoforms of this enzyme through alternative 
splicing of exons 1 and 2 (Desnick et al. 1985; Raich et al. 1986; Grandchamp et al. 1987; 
Lee et al. 1991). One of the two isoforms is expressed in all cells (housekeeping) while the 
other is only found in erythroid cells. The former is encoded by an mRNA containing exons 
1 and 3-15 while the latter, which is expressed during erythroid differentiation, is encoded by 
exons 2-15 (Chretien etal. 1988). 
Mutations in the PBGD gene lead to an autosomal dominant condition termed acute 
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intermittent porphyria (AlP). To date, over 100 mutations have been identified in the PBGD 
gene of Al? patients (Deybach and Puy 1995; Kauppinen et al. 1995; Grandchamp 1998). 
The nucleotide sequences encoding the PBGD enzyme of nine mammalian species, 
including Homo sapiens, Bos taurus and Mus misculus but excluding C. elaphus and C. 
canadensis are available from online databases. 
1.30 Population Genetics 
Adaptive pressures on coding and non-coding genomic regions shape nucleotide variation 
and leave characteristic signatures in the DNA. The study of these patterns provides an 
insight into the evolutionary history of the different genomic areas and enables the 
interpretation and understanding of the evolutionary forces governing them. The presence of 
selection can be identified by applying statistical tests to the patterns of sequence variation. 
Most of the tests available are based on the variability patterns predicted by the neutral 
theory of molecular evolution: this theory states that the majority of DNA variation observed 
within and between species is due to random fixation (random drift) of selectively neutral 
mutations rather than natural selection (Kimura 1983). Different tests utilize different 
information carried by intraspecific and interspecific variation or combinations of the two, 
but despite this, all neutrality tests use the neutral theory as null hypothesis. The detection of 
genetic patterns which differ significantly from neutral expectations is seen as an indication 
for the possible presence of selection (Nielsen 2001). All these neutrality tests have been 
widely reviewed (Ludwig etal. 2000; Nielsen 2001) and the one implemented as part of this 
thesis are described in Chapter 2. 
One of the main possible disadvantages of these tests is the violation of the 
assumptions that they are based on. This can have a significant effect on the outcome of the 
analysis and result in both type I and type II errors. Demographic and population factors can 
have major effects on the patterns of variability thus complicating the interpretation of the 
statistical analysis (Beaumont and Nichols 1996; Nielsen 2001). However, selection and 
demography can be distinguished by the genomic range of their effect: while selection only 
targets a specific gene/codon, demography produces a genome-wide skew (Beaumont and 
Nichols 1996). As a result of this, the analysis and comparison of variability patterns from a 
number of different genomic loci tends to improve the reliability of the analysis. 
To date, many of the studies aimed at understanding the genetic variability of 
genomic loci and the evolutionary forces shaping them have concentrated on species with 
well-characterized genomes such as Drosophila species and humans (Wall, Andolfatto, and 
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Przeworski 2002; Glinka et al. 2003; Stajich and Hahn 2005). In the order Artiodactyla, most 
of the studies carried out focussed on livestock populations and more precisely on genes 
known or believed to be involved in agriculturally important traits. Examples of the latter 
studies include: the casein genes in goats (Mathiason et al. 2006), which are involved milk 
production traits (Recio et al. 1997; Martin et al. 2002); the growth hormone releasing 
hormone (GHRH) in Korean cattle (Cheong et al. 2006) and the myostatin (MSTN) gene in 
goat and sheep (Li et al. 2006b), which have both been associated with carcass traits 
(Cheong et al. 2006); the chemokine interleukin-8 receptor gene (CXCR2) in cattle, which is 
believed to be potentially involved in immune function and disease resistance (Youngerman, 
Saxton, and Pighetti 2004), -defensins in the subfamily Caprinae, which encode 
antimicrobial peptides (Luenser, Fickel, and Ludwig 2005; Luenser and Ludwig 2005). Low 
levels of genetic variability, high levels of linkage disequilibrium (LD) and reduced 
recombination were observed in caprine casein genes (Hayes et al. 2006). Low levels of 
genetic variability were also in the GHRI-I gene in cattle (Cheong et al. 2006) and in the 
MSTN gene in goats and sheep (Li et al. 2006b). 
Selection was detected in a number of these sites. In the family Caprinae, both 
positively as well as negatively selected -defensin genes were identified and to date, the 
signature of positive selection has also been detected in a- and f3- defensins of other 
mammalian species (Hughes 1999; Luenser, Fickel, and Ludwig 2005; Luenser and Ludwig 
2005). The amino acid sites under positive selection within the mammalian a-defensin genes 
have also been identified using a maximum-likelihood approach (Lynn et al. 2004). These 
studies highlight the different variability patterns detectable in different genomic areas and 
the adaptive pressures shaping them. However, some of them also illustrate the difficulties 
related to the study of populations that have been subjected to high levels of selective 
breeding, since the influence of demography in these populations can be very high. 
The genetic variability of the interferon gamma (IFNg), the macrophage protein 
(NRAMP) and the major histocompatibility complex (MIHC) DRB genes of wild sheep (Ovis 
da!!i), which are involved in immune response, have also been investigated (Worley et aL 
2006). While, the DRB locus was highly polymorphic, the other two genes were highly 
conserved. No evidence of selection was found for IFNG and NRAMP genes. The presence 
of balancing selection has been identified in the MHC gene of Ovis canadensis (Gutierrez-
Espeleta et al. 2001) and it is also suggested to be present in the M1-IC-DRB locus of Ovis 
dalli (Worley et al. 2006). 
The information currently available on the genetic variability of natural populations 
of Artiodactyl species and the possible differences in genetic and selective patterns between 
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wild and farmed populations are very low. 
1.31 Aims of the Thesis 
Despite an increasing body of data suggesting that the PrP gene has been under strong 
selective constraint throughout the mammalian evolutionary history, a number of studies 
have now suggested the presence of species-specific evolutionary processes. One of the aims 
of this thesis was to investigate the selective forces acting on coding and non-coding areas of 
the cervid PrP gene, through the analysis of the PRNP genetic variability in Cervus elaphus 
and Cervus canadensis. This project also aimed at exploring the possible influence of CWD 
on the evolutionary forces shaping the genetics of PRNP in wapiti through the analysis of 
CWD+VE and CWD VE  samples. 
The ability of polymorphism M132L to modulate CWD in wapiti was suggested in a 
genotyping study by O'Rourke and colleagues in 1999. This result was of particular interest 
due to the fact that variation at the corresponding position in humans has disease 
susceptibility and phenotype modifying effects in all human TSEs. However, this study only 
analysed a low number of CWD+VE samples and focussed on a single CWD-affected wild 
population. Part of this thesis aimed at further investigating the CWD modulatory role of 
wapiti codon 132 in wild populations through the analysis of the codon 132 genotypic 
patterns in CWD +VE and CWD VE animals. 
The current knowledge of the genetic diversity of autosomal genes of nonmodel 
mammalian species is still limited. A further objective was to increase the understanding of 
the genetic diversity of autosomal mammalian genes through the analysis of the fine-scale 
genetic variability of the PrP and PBGD genes in C. canadensis and C. elaphus populations. 
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Chapter II: Materials and Methods 
This chapter describes the origin of the samples analysed, the experimental techniques 
implemented during the laboratory stage and the statistical methods and software packages 
utilised for the analysis of the genetic variability. 
2.1 Samples 
Extracted DNA from fifty red deer samples from the Isle of Rum, were obtained from Prof. 
J. M. Pemberton (hstitute of Evolutionary Biology - Edinburgh University). The Isle of 
Rum is a 10,600 ha island situated 20 km off the West coast of Scotland and it is a nature 
reserve owned and run by Scottish Natural Heritage. The samples were collected in the 
North Block study area of the island; red deer in this area have been the subject of intensive 
study since 1973, when the population was released from culling (Clutton-Brock 1982). 
Wapiti DNA samples, 171 in total, were received from Dr. M. Miller (Colorado 
Division of Wildlife - Wildlife Research Center) and included 47 confirmed CWD +VE and 
124 confirmed CWD13 samples. The wapiti samples were collected in three Data Analysis 
Units (DAUs). These are geographic areas where a particular herd resides; each unit 
encompasses a herd's entire range throughout the year and is specific to a single wapiti 
population. DAUs are used by the Colorado Division of Wildlife to manage wildlife 
populations on a local biological unit basis. DAUs are divided into Game Management 
Units (GMUs); these are administrative units established for management purposes, which 
are based on road and county boundaries and are used to distribute hunting pressure (Conner 
and Miller 2004; Miller and Conner 2005). 
The wapiti samples were collected in nine different GMUs located within the 3 
different DAUs (E6, E8 and E9): GMU 11, 12, 13,23,24 and 231 are part of E-8, GMIU 18 
and 181 are part of E-8 and GMU 20 is part of E-9. The exact location of the DAUs is shown 
in Figure 2. 
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Figure 2 - Wapiti DAUs 
The samples genotyped in this study were obtained from E6, E8 and E9, highlighted below. 
CWD has been found in 11 out of 46 wapiti DAUs of Colorado between 2003 and 2005. 
Among the three studied DAUs, E-9 had the highest CWD prevalence estimate with 1 .7% 
(95% confidence interval = 0.9% - 2.5%). This was followed by E-8 with a prevalence 
estimate of 1.2% (0.4% - 2.1%) and E-6 with an estimated prevalence of 0.3% (0.1% - 0.4%) 
(Miller, M. W., 2006. Personal communication). 
A number of additional mammalian blood and DNA samples were also analysed. 
these were obtained by Dr. W. Goldmann in 2002 from three different sources. Table 4 
summarizes the species that were analysed and the source of the samples. A number of DNA 
extractions had to be carried out for the caribou blood sample and yak blood sample; the 
sample preparations remained individually identifiable during the experiments. 
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Table 4 - Mammalian Samples 
Mammalian samples obtained from Dr. W. Goldmann (Neuropathogenesis Unit), D. Gotelli 
(London Zoo - LZ) and Dr. H. W. Reid (originally Whipsnade Zoo - WS). 




Bison bonasus European bison 1 WS 
Bos frontalis Gaur 1 LZ 
Bos grunniens Yak 1 LZ 
Caprahircus Goat 1 NPU 
Gaze/Ia thomsonhi Thomson's gazelle 1 LZ 
Kobus ellipsiprymnus Waterbuck 1 LZ 
Ran gifer farandus Caribou 1 LZ 
Tragelaphus angasii Nyala 2 WS 
Tragelaphus angasii Nyala 1 LZ 
2.2 General Chemicals and Solutions 
All solutions for the experiments described in this thesis were prepared with high quality 
chemicals and water obtained from a Milli-QUF system (Millipore, UK). Water and 
solutions were sterilised by autoclaving when necessary. Reagents from commercial 
suppliers were used as supplied or diluted in sterile dH 20. 
2.3 Incubations 
Incubations were carried out on: 
Hot block = Dri-Block' DB-3 (with thermometer monitoring) - Techne (UK) 
. Incubator shaker = Series 25, Incubator Shaker - New Brunswick Scientific (USA) 
. Oven = Economy Incubator, Size 1 - Gallenkamp (UK) 
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2.4 Centrifuges 
• GS-6R Centrifuge (Bechman Coulter, USA) (abbreviated as GS-6R) 
• Micro Centaur (MSE, UK) (abbreviated as Microfuge) 
• Centrifuge 5417C (Eppendorf, Germany) (abbreviated as Eppendorf) 
2.5 DNA Extraction 
The DNA from the ruminant samples listed in Table 4 was extracted from 1001il aliquots of 
blood using the NucleonTM BACC2 genomic DNA extraction kit (Amersham Biosciences, 
UK). The only modification to the manufacturer's protocol was the omission of the 
Nucleon® resin in the DNA extraction step. Some of the blood samples were coagulated and 
for this reason these samples were subjected to a tissue extraction protocol. A volume of 
clotted blood which was considered equivalent to 100j.tl of uncoagulated blood was 
incubated overnight at 37°C on a hot block (Section 2.3) with 200pi of Proteinase K (Qiagen, 
Germany) and 400 jil of a 1:1 solution of Dutbecco's Phosphate Buffered Saline (GibcoTM, 
UK) and Lysis buffer (Applied Biosystems, USA). After enzyme digestion, the samples were 
subjected to two phenollchloroform extractions to separate the DNA from the proteinaceous 
component of the samples. This was achieved by the addition of 400 jd of each reagent and a 
subsequent centrifugation at 14,000rpm (20,800rcf - Eppendorf) for three minutes. The 
aqueous (DNA-containing) upper phase was then transferred to another tube while the lower 
phases were discarded. This step was repeated. Then, chloroform alone was added and a 
final centrifugation was carried out at 14,000rpm (20,800rcf - Eppendorf) for three minutes. 
The aqueous phase obtained from the last centrifugation step (-550ji1) was combined with 
55tl of 3M NaAc (pH 7.0) and 750111 of cold 100% ethanol. The resulting solution was 
vortexed and placed at -20°C for at least 30 minutes. The solution was then centrifuged at 
14,000rpm (20,800rcf - Eppendorf) for 10 minutes. The supernatant was then discarded and 
imI of cold 75% ethanol (Appendix 1) was added, the resulting solution was mixed gently 
and centrifuged at 14,000rpm (20,800rcf - Eppendort) for 5 minutes. The supernatant was 
discarded and after drying the pellet was re-suspended in 100 j.tl of sterile dH 20. All the DNA 
samples received from the Colorado Wildlife Research Center were obtained using the 
DNeasy Tissue Kit (Qiagen, Germany). The manufacturer's instructions were followed. The 
extracted DNA was then treated with phenol and chloroform and then precipitated using 
ethanol. The phenol treatment was aimed at the inactivation of the CWD infectious agent 
(Hunter et al. 1969; Kimberlin 1976; Prusiner 1982). The red deer DNA samples obtained 
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from Prof. J. M. Pemberton were produced using both the GenomicPrepTM Cells and Tissue 
DNA Isolation Kit (Amersham Biosciences, UK) and the DNAce Spin Tissue Mini Kit 
(Bioline, UK). 
2.6 Polymerase Chain Reaction (PCR) 
The target region of the prion gene (Figure 3) was amplified using the polymerase chain 
reaction (Sambrook and Russell 2001). In the sheep PRNP gene, the target area is flanked by 
two repetitive elements; LINE2a (Long interspersed nuclear element) and BovB (LINE-like 
element specific to ruminants) (Lee et al. 1998). The PCR and sequencing oligonucleotides 
designed for this thesis were based on conserved areas identified by the comparison of the 
PRNP gene of a number of mammalian species. The target region of most of the red deer and 
all the wapiti samples was amplified using oligonucleotides MP-574d and MP+690u (Table 
6; Figure 3), which resulted in a 2067bp PCR fragment. Some of the C. elaphus samples 
were amplified using MP-540d and MP+690u (Table 6; Figure 3); in this case the size of the 
PCR amplicon was 203 2bp. None of the identified variants (Chapter 3) were located in this 
missing 34bp. However, the possible presence of rare polymorphisms in this sequence 
cannot be excluded. A smaller fragment of the target region (1317bp) was amplified using 
oligonucleotides MP-540d and MP252u (Table 6; Figure 3) and it was utilised for the codon 
132 genotyping study (Chapter 4). 
The target area of the PBGD gene (Figure 3) included exons LX to XIV and a section of 
the 3 'UTR as well as the introns separating the six exons. The length of the PCR amplicon 
was 1840bp for both wapiti and red deer and it was obtained using oligonucleotides PBGD-
I-viii-ld and Cattle-Intergenic, which were based on cattle genome sequence (Table 6; 
Figure 3). 
During the optimisation of the PCR reaction, different reagent concentrations as well as 
temperature and time settings were tested to obtain the optimal amplification level. All the 
PCR reactions were carried out on a Thermo Flybaid Touchdown PCR Thermocycler 
(Thermo Electron Corporation, USA). The PCR mixture, used for both the red deer and the 
wapiti samples, contained 5j.tl of Qiagen PCR buffer (Qiagen, Germany), 0.5j.tl recombinant 
Taq DNA polymerase (2.5 units - Qiagen, Germany), 1,ii of 10mM dNTPs (final 
concentration = 200tM - Roche, Switzerland), 0.2jtl of each oligonucleotide primer (final 
concentration = 0.4 jiM - Sigma Genosys, UK), 2Ltl  of MgCl2 (final concentration = 2.5mM 
- Qiagen, Germany) and 21i of extracted DNA. For more information on the 
oligonucleotides see Table 6 and Figure 3. This solution was diluted to a final volume of 
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50pi with sterile dI-1 20. 
Reactions with no DNA template were used as negative controls. Initially, ovine samples 
which had been previously sequenced by a member of the sheep genetics group were used as 
positive controls, while red deer and wapiti samples were used as positive controls after 
successful amplification was obtained. Throughout this thesis, when programs or reagents 
different from the one listed below were used, a description of such differences is given. 
Different oligonucleotide primers had to be used for the optimal amplification of the two 
target regions; the location of these oligos can be found in Figure 3 while the main 
characteristics of the oligonucleotides are listed in Table 6. 
2.6.1 	Program-A 
Program-A, experimentally defined as program-5, was designed for the amplification of the 
target area of the wapiti PrP gene using PCR primers MP-574d and MP+690u Figure 3. This 
program was also used for the amplification of the smaller PCR amplicon used for 
genotyping codon 132. 
Si: 2 minutes at 94°C (RAMP 2)! 1'/2 minutes at 66°C (R-2) / 2'/z minutes at 72°C (R-l) -2 cycles 
1 minute at 94°C (RAMP 2) / 1Y2 minutes at 65°C (R-2) / 2V2 minutes at 72°C (R-l) -2 cycles 
1 minute at 94°C (RAMP2) / 1V2 minutes at 64°C (R-2) / 2V2 minutes at 72°C (R-1) - 2 cycles 
1 minute at 94°C (RAMP 2)! 1'/2 minutes at 63°C (R-2)/ 2Y2 minutes at 72°C (R-1) -2 cycles 
1 minute at 94°C (RAMP 2) / I V2 minutes at 62°C (R-2) / 2Y2 minutes at 72°C (R-1) - 2 cycles 
1 minute at 94°C (RAMP 2)! 1Y2 minutes at 61°C (R-2)/ 2V2 minutes at 72°C (R-l) -2 cycles 
1 minute at 94°C (RAMP 2) / 1'/2 minutes at 60°C (R-2) / 2V2 minutes at 72°C (R-1) -2 cycles 
1 minute at 94°C (RAMP 2) / 1% minutes at 59°C (R-2) / 2Y2 minutes at 72°C (R-1) -26 cycles 
10 minutes at 72°C (RAMP 1) 
SlO: Hold at 4°C 
2.6.2 	Program-B 
Program-B, experimentally defined as program-6, was designed for the amplification of the 
target area of the red deer PrP gene using PCR primers MP-540d or MP-574d and MP+690u 
(Figure 3): 
51: 15 minutes at 95°C (RAMP 2) 
1 minute at 94°C (RAMP 2) / 1V2 minutes at 62°C (R-2)/ 2'/2 minutes at 72°C (R-l) -40 cycles 
10 minutes at 72°C (RAMP 2) 
Hold at 4°C 
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2.6.3 	Program-C 
Program-C, experimentally defined as program-7, was designed for the amplification of the 
target area of the wapiti PBGD gene (Figure 3) using PCR primers PBGD-I-viii-ld and 
Cattle-Intergenic: 
Si: 2 minutes at 94°C (RAMP 2) / 1¼ minutes at 66°C (R-2) / 2¼ minutes at 72°C (R-1) - 3 cycles 
1 minute at 94°C (RAMP 2) / 1¼ minutes at 65°C (R-2) / 21"2 minutes at 72°C (R-l) - 3 cycles 
1 minute at 94°C (RAMP2)/ 1¼ minutes at 64°C (R-2)/ 2¼ minutes at 72°C (R-l) -3 cycles 
1 minute at 94°C (RAMP 2)! 1¼ minutes at 63°C (R-2)/2Y2 minutes at 72°C (R-1) -3 cycles 
1 minute at 94°C (RAMP 2) / 1¼ minutes at 62°C (R-2)/ 2'/2 minutes at 72°C (R-1) - 3 cycles 
1 minute at 94°C (RAMP 2) / 1¼ minutes at 61°C (R-2) / 2¼ minutes at 72°C (R-1) - 3 cycles 
1 minute at 94°C (RAMP 2) / 1'/2 minutes at 60°C (R-2) / 2¼ minutes at 72°C (R-1) - 3 cycles 
1 minute at 94°C (RAMP 2) / 1¼ minutes at 59°C (R-2) / 2¼ minutes at 72°C (R-l) - 19 cycles 
10 minutes at 72°C (RAMP 1) 
SiO: Hold at 4°C 
2.6.4 	Program-D 
Program-D, experimentally defined as program- 1, was designed for the amplification of the 
target area of the red deer PBGD gene (Figure 3) using PCR primers PBGD-I-viii-ld and 
Cattle-Intergenic: 
Si: 2 minutes at 94°C (RAMP 2) / 1¼ minutes at 66°C (R-2) / 2¼ minutes at 72°C (R-1) - 5 cycles 
1 minute at 94°C (RAMP 2)! 1¼ minutes at 65°C (R-2) / 2¼ minutes at 72°C (R-l) - 5 cycles 
1 minute at 94°C (RAMP 2) / 1Y2 minutes at 64°C (R-2) / 2'/2 minutes at 72°C (R-1) -4 cycles 
1 minute at 94°C (RAMP 2)! 1¼ minutes at 63°C (R-2) / 2 1/2 minutes at 72°C (R-1) - 3 cycles 
1 minute at 94°C (RAMP 2) / 1¼ minutes at 62°C (R-2) / 2¼ minutes at 72°C (R-l) -3 cycles 
1 minute at 94°C (RAMP 2) / 1¼ minutes at 61°C (R-2) / 2¼ minutes at 72°C (R-l) - 3 cycles 
1 minute at 94°C (RAMP 2) / 1'/2 minutes at 60°C (R-2) / 2¼ minutes at 72°C (R-l) - 3 cycles 
1 minute at 94°C (RAMP 2) / 1¼ minutes at 59°C (R-2) /2¼ minutes at 72°C (R-l) - 14 cycles 
10 minutes at 72°C (RAMP 1) 
SlO: Hold at4°C 
The target regions of the goat PBGD and PrP gene were amplified using Program-C (PBGD-
I-viii-ld and Cattle-Intergenic) and Program-A (MP-540d - MP+690u), respectively. For the 





Program-E, experimentally defined as program-9, was designed for the amplification of the 
target area of the red deer PrP gene (Figure 3): 
Si: 1 1/2 minutes at 92°C (RAMP 2)/I V2 minutes at 62°C (R-2)/ 1 V2 minutes at 70°C (R-1) - 30 cycles 
S2: Hold at 4°C 
Figure 3 - Target Regions 
A) The PrP target region was approximately 2.07 kb in length although the consensus 
sequences obtained from the sequencing of both wapiti and red deer loci were slightly 
smaller due to the primers used for PCR amplification and sequencing. The PCR 
oligonucleotides used for the amplification of the red deer and wapiti target region are 
represented by the black arrows. The red arrows indicate the location of the PCR 
oligonucleotides used to generate the fragment utilised for the genotyping of codon 132 in C. 
canadensis. Oligonucleotides MP-540d was also used for some of the red deer samples for 
the amplification of the target region B) The PBGD target regions was approximately 2.14 kb 
in length. The black numbers represent the exons. The structure of the cervid PBGD gene is 
not known and the diagram was based on the structure of the bovine PBGD gene. The PCR 
oligonucleotides used for the amplification of the red deer and wapiti PBGD target region are 
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2.7 Agarose Gel Electrophoresis of PCR Products 
The electrophoresis runs were carried out in one of the following electrophoresis units, 
depending on the number of samples to be analysed: 
• Less than 20 samples - MP-1015, Multi Purpose (Shelton Scientific fBI, USA) 
• More than 20 samples - I-IR-2025, High Resolution (Shelton Scientific fBI, USA) 
A selected quantity of multi purpose agarose (ROCHE, Switzerland) (Appendix 1) was 
placed in a conical flask and mixed with I x TBE buffer of the required volume (Appendix 
1). The resulting mixture was heated in a microwave until the agarose was completely 
dissolved. The mixture was cooled and mixed with ethidium bromide (Appendix I) to a final 
concentration of 400ng/ml. The agarose mixture was poured into the selected casting tray 
and after the positioning of the plastic combs it was allowed to set at room temperature. 
When ready, the combs were removed and the gel was placed in the electrophoresis unit. If 
not otherwise stated, following the completion of the PCR reaction, an aliquot of the PCR 
product was mixed with 5x  gel loading buffer 
(1/5th  the PCR sample volume) (Appendix 1) 
and loaded directly onto a 0.7% agarose gel. The gel was then run at 115V (25mA) in lx 
TBE buffer to achieve sample separation. At the end of the electrophoresis stage, the DNA 
bands were visualised over UV light using an UV trans-illuminator (Appligene Oncor, 
France). Two different DNA molecular weight marker sets were used depending on the size 
























Figure 4 - DNA Molecular Weight Markers 
The two images show the size range of the two DNA molecular weight markers used. A) 
DNA Molecular Weight Marker VI (Roche, Switzerland), B) 1kb DNA Ladder (New England 
BioLabs, USA). 
2.8 Gel Extraction 
if after gel electrophoresis of the PCR products, unexpected additional PCR bands were 
detected, the target product was gel extracted prior to direct sequencing. This ensured low 
levels of background signal in the sequencing results. This was achieved using the QlAquick 
DNA Gel Extraction Kit (Qiagen, Germany). The manufacturer's protocol was followed and 
all the reagents needed were included in the kit. 
2.9 Activated Charcoal Purification of PCR Products 
The PCR products (-45l.l) were mixed with 15il of PCR clean up mix (Appendix I) in a 
0.5m1 microcentrifuge tube (Treff Lab, Switzerland), vortexed and left to stand at room 
temperature for 15 minutes. The solution was then centrifuged at 13,000rpm (1 7,900rcf - 
Centrifuge 541 7C) for 5 minutes to pellet the charcoal. An aliquot of the supernatant (8111) 
was then used for direct sequencing 
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2.10 Automated sequencing 
Purified PCR products were sequenced directly on an ABI Prism 377 DNA sequencer 
(Applied Biosystems, USA). The solutions of the sequencing reactions contained 3pi of Big-
Dye® Terminator (Applied Biosystems, USA), 3jil of Better Buffer (Microzone limited, 
UK), lj.tl of sequencing oligonucleotide (Table 6) (201tM - Sigma Genosys, UK) and 81il of 
purified PCR product for a final volume of 15il. A single sequencing cycle consisted of 10 
seconds at 96°C, 5 seconds at 50°C and four minutes at 60°C. The cycle was repeated 25 
times on a PCR thermal cycler (Hybaid, UK). At the end of the reaction, the sequenced 
products were mixed with 60j.tl of 75% isopropanol (Appendix 1), left to precipitate at room 
temperature for 15 minutes, and then centrifuged at 2750 rpm for 20 minutes (GS-6R 
Centrifuge). The supernatant was discarded and the pellets air dried. When dry, the samples 
were dissolved in 8p.l of MicroSTOP-Red loading buffer (Microzone limited, UK) and 
approximately 1.3 tl of the resuspended samples were loaded onto a 5% Long Ranger 
PAGE-PLUS sequencing gel and analysed using the ABI PRISMTM  377 DNA sequencer 
(Applied Biosystems, USA). Each chromatogram was analysed by eye to identify mutations 
and possible artefacts using Chromas v. 1.45 (Conor McCarthy, School of Health Sciences, 
Griffith University, Gold Coast Campus, Southport, Queensland, Australia). All the 
chromatograms covering the target area of a specific sample were aligned and analysed using 
STADEN 1.6.0 (Dear and Staden 1991). The target area was sequenced bidirectionally using 
multiple PCR reactions and different sequencing oligonucleotides (Table 6). All the variable 
sites were confirmed by the sequencing of at least two independent PCR reactions. If 
suboptimal sequencing resolution was obtained for specific areas of the target region, the 
PCR and sequencing steps were repeated until acceptable resolution was obtained. 
Heterozygosity was defined by the presence of two chromatogram peaks at a specific 
position (double peak); the differentiation between a real double peak and an artefact was 
based on the shape, size and relative position of the two peaks with respect to each other. 
The level of background noise was also considered. Figure 5 gives an example of the 
differences between a heterozygote and an artefact. Sequence alignments were produced 
using Clustal W (Thompson, Higgins, and Gibson 1994) and edited using both GeneDoc 
(Nicholas and Nicholas Jr. 1997) and BioEdit. Vector NTFM  Advance 10 (Invitrogen) was 
used for graphical representation of the DNA molecules. 
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Figure 5 - Heterozygous Sites and Artefacts 
The two chromatograms below show the differences between heterozygosity and artefacts. 
a) The red arrow indicates the heterozygous site. b) The red arrow indicates an artefact (the 
peak is not in line with any of the other peaks) while the black arrow indicates background 
noise. 
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211 Promega pGEM®-T Easy Vector System 
The Promega pGEM-T Easy Vector System was used, the protocols provided by the 
manufacturer were used for the ligation and transformation reactions. Three test reactions 
were carried out for each ligation: 12, 6 and 3 i.tl of PCR product were used respectively. 
Test 1: 15.tl of x2 Rapid Ligation Buffer, lxl of pGEM-T Easy Vector (50ng), 12j.tl of 
PCR product, l.tl of T4 DNA Ligase (3 Weiss units/i.tl) and dH 20 to a final volume of 30.tl. 
Test 2: 10pil of x2 Rapid Ligation Buffer, lj.tl of pGEM ®-T Easy Vector (50ng), 6.tl of PCR 
product, lj.tI of T4 DNA Ligase (3 Weiss units/.tl) and dI-120 to a final volume of 201.11. 
Test 3: 5j.tl of x2 Rapid Ligation Buffer, li.tl  of pGEM-T Easy Vector (SOng), 3111  of PCR 
product, l.tl of T4 DNA Ligase (3 Weiss units/pil) and dH 20 to a final volume of lOi.tl. 
The reactions were placed at 4°C overnight. All the reagents needed for the ligation reactions 
were provided by the manufacturer. 
High efficiency JMIO9 competent cells (1 x 108 cfu/pig DNA) (Promega, USA) were 
transformed using 21.11  of each ligation reaction. Blue/white colour screening and ampicillin 
selection were used to identify transformed clones. The method is based upon the ability of 
B-galactosidase (Lac Z gene) to cleave X-gal into galactose and a compound which turns 
blue when it comes in contact with oxygen. The multiple cloning region of the plasmid 
vector is embedded within the amino-terminal fragment of an IPTG-induced Lac Z gene. 
Successful ligation of a DNA fragment into the multiple cloning site disrupts B-galactosidase 
expression resulting in white transformed colonies while without insertion, expression is 
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uninterrupted and blue colonies are obtained. Only transformed bacterial cells will grow onto 
Luria-Bertani (LB) plates containing ampicillin. The transformed cells were incubated 
overnight at 37°C in an Economy Incubator (Section 2.3). Both false positives and false 
negatives can be obtained in this screening reaction and for this reason restriction enzyme 
digestions of plasmid DNA isolated from the transformed cells and colony PCR reactions 
were used to confirm the presence of the target insert in the transformed clones. 
2.12 Isolation of Plasmid DNA from 2m1 Cultures (Miniprep) 
White colonies, usually eight per ligation reaction, were selected and placed into 2m1 of LB 
broth, containing ampicillin at a final concentration of 1 ltlIml, (Appendix 1) and incubated 
overnight at 37°C in an incubator shaker. In a 1 .5m1 microcentrifuge tube (Treff Lab, 
Switzerland), 1 .5m1 of the bacterial culture incubated overnight was centrifuged at 
14,000rpm (20,800rcf- Centrifuge 5417C) for 1 minute. The supematant was discarded and 
the pellet was resuspended by vortexing in 100 jil of Solution A (Appendix 1) and left for 10 
minutes at room temperature. A 200 jil volume of Solution B (Appendix 1) was added and 
the resulting solution was mixed gently before the addition of 150111 of chilled Solution C 
(Appendix 1). The solution was then vortexed and placed on ice for 20 minutes. Following 
the incubation the solution was centrifuged at 14,000rpm (20,800rcf- Centrifuge 5417C) for 
1 minute and the supematant (-45 Ojil) was then transferred to a new 1 .5m1 microcentrifuge 
tube (Treff Lab, Switzerland) and mixed with 45pJ of sodium acetate (pH 5.2) (Appendix 1) 
and 450jil of 100% isopropanol. The solution was mixed well and centrifuged at 14,000rpm 
(20,800rcf- Centrifuge 5417C) for 10 minutes after being placed at -20°C for 1 hour. The 
supernatant was discarded and the pellet was washed with 500111 of cold 75% ethanol. The 
solution was then centrifuged at 14,000rpm (20,800rcf - Centrifuge 5417C) for 5 minutes 
and the pellet was resuspended in 50jil of dH 20 after being air dried at room temperature. 
The RNA present in the solution was removed by the addition of 5 jig of DNase free RNase 
(Roche, Switzerland). 
2.13 Restriction Enzyme Digestions 
Restriction enzyme digestion of the plasmid DNA isolated from 2m1 bacterial cultures was 
used to determine if the clones selected contained the correct vector-insert complex. The 
DNA restriction enzymes were purchased from Roche (Switzerland) (Table 5). The 
restriction enzyme buffers provided by the manufacturers were used (Table 5). Plasmid DNA 
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restriction enzyme digestions, for 'miniprep' analysis, were prepared as follows: lOx 
restriction enzyme buffer, 10 units of restriction enzyme and 5 jil of plasmid DNA were 
mixed in a 0.5m1 microcentrifuge tube (Treff Lab, Switzerland) with sterile dH 20 to a final 
volume of 30j.tl. This was followed by incubation on a hot block (Section 2.3) at 37°C for 2 
hours. The digestion was stopped by the addition of 5x  gel loading buffer and the results 
were visualised by agarose gel electrophoresis. Vector NTPM  Advance 10 (Invitrogen) was 
used for the in silico digestions. 
Table 5 - Restriction Enzymes 
The table shows all the restriction enzymes that were used during the PhD project. Sca I and 





5'... GT1MKAC. . .3' 
Acc I A 37°C 3'... CAKM 1TG ... 5' 
5'... G 1AATTC 	3' ... 
EcoR I H 37°C 3'... CTTAA 1G .. . 5' 
5'... ATGCA 1T. ..3' 
Nsi I H 37°C 3'... T 1ACGTA ... 5' 
5'... AGTACT. . .3' 
Sca I H 37°C 3'... TCA 1TGA. ..5' 
5'... GAGCT1C 	3' ... 
Sac I A 37°C 3'... C 1TCGAG ... 5' 
2.14 Preparation of Glycerol Stocks 
A sample (-.5001.il) of each bacterial culture obtained from positive clones was placed in a 
1 .Sml screw cap microcentrifuge tube (Treff Lab, Switzerland) and mixed with 5001.tl of 
sterile 50% glycerol (Appendix 1). The final solution was stored at -70°C. 
2.15 Colony PCR 
This application of the PCR technique was also used to identify bacterial colonies 
successfully transformed with the correct vector-insert complex, this technique was faster 
than obtaining miniprep DNA (Section 2.12) but it only produced a limited amount of DNA 
thus limiting successive analyses. A sample of the selected white colonies was suspended in 
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lOOjil of dH20 and a 2tl aliquot of the resulting solution was used in the PCR mix. 
Depending on the species and the gene being targeted, the same PCR mixture and 
amplification programs that were used for the genomic DNA were applied here (Section 2.6 
and Section 2.10). The products of the PCR colonies were also sequenced to determine the 
haplotypes of the cloned regions. Alternatively, a PCR reaction was set up using 2.tl of 
miniprep DNA and the resulting PCR product was then sequenced with the PCR mixture and 
amplification programs described in (Section 2.6). 
2.16 Haplotypes 
T-vector cloning (Section 2.11) and in silico techniques were used to define the haplotypes 
of the sequenced samples. The genotypes were first analysed using the software PHASE v. 
2.1 (Stephens, Smith, and Donnelly 2001; Stephens and Donnelly 2003); after the analysis, 
samples which still had ambiguous haplotypes were cloned and the haplotypes determined 
through the sequencing of multiple clones. Problems were encountered due to the disruption 
of phase (linkage) between the heterozygous sites during the initial PCR step and the 
subsequent cloning of these PCR products into T-vector, thus resulting in more than two 
haplotypes (Jansen and Ledley 1990). To overcome this problem, between 6 and 10 clones 
were sequenced for each sample. 
2.17 Hardy-Weinberg Equilibrium 
Departure from Hardy-Weinberg Equilibrium (HWE) was tested for the three wapiti 
Colorado populations (Figure 2) analysed as part of the codon 132 CWD modulation study 
(Chapter 4). The Hardy-Weinberg principle relates allele frequencies to genotype 
frequencies. If the expected genotype frequencies obtained from the observed allele 
frequencies are significantly different from the observed genotype frequencies, then the 
population being analysed is not at HWE. A chi-square test can be used to determine if the 
difference between expected and observed genotype frequencies is statistically significant. 
Deviation from the HWE can provide an insight into processes shaping genetic variability 
and evolutionary change. 
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2.18 Statistical Analysis of Allelic Frequencies 
The Freeman-Halton extension of the Fisher exact probability test for a two-rows by three-
columns contingency table (Freeman and Halton 1951) was used to compare the codon 132 
genotype frequencies of the three analysed wapiti populations (Figure 2). The test was 
applied using an online statistical calculator: http://faculty.vassar.edu/lowry/fisher2x3.html.  
Table 6 - Oligonucleotide Primers 
The two tables list all the oligonucleotides that were used to analyse the PBGD (A) and PrP 
(B) genes. The name, molecular weight (MW), melting temperature (Tm) and G + C content 
(GC) of the oligonucleotides are all shown together with the direction of DNA synthesis and 
the nucleotide sequence of the oligonucleotides. All the oligonucleotides were designed 
using Primer3 (http-.//frodo.wi.mit.edu/cgi-bin/primer3/primer3  - www.cgi). The 
oligonucleotides used for PCR amplification are shaded in light yellow (Figure 3). Both 
shaded and non-shaded oligonucleotides were used for sequencing. The oligonucleotides 
shaded in light blue were used as the main sequencing oligonucleotides for the target 
regions of both wapiti and red deer, the remaining oligonucleotides were used when 
additional sequencing of specific sections was required. A total of 12 sequencing 
oligonucleotides were used for the PRNP target region of both wapiti and red deer samples. 
Oligonucleotides MP-153u, MP-540d and MP230d were used in addition to the shaded 
primer for the sequencing of the PRNP target region of all wapiti samples. Oligonucleotides 
MP-534d, MP-206u and MP255d were used in addition to the shaded primer for the 
sequencing of the PRNP target region of all red deer samples. 
A) 
MP-Code Synthesis 
Sequence (5' - 3') MW Tm GC 
Cattle-I ntergenic Upstream GCACCTAGATACCAGCACAAGT 6697.31 62.03 50.00 
Deer-Intergenic-1 6u Upstream TTTCTGCAGCCCCACCAA 5379.43 67.90 55.56 
PBGD-3UTR-1 01 7d Downstream GCCACAGCCTTTGATGTAACCA 6663.26 65.72 45.45 
PBGD-3UTR-1021u Upstream GTACAACTGGTTACATTCAAAGGCT 7664.87 63.05 40.00 
PBGD-3'UTR-901 d Downstream TGAGGAGTGACTACCCCCAcA 6400.09 66.81 57.14 
PBGD-3UTR-901 U Upstream TGTGGGGGTAGTCACTCCTCA 6453.04 66.81 57.14 
PBGD-E ix-14d Downstream GCAGGAGUCAGTGCCAT 614787 61.51 55.56 
PBGD-E.ix-ld Downstream CGGGGAMCCTCAACAC 5173.35 61.59 58.82 
PBGD-E.xi-63d Downstream cAGGAcATcTTGGATcTGGT 6756.23 61.55 50.00 
PBGD-E.xi-65u Upstream CACCCACCAGATGCAAGA 6014.88 62.26 55.56 
PBGD-l.viu-ld Downstream GGTCCTTAGTGTCTCTCCACAG 7285.54 6168 54 55 
PBGD-E.xiii-126u Upstream GTGGTCTGCATGGTGTCCT 5841.62 63.84 57.89 
PBGD-I.ix-128u Upstream GATccCccCTTCcCAC 5637.62 65.37 57.89 
PBGD-1 ix- 1 30d Downstream TGGGAAGGTTGGGGATCAG 5988.77 67.16 57.89 
PBGD-I ix-1 93d Downstream GGAAACCCCAACTCAGTGC 5766.71 64.50 57.89 
PBGD-I .viii-5d Downstream cTTAGTGTCTCTCCACAGCGG 6373.00 63.87 57.14 
PBGD-l.x-275u Upstream ACATGGCTTCGCTGGTCAAG 6132.87 67.51 55,00 
PBGD-I.xi-562u Upstream CCCTTATCACCACCCTGTAACCA 6848.37 67,55 52.17 
P13GD-I.xii-654d Downstream TCTGGCGTUCCCCTGTGTA 6065.76 67.69 55.00 
PBGD-I.xiii-810d Downstream AcccAACcCUcUCCcTACC 6181.93 66.09 57.14 
PBGD-E xiv-164d Downstream TGCTGAGA.ACCTGGGCATCA 5828.69 66.51 57.89 





Sequence (5' - 3') MW Tm GC 
MP+124d Downstream ATACCCT1GGCGCTTACAGC 6052,83 65,06 5500 
MP+16u Upstream AACAGGAAGGTTGCCCCTATCC 6704.27 67.96 54.55 
MP+296u Upstream TATGTGGCCTCCTTCCAGACTTGG 7310.56 70.88 54.17 
MP+297d Downstream CGTCTGGMGGAGGCCACAT 679134 68.49 54.55 
MP+38u Upstream GTAGACACTCCCTCCCCCAACCTGGC 7796,94 76,12 65.38 
MP4-54u Upstream ACTACAGGGCTGCAGGTAGACACTC 7675,88 67.57 56.00 
MP+567u Upstream GGGCACCTCTCCCATATGTTGG 6702.20 7037 59.09 
MP+587u Upstream AMTAGAAGGCTGCCACCAAGG 6786.38 67.07 50.00 
MP+594d Downstream CTTGGTGGCAGCCTTCTATT1T 6698.15 65.11 45.45 
MP+690u Upstream CAGATTTGCTCTCAGTGTCTAGAAGG 8001.03 65.25 46.15 
MP+692u Upstream TGCTCTCAGTGTCTAGAAGGTAGT 7398.64 60,15 45.83 
MP102d Downstream TGGAACA.AGCCCAGTAAGCC 611994 6616 55.00 
MP1 12d Downstream ATGAGCATGTGGCAGGAG 5941 79 63.94 52.63 
MP1 15u Upstream GCAGCAGCTCCTGCC 4513.87 62.29 73.33 
MP129d Downstream TGGCTACATGCTGGGMGTGC 6502.09 69.44 57.14 
MP135d Downstream GTGCCATGAGCAGGCCTC 5500.48 67.30 66.67 
MP136u Upstream TAAGAGGCCTGCTCATGGC 5828.69 65.36 57.89 
MP147d Downstream CTATGAGGACCGTTACTATC 6091.86 52.70 45.00 
MP- 1 53u Upstream CTTCACATTCCATACATCTCACG 6878.37 63.15 43.48 
MP157d Downstream GTACCGTTACCCCAACCAAGTG 6664.25 66.05 54.55 
MP157u Upstream CACTTGGTTGGGGTAACGGTACAT 742366 68.26 50.00 
MP179u Upstream ATGTTGACACAGTCATGCAC 6100.89 59.58 45.00 
MP185u Upstream TGTGTGTTGCTTGACTGTGA 6184.83 61.68 45.00 
MP191d Downstream CAGTCACCACCACCACCAAGG 6314.08 69.99 61.90 
MP192d Downstream GTCACCACCACCACCAG 538249 62.71 61.11 
MP196u Upstream GGTGAGUCTCCCCCTTGGT 640199 67.34 57.14 
MP1d Downstream GGTGAAAGCCACATAGGCAGTTGG 7779,95 71 72 52.00 
MP1u Upstream GCTGCCTATGTGGCTTTTCACC 6668.15 68.64 54.55 
MP-206u Upstream CAACTCTTTCTCCTCCAAGGACAAAG 7859.01 67.81 46.15 
MP208u Upstream GCTCCACCACTCGCTCCATT 5948.76 68.78 60.00 
MP209d Downstream GGAGCGAGTGGTGGAGCAAA 6296.01 69.86 60.00 
MP209u Upstream GCTCCACA.ACTCGCTCCAT 5668.61 65.46 57.89 
MP-21d Downstream TTAI'TTTGCAGAGAAGTCATC 6435.07 56.04 33.33 
MP-213d Downstream AGGTCAACTTTGTCCTTGGAGGAG 7423.66 67.45 50.00 
MP209u Upstream GCTCCACAACTCGCTCCAT 566861 65.46 57,89 
MP230d Downstream CMAGAGGGGCAJkGTGTGATCC 683336 68.78 54.55 
MP252u Upstream TrGCCCCTATCCTACTATGAGA 6645.20 61.33 45.45 
MP255d Downstream TAGGATAGGGGCACCCUCCT 6422.05 66.60 57.14 
MP-410u Upstream CAACTGGACTTATTCTTGTGGGGAC 7687.82 67.33 48.00 
MP-420d Downstream AGCTTCCAGTGTCCCCACAGAAT 7281.64 69.69 50.00 
MP-444d Downstream CCCTTATAACAACCCAATAGGCAG 7274.68 65.02 45.83 
MP44d Downstream AGGGCAGTCCTGGAGGCAAC 6191.94 69.92 65.00 
MP-45d Downstream GGGCATATGATGCTGACACC 6141.90 6528 55.00 
MP46u Upstream TAGCGGTTGCCTCCAGGACT 6108.84 68.12 60.00 
MP-489d Downstream CCATAGGGTCCATGCCAGGG 6142 89 7058 65.00 
MP50d Downstream CCGCTATCCACCTCAGGGA 573165 67.40 63.16 
MP-534d Downstream CAGCACCTACCTTGGGGTCT 606882 65.25 60,00 
MP540d Downstream TGATCTCAGCACCTACCTTGG 6357.01 64.10 52.38 
MP-574d Downstream GAGGATGTGAGCCAATATTCAG 6823.34 62.31 45.45 
MP5d Downstream CACATAGGCAGTTGGATCCTGGTTCT 8266.18 71.82 51.85 
MP86d Downstream GCCACATGGTGGTGGAGGC 5909.72 71.41 68.42 
MP95d Downstream AAGGTGGTACCCACGGTCAA 6150.93 66.35 55.00 
MP98u Upstream CTTGTrCCACTGACTGTGGGT 6418.99 64.01 52.38 
MPO1d Downstream CGATGGTGAAAAGCCACAT 5845.76 63.52 47.37 
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2.19 Haplotype and Nucleotide Diversity 
Haplotype and nucleotide diversities were estimated using DnaSP v.4.10 (Rozas and Rozas 
1999). Nucleotide diversity (n) is the average number of nucleotide differences per site 
between sequences and provides an indication of the possible biological and historical events 
that could have affected the populations under study. Haplotype diversity has a range of zero 
(all individuals share a common haplotype) to one (every individual has a unique haplotype) 
and estimates the probability that two randomly selected individuals in a sample will 
different haplotypes (Nei 1987). 
2.20 Neutrality Tests 
The majority of the tests used to detect the presence of natural selection utilise the neutral 
theory of molecular evolution as a null hypothesis against which the presence of selection is 
tested. This theory states that most observed molecular variation, within and between 
species, is due to random drift of selectively neutral mutations (Kimura 1983). Departure 
from neutrality can indicate the presence of natural selection acting either at the site under 
investigation or at linked sites. 
Test statistics including Tajima's D (DT) (Tajima 1989), Fu & Li's D*  and  F*  (Fu and Li 
1993) and Fay & Wu's H (Fay and Wu 2000) were applied to the target region of the PrP 
and PBGD genes, to detect a possible departure from neutrality. All these tests were 
implemented in the program DnaSP v.4.10. The null distributions of D, D* and  F*  were 
also obtained in DnaSP v.4.10. using coalescent simulations (10,000 replicates). 
DT, D* and F* are based on the differences between three estimators of 0 = 4Nep, where 
Ne is the effective population size and p is the mutation rate per generation (Tajima 1989). 
The three estimators of theta are: 
O = ir, (Nei & Tajima's estimator) where iv is a measure of nucleotide diversity, 
which estimates the mean pairwise difference between the sequences in the sample. 
O, = S / a (Watterson's estimator), where S is the number of segregating sites in a 
sample of n sequences and a is the Watterson's constant for n. 
O = (n —1 / n)ij , where q is the number of singletons 
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DT compares O and O: 
D - OT  — O W  
T 
- .Ji'ar(Or _tW) 
Genetic hitchhiking, or a selective sweep, reduces the genetic variability at a target locus 
and at linked sites (Smith and Haigh 1974). As a result of this, mutations that have occurred 
since the sweep will at first be rare, thus resulting in an excess of low frequency variants. 
This will reduce the value of DT  below its neutral expectation of 0. Conversely, balancing 
selection will result in a higher number of variants at intermediate frequency, generating 
values of Dr significantly higher than zero (Tajima 1989; Simonsen, Churchill, and Aquadro 
1995). 
Fu and Li's D*  compares 0 and O while F* compares 0,. and O. Natural 
selection affects the values of these test statistics in a manner very similar to D. These three 
tests make strong demographic assumptions regarding the target population. Departure from 
these demographic assumptions affects the outcome of these tests in ways similar to natural 
selection: a population expansion could reduce the values of the test statistics below zero 
while population structure or a recent bottleneck could result in values significantly higher 
than zero (Nielsen 2001). 
However, selection and demography can be distinguished by the genomic range of 
their effect: while selection only targets a specific locus or even a single amino acid, 
demography produces a genome-wide skew (Beaumont and Nichols 1996). For this reason, 
comparing the test statistics obtained from a range of loci throughout the genome should aid 
the differentiation between selection and demography. Due to this, the genetic variability of 
the PBGD gene was investigated. Ideally, several genes should have been analysed to better 
investigate the possible effects of demography on the neutrality tests. However, this was not 
possible in the current study. 
Although D*  and  F* have been shown to have more power for the detection of 
background selection (Charlesworth, Morgan, and Charlesworth 1993), while DT  is more 
sensitive to hitchhiking by favourable mutations (selective sweep) (Simonsen, Churchill, and 
Aquadro 1995), it is often difficult to differentiate between these two selective processes by 
only using the three tests mentioned above and for this reason other tests were implemented. 
A neutrality test which focuses on a genetic signature specific to selective sweeps is 
the Fay and Wu's H test, which uses an estimator of 0 (OH)  to quantify the levels of high 
frequency derived mutations (Fay and Wu 2000). An excess of high-frequency derived 
mutations could indicate a selective sweep. An outgroup is required to distinguish derived 
50 
and ancestral variants. The target regions of the PrP and PBGD genes were amplified for a 
goat sample (Figure 3). 
However, a variety of demographic models have been shown to have the same effect 
as hitchhiking on H. For example, population structure could result in negative values of H 
for samples from single populations (Przeworski 2002). The wapiti samples are known to 
originate from two different populations (Section 2.1) and for this reason, the genetic 
distance between these two populations was estimated prior to neutrality testing to determine 
the possible presence of genetic structure. To achieve this, two distinct classes of test 
statistics were implemented: haplotype statistics and sequence statistics. 
Haplotype statistics are based on haplotype frequencies and do not take the level of 
nucleotide divergence between haplotypes into account; these include HST and GsT  (Nei 
1987). Contrarily, differences between haplotypes are considered by the sequence statistics. 
This class includes Snn (Hudson 2000) and FST (Wright 1951). All the statistical tests for 
genetic subdivision were implemented using DnaSP v.4.10. 
The statistical significance of HST and Snn was assessed using a permutation-based 
method (Hudson, Boos, and Kaplan 1992) implemented in DnaSP v.4.10.; 1000 partitions of 
the sample were generated to test the null hypothesis of no genetic difference between 
populations/species. 
Another measure of genetic distance, the average number of net nucleotide 
substitutions per site (dA) (Nei 1987) was also estimated using DnaSP v.4.10.: 
dA  =d,  —(,r +r)/2 
rx  and iry  are the nucleotide diversity of populations X and Y, respectively, and d,y is 
the average number of nucleotide substitutions per site between X and Y (Nei and Li 1979). 
As mentioned in (Section 1.28), despite being considered as separate species in the present 
study, there is still disagreement on whether C. elaphus and C. canadensis should be 
considered as two independent species; the genetic distance test statistics used for the wapiti 
populations were also implemented to determine the genetic distance between wapiti and red 
deer. 
Two haplotype based neutrality tests were also implemented: the haplotype number 
test (K-test) and the haplotype diversity test (H-test) (Depaulis and Veuille 1998). The values 
of H and K were estimated using DnaSP v.4.10. The significance of the two test statistics 
was also determined using DnaSP v.4.10, by coalescent simulations (10,000 replicates) 
conditioned on the observed number of polymorphic sites. The simulations were run 
assuming no recombination. These tests assess whether or not the haplotypes originated 
under a neutral coalescent process and both selective and demographic forces can cause 
departure from neutral expectations. For both H and K, significantly low values could 
indicate the presence of population subdivision, a recent bottleneck or a balanced 
polymorphism without recombination, while high values can be the result of an ancient 
balanced polymorphism with partial linkage, population expansion, or from a complete 
hitchhiking event without recombination (Depaulis and Veuille 1998). 
All the neutrality tests mentioned above are sensitive to recombination, and for this 
reason, the population recombination rate per locus (j) (Section 2.22) was estimated prior to 
their estimation. The population recombination rate was also utilised in the estimation of the 
null distribution of the test statistics. 
The Hudson-Kreitman-Aguade (FIKA) and the McDonald-Kreitman (MK) tests 
were also implemented using DnaSP v.4.10. These two neutrality tests assess departure from 
neutrality by looking at genetic differences between two different loci (1-IKA test) or between 
classes of mutations (MK test). HKA and MK utilise the information present in both 
polymorphism and divergence (Hudson, Kreitman, and Aguade 1987; McDonald and 
Kreitman 1991). In the HKA test PRNP (the locus of interest) was compared with PBGD 
(the reference locus), which is assumed to be neutral, to determine the presence of unusual 
patterns of polymorphism. The two main types of selection detected by the HKA test are 
recent selective sweeps and balancing selection. The MK test is able to detect positive 
selection even in the presence of strong selective constraint. This test compares the ratio of 
nonsynonymous to synonymous polymorphic sites to the nonsynonymous to synonymous 
ratio of fixed difference between species (McDonald and Kreitman 1991). One of the 
advantages of the MX test is that it is not strongly influenced by demography; sequence data 
from Capra hircus were used (Section 3.2.8). 
2.21 Analysis of Silent Sites 
Some of the population genetics test statistics were also performed on the silent sites of the 
genomic regions under investigation. DnaSP v.4.10 was used to create NEXUS data files 
that only included silent changes: noncoding positions plus synonymous sites from the 
coding region. The removal of the nonsynonymous SNPs should provide a better picture of 
the neutral evolution of the gene. 
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2.22 Linkage Disequilibrium and Recombination 
Linkage Disequilibrium refers to the nonindependence of alleles at different sites. Patterns of 
LD are commonly used for association studies (Klein 2005; Maraganore et al. 2005; Ozaki 
and Tanaka 2005) and disequilibrium mapping (McPeek and Strahs 1999; Morris and 
Whittaker 2000). However, the analyses of LD patterns can also be useful to understand the 
forces shaping the patterns of sequence variation. Thus, the levels of LD in the target regions 
of the PrP and PBGD genes were investigated to complement the results of the neutrality 
tests. 
In this study, pairwise LD between segregating sites was estimated by the r2 statistic 
(Hill and Robertson 1968). Fisher's exact test was also computed to determine the 
significance of the associations between SNPs. Both tests were implemented in DnaSP 
v.4.10 (Rozas and Rozas 1999). The range of r2 is 0 to 1, with r2 = 0 indicating no LD and 
perfect LD represented by r2 = 1. The values of r2 were represented graphically using the 
software GOLD (Graphical Overview of Linkage Disequilibrium) (Abecasis and Cookson 
2000). Low frequency SNPs have been shown to have little power for detection of LD 
(Lewontin 1995; Goddard et al. 2000) and for this reason SNPs with an allele frequency 
0.05 were excluded from the LD analyses. For a summary of the SNPs present in the 
different datasets and their frequencies see Table 9 and Table 12. Despite their popularity, 
pairwise LD measures can be difficult to interpret (Wall 2001). For this reason, the data were 
also analysed using a model-based LD measure (McVean, Awadalla, and Fearnhead 2002) 
which estimates the population recombination rate (p) per locus, a numerical summary of the 
extent of LD among multiple SNPs. This method estimates p using a composite likelihood 
estimation (CLE) method (Hudson 2001), implemented in the program LDhat (McVean, 
Awadalla, and Fearnhead 2002). The composite likelihood is estimated by combining the 
coalescent likelihoods of all pairwise comparisons of segregating sites. LDhat uses a 
modified version of the CLE method, which enables the estimation of recombination under a 
finite-sites model (McVean, Awadalla, and Fearnhead 2002). The model assumes a uniform 
mutation rate across the analysed sites, and for this reason the analysis is restricted to 
polymorphic sites with only two variants (Hudson 2001). The population recombination rate 
is equal to 4Ner; where Ne  is the effective population size and r is the per-generation 
recombination rate (McVean et al. 2004). However, p is affected by demographic history and 
for this reason can differ substantially between populations. To avoid such problems, the 
samples were divided into the two source populations E-8 and E-9 before being analysed. 
Under the coalescent model, the speed of decay of LD between polymorphism at 
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different sites, when factors such as selection, recurrent mutations and demographic 
processes are not affecting the target locus, depends on the amount of recombination (Wall 
2001): when p increases, the level of LD is reduced. After estimation, the significance of the 
population recombination rate was tested using a permutation-based method also 
implemented in LDhat. The permutation-based test [likelihood permutation test (LPT)] tests 
the hypothesis of no recombination (4Ner = 0). In this test, significance is determined by 
comparing observed data to 1,000 data sets where all sites have been randomly rearranged. 
This test is based on the fact that, under a model of no recombination and uniform mutation 
rate, the likelihood of observing the data is independent of the order in which sites occur, 
while if recombination is present, sites are no longer exchangeable and the likelihood of 
observing the data is dependent on the order of the sites (McVean, Awadalla, and Feamhead 
2002). 
Six different programmes are included in the LDhat software package but only three 
were used in this study: convert, pairwise and lkgen. The program convert was used to covert 
aligned nucleotide sequence data into the two input files needed for further analysis: sites 
and locs. Haplotype data were used for all the datasets analysed as there is evidence that 
direct analysis of genotype data reduces the power of the estimation (Pritchard and 
Przeworski 2001). 
The lookup table needed for pairwise was generated using lkgen from an existing 
lookup table downloaded together with the software (http://www.stats.ox.ac.ukl—mcveanlLDhatl). 
This approach was preferred to the generation of a lookup table specific for the analysed 
dataset, due to its much lower computational costs. The downloaded lookup table had been 
generated for n = 100 and 0 = 0.001 per site. The values of theta per site obtained for the 
analysed datasets are given in Table 21. The small differences in the value of theta per site 
did not pose a problem as minor changes in its value do not seem to have a large influence 
on the estimated recombination rate (McVean et al. 2004). The default values were used for 
both the maximum value of 4Ner (default value = 100) for the grid and for the number of 
points on the grid (default value = 101). 
The DnaSP software was also used to estimate the minimum number of 
recombination events (Rm) in the history of the sample using the four-gamete test (Hudson 
and Kaplan 1985). Rin is a conservative estimate of the minimum number of recombination 
events that have occurred in the history of the analysed sequences (Hudson and Kaplan 
1985; Stumpf and McVean 2003). 
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2.23 Mutation Rate and Effective Population Size 
The neutral theory of molecular evolution explains patterns of genetic diversity using only 
mutation and genetic drift. Mutation is the source of new variants while drift is a random 
force that affects the frequency of alleles from generation to generation (Kimura 1983). If the 
effective population size (Ne) is small, then the effect of genetic drift on the population will 
be large. The Ne is the population size of an ideal population (i.e., one that meets all the 
Hardy-Weinberg assumptions) which experiences the same level of genetic drift as the 
census population and it is a measure of the genetic population size (Kimura and Crow 
1963). The effective population size of a studied group can be determined by first estimating 
the mutation rate per site per year (u). Under the neutral model, the mutation rate at silent 
sites is equal to: 
N 
- 2T,1e 
where Ns  is the number of substitutions between a sequence from a studied species and an 
outgroup sequence, T pli, is the time in years since the split between the target and the 
outgroup species and e is the length of the sequences. Nucleotide sequences obtained from 
the PrP and PBGD genes of Cervus elaphus (both the consensus sequences of the red deer 
and wapiti were used) and Capra hircus were compared to estimate the neutral mutation 
rate: silent (non-coding and synonymous) sites of the target regions were compared. The 
evolutionary divergence between sequences was estimated by using the Tamura-Nei 
nucleotide substitution model. This model corrects for multiple hits, taking into account the 
differences in substitution rate between nucleotides and the inequality of nucleotide 
frequencies. It also accounts for different rates of transversions and transitions between 
purines and between pyrimidines respectively. Equality of substitution rates among sites is 
also assumed (Tamura and Nei 1993). 
The infraorder Pecora comprises the five extant families Antilocapridae, Bovidae, 
Cervidae, Giraffidae and Moschidae. The fossil record provides evidence for the appearance 
of these five families through a rapid radiation around 17-2 1 million years ago (MYA) in the 
Miocene. The divergence of the Giraffidae and Cervidae families is dated to 17.8 MYA with 
the appearance of Canthumeryx (Drake et al. 1988), while the split between Giraflidae and 
Bovidae has been dated to 18.3 MYA (Solounias et al. 1995). These data, together with the 
dating of the first members of the family Cervidae, Lagoineryx and other muntiacines, to the 
Early Miocene, suggest this 4 million years interval as the period of the divergence of the 
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Bovidae and Cervidae; 19 MYA was used to estimate the mutation rate per site per year. 
The effective population size was then estimated from the formula 0 = 4Nu. To 
convert p into a rate per gene per generation, a generation length of 6 years was used 
(Pemberton, J. M., 2006. Personal communication). The values of 0 were obtained using 
DnaSP v.4.10. 
2.24 Tests based on the dNIds  ratio 
Likelihood methods were used to test the presence of positive selection acting on individual 
amino acid sites of the PrP prion protein. Most neutrality tests previously described, despite 
being powerful tools for trying to understand the evolutionary forces acting on a specific 
genomic region, rely on strong assumptions regarding the demographics of the target 
population, which makes it hard for them to provide unequivocal evidence for positive or 
balancing selection (Nielsen 2001). 
A number of statistical methods which do not make demographic assumptions have 
now been developed. These methods measure the selective pressure on a protein-coding gene 
by comparing synonymous (silent, d5) and nonsynonymous (amino acid-changing, dN) 
substitution rates (Goldman and Yang 1994). 
dN /ds = 
w is the nonsynonymous/synonymous substitution rate ratio, also known as the "acceptance 
rate". It is a measure of the selective pressure on a protein (Miyata, Miyazawa, and 
Yasunaga 1979). When w> 1, nonsynonymous mutations offer a selective advantage and 
have a higher fixation rate than synonymous mutations, thus indicating the presence of 
positive selection. If silent and amino acid-changing mutations have the same fixation 
probability w = 1, then the protein is considered to be subject to neutral evolution. The 
detection of w < I indicates the presence of purifying selection (Miyata and Yasunaga 1980; 
Goldman and Yang 1994). 
The models used in this thesis originated from a codon-based model developed by 
Goldman and Yang in 1994. Maximum likelihood (ML) is used to estimate parameters such 
as dN, d, the transitionitransversion rate ratio (K) and sequence divergence (t) under Markov 
process codon models (Goldman and Yang 1994; Muse and Gaut 1994; Yang and Bielawski 
2000). In the original model developed by Goldman and Yang in 1994, the instantaneous 
rate of substitution from codon I toj (i :AJ), is given by: 
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1 o 	if i andj differ at more than one position, 
it-, 	for synonymous transversion, 
q, K1tJ, 	for synonymous transition, 
anr, for nonsynonymous transversion, I  COKitj, 	for nonsynonymous transition. 
where iç, is the equilibrium frequency of codon j. This model allows the calculation of the 
likelihood function for w and for the other parameters using the general algorithm of 
Felsenstein. 
Despite having been used to detect positive selection in a number of protein-coding 
genes (Yang and Bielawski 2000), this model is very conservative (Crandall et al. 1999). 
Most sites in a functional gene are expected to be under purifying selection throughout most 
of the evolutionary history of the protein and positive selection may only affect few sites at 
specific time points. Due to this, the presence of positive selection is masked by purifying 
selection, which causes the synonymous substitution rate to be significantly higher than the 
nonsynonymous one (Kreitman and Akashi 1995). 
New models have now been developed which enable the identification of positively 
selected sites, even when most sites are under purifying selection. These models use a 
statistical distribution to describe the variation in w among sites and lineages. Likelihood 
ratio tests between different models are used to test for adaptive evolution: significant 
likelihood ratio tests confirm the presence of sites with w> I (Nielsen and Yang 1998; Yang 
etal. 2000). 
An empirical Bayes (EB) method is then used to calculate posterior probabilities for 
the site classes: the posterior probability that each site is from a specific site class. 
Depending on the Markov process models used in the likelihood ratio test, either a naive 
empirical Bayes (NEB) or a Bayes empirical Bayes (BEB) are used. The difference between 
these two methods is that NEB does not take sampling errors into account (Nielsen and Yang 
1998; Yang et al. 2000; Anisimova, Bielawski, and Yang 2002). Site-specific models have 
been used to detect positive selection in a variety of genes and species (Zanotto et al. 1999; 
Bishop, Dean, and Mitchell-Olds 2000; Yang, Swanson, and Vacquier 2000; Bielawski and 
Yang 2001; Haydon et al. 2001; Swanson et al. 2001; Mondragon-Palomino et al. 2002; 
Twiddy, Woelk, and Holmes 2002; Filip and Mundy 2004). 
Despite their ability to detect positive selection at specific sites, these tests remain 
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conservative as they imply the same level of selection throughout the studied phylogeny. For 
this reason, two datasets were analysed: a dataset that represented the class Mammalia and a 
smaller one, which focussed on the order Artiodactyla (Figure 6). Low levels of divergence 
between the analysed species negatively affects the ability of PAML (for Phylogenetic 
Analysis by Maximum Likelihood) to detect positively selected sites (Anisimova, Bielawski, 
and Yang 2002); due to the fact that the prion gene is highly conserved between mammalian 
species (Schatzl et al. 1995; Wopfner et al. 1999; Van Rheede et al. 2003) this type of 
analysis was not applied to more narrow phylogenetic ranges (e.g. individual mammalian 
families). 
Only a small proportion of the 130 mammalian PrP nucleotide sequences available 
in online databases were selected. The selection of the sequences aimed at covering the range 
of divergence for the PrP gene without using too many sequences, and only full-length 
sequences were considered. In addition to this, before being used, each sequence was aligned 
to the ovine PrP sequence (U67922) and to the PrP sequence of a closely related species to 
avoid the selection of sequences affected by experimental errors. When possible, sequences 
that had been obtained at NPU were used (Figure 6 and Table 4). For the Artiodactyla 
dataset, one species was selected from each available genus; for a total of 24 sequences 
(Figure 6). The human PrP sequence was used as outgroup. A sequence for each subfamily 
of the class Mammalia was selected for the second dataset. A total of 28 sequences (Figure 
6) were used and Macropus eugenii (Tammar wallaby) was used as outgroup. The sequence 
alignments for the two datasets (FASTA format) were created using Clustal W (Thompson, 
Higgins, and Gibson 1994) and analysed using GeneDoc (Nicholas and Nicholas Jr. 1997). 
The codemi program from PAML was used to perform the likelihood analyses and 
test for positively selected sites. The FASTA alignments were converted into the PHYLIP 
format using DnaSP v.4.10. Unrooted phylogenetic trees (parenthesis notation) based on the 
DNA alignments were obtained from MrBayes 3.1.2., a software package for Bayesian 
estimation of phylogeny, (Huelsenbeck and Ronquist 2001). Before constructing the tree, a 
substitution model was selected using FindModel (http://hcv.lanl.gov/contentlhcv-
db/findmodellfindmodel.html),  a web implementation of Modeltest (Posada and Crandall 
1998). FindModel uses the program Weighbor (Bruno, Socci, and Halpern 2000) to generate 
the tree based on Jukes-Cantor distances. This online application then uses PAML to 
calculate the negative log likelihood of twelve substitution models and selects the model that 
best fits the sequence data. 
The model selected through FindModel was applied in MrBayes 3.1.2. The 
phylogenies are constructed using Bayes' theorem in combination with a Metropolis- 
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Coupled Markov Chain Monte Carlo (MCMCMC or MC) simulation. This tree building 
approach has been shown to be robust and it is also considerably faster than maximum 
likelihood methods. Two simultaneous, completely independent analyses were run in 
MrBayes for each dataset, starting from different random trees. During the analysis, as the 
two runs converge onto the stationary distribution, the trees sampled become very similar. 
This provides a good indication of when the program has obtained a good sample from the 
posterior probability distribution. Convergence of the two runs is essential for the 
construction of a reliable phylogeny. A diagnostic for convergence in tree topology is the 
average standard deviation of split frequencies, which is a measure of how similar the tree-
samples of the two independent runs are (Huelsenbeck and Ronquist 2001; Ronquist and 
Huelsenbeck 2003). As the two runs converge, this value will approach zero; values of less 
than 0.01 are usually considered acceptable. As part of the output, two additional 
convergence diagnostics are available: the Potential Scale Reduction Factor (PSRF) (Gelman 
and Rubin 1992) and the plot of the generations versus their log likelihood values. At 
stationarity the PSRF has a value of one for each parameter while the plots should look like 
white noise. 
MrBayes' output includes the phylogenetic tree and, for each node, a value which 
indicates the support for that specific node within the selected configuration of the 
evolutionary history. These support values are termed posterior probabilities and indicate the 
probability of a node being correct (Harrison and Langdale 2006). 
The phylogenetic analysis was run for 5x106 generations, with Markov chain 
sampling every 100 steps, resulting in 50,000 sampled trees. Four discrete categories were 
used to approximate the gamma distribution. The default priors were used, which assumed 
no molecular clock and no prior knowledge of the values of the substitution rates, the 
stationary nucleotide frequencies and, the proportion of invariable sites. The Markov chains 
perform correlated random "walks" through the parameter space and samples values of the 
parameters at intervals specified by the investigator (Lewis 2001). Four Markov chains (1 
cold chain and three heated chains) were used, the default temperature (T = 0.2) was used; 
the temperature modulates the ability of the heated chains to move through the treespace. To 
ensure a robust approximation of the posterior probability distribution of all the parameters 
estimated by MCMCMC, the counting chain (cold chain) needs to be able to effectively 
sample and move through the treespace; in a process called mixing (Beiko et al. 2006). The 
purpose of the three heated chains is to help the evaluation of the topology of the 
phylogenetic space and thus improve mixing. The level of mixing is determined by a matrix 
of the acceptance rates between chains generated at the end of the MC 3 run. Satisfactory 
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values should be between 0.1 and 0.7. 
The phase of the run which precedes stationarity is defined as the "burn-in" phase, 
the trees generated in this phase are discarded due to the large levels of variability of their 
likelihood scores; 10% of the total trees were discarded as burn-in in this study. 
The two datasets had identical PAML control files. For CodonFreq, F3 x4  was used. 
This feature calculates expected codon frequencies in the codon substitution model using the 
nucleotide frequencies at the three codon positions. Six different models were used NSsites: 
MO, Mia M2a, M3, M7 and M8. These models represent different evolutionary scenarios. 
MO assumes a constant cv for all sites (Goldman and Yang 1994; Yang et al. 2000) while the 
nearly neutral model (Mia) enables the acceptance rate to vary between 0 and 1 (CO < I and 
c) = 1). The positive selection model (M2a) includes an additional category for positively 
selected sites, cv> 1 (Nielsen and Yang 1998). Model 3 assumes the existence of K different 
classes of cv ratios, 3 in this thesis. The two remaining models (M7 and M8) assume a beta 
distribution of cv ratios among sites. They differ in the fact that M7 does not allow positively 
selected sites while M8 allows the existence of sites with cv> 1 (Yang et al. 2000). 
The likelihood ratio tests cannot be used to compare the nonnested models M3 and 
M8. These two models were compared using the Akaike information criterion (AIC) (Akaike 
1974): 
AIC = -2 (estimated likelihood of the model) + 2 (number of free parameters of the model) 
The model that minimized the value of AIC was considered the most appropriate model. 
As PAML treats alignment gaps as an ambiguity, all the sites at which at least one 
sequence involved an alignment gap were removed from all the sequences before the 
analysis using the cleandata = 1 command in codemi. 
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Figure 6 - Mammalian Alignments 
The open reading frame of the PrP gene from the following mammalian species was used for 
the study of w in mammals and artiodactyls. Most of the sequences were obtained from the 
online genetic sequence database Gen Ban k® .  The sequences without an accession number 
were sequenced as part of the current study, for more information see Section 3.2.9 and 
Table 4. A) Dataset containing 24 species from the order Artiodactyla. B) Dataset containing 





Genus, species (Common name) - Gen Bank Accession n. 
it id.tcty Ia 
Anti locapridae 
Antilocapra americana (Pronghorn) AF 156187 
l3ovidae 
Anti lopinae 
Antilope cervicapra (Blackbuck) AY720705 
Gazella thomsonii (Thomson's gazelle) EU03230 I 
It)ViflilC 
Bison bonasus (European bison) EU032297 
Bosfronialis ( Gaur) EU032300 
Bose/aphus Iragocainelus (Nilgai) AY720700 
Bubalus bubalis (Water buffalo) AY720689 
Syncerus caffer (African buffalo) AY720683 
Tragelaphus angasii (Nyala) EU032295 
Caprinae 
Budorcas iaxico/or(Takin) AB060290 
Capra hircus (Domestic goat) EU032304 
Ovibos moschaius (Muskox) AFI 17320 
Ovis aries (Sheep) U67922 
Rupicapra rupicapra (Chamois) AY73 5496 
II ippotraginae 
Oryx dammah ( Scimitar-horned oryx) AX 164 163 
Reduncinae 
Kobus ellipsiprymnus ( Waterbuck) EU032302 
Camelidae 
Came/us dromedarius (Dromedary) Y09760 
Cervidae 
Capreol mae 
A Ices alces (Moose) AY639095 
Capreolus capreolus (Western roe deer) AY639096 
Odocoileus virginianus(White-tailed deer) AY2757 12 
Rangfer tarandus (Caribou) EU032303 
Cervinae 
Cervus elaphus scoticus (Red deer) EU03 2277 
Dama dama (Fallow deer) AY639094 
I Ivdropotinae 
Hydropotes inermis ( Chinese- water deer) DQ3 58969 
Hominidae 
Homo sapiens (Human) M13899 
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Family 
Su I) (a in 1% 
Genus, species (Common name) - CenBank Accession n. 
Canidac 
f,,Iuo,s (Dog) AF042843 
\lustrl,dae 
Muslelinae 
Uusteka vtson (Mink) S46825 
:ntilocapridae 
ÂmE locapra americana (Pronghorn) AFI 56 87 
Bbs dae 
\rnt ilopinae 
Gazellathomseeui (Thomsonsgazelle) EU032301 
))ovinae 
T,agelaphus amganii (Nyala) EU032295 
I aprinae 
Capra hireas (Domestic goat) EU032304 
II ppolraginae 
(Aye dainmith (Scimitar -homed oryx) AX 164163 
Reduncinae 
Xobusethpszprymnus (Waterbuck) EU032302 
S amclidae 
Carnelus dromedarius (Dromedary) Y0976)J 
Cers dae 
Capreolinac 
Rangiferlarandus (Caribou) EU032303 
Cervinae 
Cernvselapiiusscolscus (Red deer) 51032277 
I lydropotinae 
Hydropoles memos (Chinese -water deer) DQ358969 
Moschidac 
Manchuschrysogasrrr ( Alpine musk deer) AY723286 
Suidac 
Suinae 
Sun xroJa (Pig) L07623 
Deiphinidac 
Tursiops rnaicatus (Botllenosed dolphin) DQI 30070 
'nira 
Macropodidae 
Macropus eugenmi (Tammar wallaby) AY659987 
Phalangenidae 
Trichosurus vu/peru/a (Silver-gray brushlail possum) L38993 
'ha 
l.eporidae 
O,yrtolagus cuniculus (Rabbit) 1328334 
niodartsla 
Equidan 
sorm,, (Ass) AYOOPS9O 
Cercopithecrdae 
(ercopithecoac 
Macaca ma/uUu Rhesus rnor,kes (108307 
Colobinae 
Presb)rmsfrancrnsl ( Francoi's black teal rrsor,kev 
Cheirogaledae 
(heirogaleinse 
Microcebusmumunas ( Gray mouse lernur) DQ014 5 40 
Hominidae 
Flomo sapiens (Human) Ml 3898 
Hylobatidae 
Shrnphalangus see&sctylvs (Siamang) [08308 
1 r,cetinae 
Mesocricelusanrans (Golden hamster) 1(02234 
'gmodontinae 
Sigmorion hisphiUs (Hispid cotton rat) AFI 17325 
Olu, (ac 
(erbillinac 
Menones unguicutasus (Mongolian jird) OF 117314 
Munnae 
Mus ,mcsc,thrs (House mouse) Ml 8070 
Sciuridac 
S)gnsodontinar 
Ssgmruionfulrrwnter (Tasny-bellied cotton rat) AFI i7524 
B) 
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Chapter III: Genetic Variability of the PrP and 
PBGD Genes 
3.1 	Introduction 
One of the main aims of this thesis was to investigate the selective forces acting on coding 
and non-coding areas of the cervid PrP gene. On this basis, PRNP gene sequences 
(approximately 2kb) were generated from 98 animals (50 C. elaphus and 48 C. canadensis), 
which were then analysed for polymorphisms. While the studied C. elaphus samples 
originated from a single red deer population from the Isle of Rum, the C. canadensis samples 
were obtained from two neighbouring populations in Colorado: DAUs E-8 and E-9 (Section 
2.1). To date, the open reading frame of the wapiti PRNP gene has been sequenced in 
approximately 400 animals and low levels of genetic variability have been identified: three 
silent polymorphisms at codons 21, 104 and 246 and a single nonsynonymous polymorphism 
at codon 132 (Section 3.2.2) (O'Rourke et al. 1998; O'Rourke et al. 1999; Raymond et al. 
2000). These studies examined farmed and wild populations and both CWD + 1 and CWD VE 
animals were analysed. In the case of red deer, just over 100 animals have been analysed to 
date as part of two independent genetic studies. Eight SNPs have been identified: 4 
synonymous and 4 nonsynonymous (Section 3.2.2) (Kaluz, Kaluzova, and Flint 1997; 
Peletto et al. 2005). 
The sequencing data obtained in the current study were then analysed using 
population genetics statistiôal tests to investigate the selective forces acting on coding and 
non-coding areas of the cervid PrP gene (Chapter 5). To determine the possible effects of 
demography on the population genetics tests and to identif' differences in the genetic 
variability patterns of genes within the same species, a house-keeping protein gene was also 
analysed. The porphobilinogen deaminase gene was selected and gene sequences 
(approximately 1.8kb) were produced and analysed for polymorphisms in a total of 57 
animals. The PBGD gene has been intensely investigated in humans and although some 
information is available on this locus in other mammalian species, most of these sequences 
have been obtained from screening data from genome sequencing projects (Section 1.29). 
This control locus was sequenced in 32 (12 CWD, VE and 20 CWfl1) C. canadensis and 25 
C. elaphus samples. 
The target regions selected for the two genes of interest had similar size and 
structural composition (Figure 3). The same regions of the PrP and PBGD genes were also 
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amplified and sequenced for a single goat sample and the obtained sequences were used as 
out-group sequences in the population genetics study (Chapter 5). 
PRNP ORF sequences from seven additional species from the suborder Ruminantia 
(Table 4) were also obtained to enhance the power of some of the test statistics implemented 
for the detection of positively selected sites (Chapter 6). 
The numbering of the amino acid residues throughout this chapter, unless stated, is 
based on the structure of the Cervus elaphus PrP and PBGD proteins (Appendix 2 and 
Appendix 3). 
This chapter describes the genetic variation identified in the target regions of the 
studied species. 
3.2 Results 
3.2.1 	Genetic Variability of the PrP Gene 
For most of the Rum deer and all the Colorado wapiti samples, the target region (Figure 3) 
was amplified using oligonucleotides MP-574d and MP+690u (Figure 3 and Table 6). The 
target region obtained for the 50 red deer and the 48 wapiti samples was 2067bp in length. 
Some of the C. elaphus samples were amplified using MP-540d and MP+690u (Figure 3 and 
Table 6); using these oligonucleotides the size of the target region was reduced to 2032bp. 
Both species had similar levels of genetic variability within the target area of the PrP 
gene; 12 variable sites were found in red deer while 13 were found in Colorado wapiti. A 
four nucleotide deletion was also found in the 3'UTR of the red deer PrP gene. Table 9 gives 
more information on the variants identified in the study together with the frequencies of each 
allele. Both species had a higher number of nonsynonymous than synonymous variants: 3 
nonsynonymous changes for both species while the synonymous changes were one for Rum 
deer and two for Colorado wapiti. As expected, the number of transitions was higher than the 
number of transversions in both species (Table 9). Five of the 13 variants identified in the 
PRNP of wapiti had a frequency of 0.01. Four out of these five were carried by one CWDVE 
allele identified in a E-9 animal: Wh-4 (Table 11). The significance and origin of this highly 
divergent allele is unclear and it could be simply due to the presence of low numbers of 
animals within the E-9 population which were introduced or escaped from farmed wapiti 
herds and thus potentially originated from different regions or states of the US. 
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3.2.2 	Genetic Variability of the PRNP ORF 
Nine variable sites were identified in the ORF of the two analysed species. Three novel 
cervid singletons were identified: K25R and T191A in C. canadensis and P168S in C. 
elaphus. Despite their close taxonomic relationship, none of the polymorphisms identified 
within the ORF were shared by both species. The sequencing oligonucleotides used to 
sequence each polymorphic site are described in Figure 7 to Figure 15. 
Although the nucleotide sequence of the PrP N-terminal peptide repeats is highly 
conserved at the amino acid level throughout the mammalian evolution, significant variation 
in the number of repeats has been described within and between mammalian species 
(Collinge 2001; Van Rheede et al. 2003). All the C. elaphus and C. canadensis animals 
studied for this thesis possessed five histidine-glycine-proline rich octapeptide repeats; this 
was also true for the Rangfer tarandus sample analysed (Section 3.2.9). The analysis of all 
the cervid PrP sequences published in peer-reviewed papers and on online databases found 
no variation in the number of octarepeats present in the PrP protein encoded by species of 
the family Cervidae. 
3.2.2.1 Synonymous Variants 
Three of the nine variants identified within the coding regions of the two cervid species did 
not result in a change in the encoded amino acid: codon 21, codon 104 and codon 136. 
Codon 21 is highly variable in the genus Cervus; to date, synonymous SNPs at this 
codon have been identified in C. elaphus, C. canadensis (AF016228 and AF016227) and C. 
nippon (O'Rourke et al. 1998; O'Rourke etal. 1999; Kataoka etal. 2005; Peletto et al. 2005). 
In this study, the red deer gene was not polymorphic at this position while a silent change 
[gtc (V)Igtt (V)] was found in wapiti (Figure 16). The probability for this mutation to occur 
is high as it is in a CpG dinucleotide (codons 2 1/22: gtcggc) which is often a mutational 
hotspot in which cytosine mutates to thymine and guanine to adenine. A nonsynonymous 
SNP has also been identified at this position in caprine PrP (Billinis et al. 2002). 
A guanine to adenine transition was identified at the third base of codon 104 (Figure 
10) of the wapiti PRNP (Table 9). This position was polymorphic in 8 of the studied animals; 
one animal homozygous for this change was also found. This SNP had been previously 
identified in a number of C. canadensis populations (O'Rourke et al. 1998; O'Rourke et al. 
1999). 
A synonymous cytosine to thymine transition at the third base of codon 136 (Figure 
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12) was identified in red deer; this was a common SNP and the variant allele was found at a 
frequency of 0.24 (Table 9). This position had also previously been found to be polymorphic 
in Cervus nippon and Italian populations of C. elaphus (Kataoka et al. 2005; Meng et al. 
2005; Peletto et al. 2005). Nonsynonymous variation at this codon plays a key role in the 
modulation of scrapie in sheep (Goldmann et al. 1991 a) (Section 1.13). 
32.2.2 Codon 25 
A nonsynonymous variation was identified at codon 25 (Figure 8) of the wapiti PRNP. This 
variant was only identified in one animal (CWD VE) and has not been found in any other 
cervid species. An adenine to guanine transition in the second base of the codon results in a 
change from lysine (K) to arginine (R) (Table 9). Although this is a conservative change of 
amino acid residue, it nevertheless changes the N-terminus of mature PrP. The N-terminus 
appears to be a region of low genetic variability and none of the SNPs identified in this 
region have been linked to disease, for any of the TSE affected species. 
3.2.2.3 Codon 98 
A nonsynonymous polymorphism at codon 98 (Figure 9) was detected in ten of the fifty red 
deer analysed and one animal homozygous for the variant allele was also identified (Table 
7). An adenine to guanine transition in the first base of the codon results in a change from 
threonine (T) to alanine (A) (Table 9). This SNP is located in the N-terminus immediately 
before the stop transfer effector region (residues 99-1 11). This polymorphism seems to be 
unique to C. elaphus and it has also been identified in a population of Italian red deer 
(Peletto et al. 2005). 
Table 7 - Codon 98 Genotype Frequencies 
The table gives the number and percentage of animals per genotypic group for codon 98. 
Thr/Thr 	Thr!Ala 	Ala/Ala 
39 (78%) 	10 (20%) 	1 (2%) 
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3.2.2.4 Codon 132 
Codon 132 was polymorphic in wapiti but not in red deer. An adenine to thymine 
transversion in the first base of the codon results in a change in the encoded amino acid from 
methionine (M) to leucine (L). This position corresponds to the human codon 129, which has 
been shown to have disease susceptibility and phenotype modifying effects in all human 
prion diseases (Mead 2006) (Section 1.15). It is located within the first of the two antiparallel 
n-sheets. A protective role of variation at codon 132 has also been proposed in wapiti 
(O'Rourke et al. 1999; Spraker et al. 2004a); this hypothesis is challenged in Chapter 4. To 
date, all the studies investigating the genetic variability of the C. elaphus PRNP gene have 
failed to identify variation at this position (Kaluz, Kaluzova, and Flint 1997; Peletto et al. 
2005), despite the close taxonomic relationship between wapiti and red deer. It is therefore 
likely that this mutation happened in the wapiti genome after the separation from the 
common ancestor. 
3.2.2.5Codon 168 
Codon 168 (Figure 13) was identified as polymorphic in one of the red deer alleles. A 
cytosine to thymine transition results in an amino acid change from proline (P) to serine (S) 
(Table 9). Codon 168 is located within the C-terminus, between the second f3-sheet and the 
first a-helix. A SNP at the same position in sheep, P168L has been shown to be associated 
with low susceptibility to experimentally inoculated BSE (Goldmann et al. 2006b), and this 
codon as been also described as polymorphic in caprine PrP (P168Q) (Billinis et al. 2002). 
No SNPs have been identified at this position in any other member of the family Cervidae 
analysed to date. 
3.2.2.6 Codon 191 
An adenine to guanine transition at the first base of codon 191 (Figure 14) results in an 
amino acid change from threonine (T) to alanine (A) (Table 9). Codon 191 is located within 
the second a-helix of the PrP protein. Heterozygosity at this position was only seen in one of 
the wapitis (CWDv1). This site corresponds to human codon 188; three SNPs at this position 
have been identified as pathogenic and are believed to result in the development of CJD: 
Ti 88K, Ti 88A, Ti 88R (Windl etal. 1999; Collins etal. 2000; Finckh etal. 2000). 
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3.2.2.7 Codon 226 
A guanine to cytosine transversion in the first base of codon 226 (Table 9 and Figure 15) 
results in an amino acid change from glutamic acid (B) to glutamine (Q) in 11 of the red deer 
alleles (Table 8). This SNP is located in the third a-helix of the PrP protein. The same 
polymorphism had been previously found in Italian red deer (Peletto et al. 2005) and CerviLs 
nippon (Meng et al. 2005). Variation at this position has also been found Odocoileus 
virginianus but in this case glutamine was replaced by lysine (Johnson et al. 2006). A 
synonymous polymorphism at codon 226 has been identified in cattle (Wopfner et al. 1999). 
A role in TSE could be possible as it is adjacent to codon 225; heterozygosity at this position 
has been linked to increased CWD resistance in mule deer (Jewell et al. 2005; Fox et al. 
2006). 
Table 8 - Codon 226 Genotype Frequencies 
The table gives the number and percentage of animals per genotypic group for codon 226. 
Glu/Glu 	Giu/Gln 	Gin/Gin 
29 (58%) 	18 (36%) 	3 (6%) 
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Figure 7 - Variability at Codon 21 
A) Cervus canadensis consensus sequence. Forward primer: MP-213d. This area was also 
sequenced using a reverse primer, MP46u (Not shown). The variable site was sequenced 
bidirectionally: B) Forward primer: MP-213d; C) Reverse primer: MP46u. See (Table 6) for 
more information on the primers. The IUPAC (International Union of Pure and Applied 
Chemistry) code for ambiguous nucleotides was used to describe the heterozygous 
positions, in yellow. 
Ivi,Nk! 
B) C) 
;TGCAOAGGCC AC OTCA C 	C C A C 
AN 
Figure 8 - Variability at Codon 25 
A) Cervus canadensis consensus sequence. Forward primer: MP-213d. This area was also 
sequenced using a reverse primer, MP115u (Not shown). The variable site was sequenced 
bidirectionally: B) Forward primer: MP-213d; C) Reverse primer: MP115u. See Table 6 for 
more information on the primers. The IUPAC code for ambiguous nucleotides was used to 






Figure 9 - Variability at Codon 98 
A) Cervus elaphus consensus sequence. Forward primer: MP50d. This area was also 
sequenced using a reverse primer, MP196u (Not shown). The variable site was sequenced 
bidirectionally: B) Forward primer: MP50d; C) Reverse primer: MP196u. See Table 6 for 
more information on the primers. The The IUPAC code for ambiguous nucleotides was used 






Figure 10-Variability at Codon 104 
A) Cervus canadensis consensus sequence. Forward primer: MP50d. This area was also 
sequenced using a reverse primer, MP196u (Not shown). The variable site was sequenced 
bidirectionally: B) Forward primer: MP50d; C) Reverse primer: MP196u. See Table 6 for 
more information on the primers. The IUPAC code for ambiguous nucleotides was used to 
describe the heterozygous positions, in yellow. 
A)t 	
C C £ G A A A CC A A A A £ 
B) 
rAcc C £ C £ GCAG T GACA A. CC CA £7 A A A CC 
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Figure 11 - Variability at Codon 132 
A) Ceivus canadensis consensus sequence. Forward primer: MP50d. This area was also 
sequenced using a reverse primer, MP196u (Not shown). The variable site was sequenced 
bidirectionally: B) Forward primer: MP50d; C) Reverse primer: MP196u. See Table 6 for 
more information on the primers. The IUPAC code for ambiguous nucleotides was used to 
describe the heterozygous positions, in yellow. 
A) 
B) 
C C I CG S G GCI £CW I S C I 55555 5 	SC CA 	GAG 
c) 
Figure 12-Variability at Codon 136 
A) Cervus elaphus consensus sequence. Forward primer: MP50d. This area was also 
sequenced using a reverse primer, MP196u (Not shown). The variable site was sequenced 
bidirectionally: B) Forward primer: MP50d; C) Reverse primer: MP196u. See Table 6 for 
more information on the primers. The IUPAC code for ambiguous nucleotides was used to 




Figure 13 - Variability at Codon 168 
A) Cervus elaphus consensus sequence. Forward primer: MP50d. This area was also 
sequenced using a reverse primer, MP+16u (Not shown). The variable site was sequenced 
bidirectionally: B) Forward primer: MP50d; C) Reverse primer: MP+16u. See Table 6 for 
more information on the primers. The IUPAC code for ambiguous nucleotides was used to 
describe the heterozygous positions, in yellow. 
B) 
Figure 14 - Variability at Godon 11 
A) Cervus canadensis consensus sequence. Forward primer: MP135d. This area was also 
sequenced using a reverse primer, MP252u (Not shown). The variable site was sequenced 
bidirectionally: B) Forward primer: MP135d; C) Reverse primer: MP252u. See Table 6 for 
more information on the primers. The IUPAC code for ambiguous nucleotides was used to 
describe the heterozygous positions, in yellow. A) 
B) 
i r ICA £ C £ TC A CA GGTC& A r,CA £ C I CEC £ c I c I 	 G I A A C I A 	A I C I I A C I A A C 	A 
ill 
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Figure 15 - Variability at Codon 226 
A) Cetvus canadensis consensus sequence. Forward primer: MP157d. This area was also 
sequenced using a reverse primer, MP+16u (Not shown). The variable site was sequenced 
bidirectionally: B) Forward primer: MP157d C) Reverse primer: MP+16u. See Table 6 for 
more information on the primers. The IUPAC code for ambiguous nucleotides was used to 
describe the heterozygous positions, in yellow. 
- 
C) 
A 	C 	C 	C 7 G G T A 
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3.2.3 	Variation in Non-coding Regions of the PrP Gene 
Six out of a total of 13 wapiti variable sites were located in the intronic section of the target 
region; while only two of them were identified in the 3'UTR. No genetic variation was 
present in 10 bases of the 5'UTR (Table 6). Similar results were obtained for red deer: 5 
variable sites within the intronic region and 4 within the 3 'UTR. One of the variants within 
the 3 'UTR was a 4bp deletion (Table 6). The only polymorphism shared by both cervid 
species was a cytosine to thymine transition in Intron II (nucleotide 235). See Figure 16 and 
Figure 17 for the chromatograms of the variants described in this section. 
Figure 16 - Variable Sites Located Outside the ORF (Wapiti PrP) 
All the genetic variants were sequenced bidirectionally. The sequencing oligonucleotides are 
given. The red deer consensus sequence (Appendix 2) was used as reference for the 
numbering of the nucleotides. A and B: Intron II nucleotide 108 (Y). Forward primer (A): MP-
540d; Reverse primer (B): MP-153u. C and D: Intron II nucleotide 123 (R). Forward primer 
(C): MP-540d; Reverse primer (D): MP-153u. E and F: Intron II nucleotide 172 (Y). Forward 
primer (E): MP-540d; Reverse primer (F): MP-153u. G and H: Intron II nucleotide 234 (Y). 
Forward primer (G): MP-534d; Reverse primer (H): MP-153u. I and K: Intron II nucleotide 
496 (K). Forward primer (I): MP-213d; Reverse primer (K): MP46u. L and M: Intron II 
#nucleotide 549 (Y). Forward primer (L): MP-213d; Reverse primer (M): MP98u. N and 0: 
3'UTR nucleotide 1718 (Y). Forward primer (N): MP230d; Reverse primer (0): MP+692u. P 
and Q: 3'UTR nucleotide 1961 (R). Forward primer (P): MP+297d; Reverse primer (Q): 
MP+692u. See Table 6 for more information on the primers. The IUPAC code for ambiguous 
nucleotides was used to describe the heterozygous positions, in yellow. 
74 
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Figure 17 - Variable Sites Located Outside the ORF (Red Deer PrP) 
All the genetic variants were sequenced bidirectionally, with the exception of the 
polymorphism at position 1548 (Y) in the 3'UTR of the PrP gene. This was due its proximity 
to the 4bp deletion. This SNP was confirmed through cloning. The sequencing primers are 
given; see Table 6 for more information on the primers. The red deer consensus sequence 
(Appendix 2) was used as reference for the numbering of the nucleotides. A and B: Intron II 
nucleotides 151 and 152 (R). Only one image was used to represent both variable sites due 
to their proximity. Forward primer (A): MP-534d; Reverse primer (B): MP-153u. C and D: 
Intron II nucleotide 235 (Y). Forward primer (C): MP-534d; Reverse primer (D): MP-153u. E 
and F: Intron II nucleotide 430 (Y). Forward primer (E): MP-213d: Reverse primer (F): 
MP46u. G and H: Intron II nucleotide 461 (R). Forward primer (G): MP-213d; Reverse primer 
(H): MP46u. I and K: 3'UTR, 4bp deletion 1451-1454 (cttt). Forward primer (I): MP230d; 
Reverse primer (K): MP+296u. L: 3'UTR nucleotide 1548 (Y). Reverse primer (L): MP+296u. 
M and N: 3'UTR nucleotide 1550 (Y). Forward primer (N): MP230d; Reverse primer (0): 
MP+296u. 0 and P: 3'UTR nucleotide 1854 (R). Forward primer (P): MP+297d; Reverse 
primer (Q): MP+692u. The IUPAC code for ambiguous nucleotides was used to describe the 
heterozygous positions, in yellow. 















Table 9 - Genetic Variability of the PrP Gene 
Genetic variants identified during the direct sequencing of the target region of the wapiti (A) 
and red deer (B) PrP gene. The allelic frequency of the least common variants is given. The 
red deer consensus sequence (Appendix 2) was used as reference for the numbering of the 
nucleotides. The IUPAC code for ambiguous nucleotides was used to describe the non 
coding variants; while for the variants within the coding region, the codon position is given 
together with the three nucleotides, and the encoded amino acid in brackets. TR = 
transversions and TS = transitions. 
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A) Nucleotide 















CDS CDS CDS CDS CDS 3'UTR 3'UTR 
Codon 21 Codon 25 Codon 104 Codon 132 Codon 191 
Alleles V R V V K V 
gtc (V)Igtt (V) aag(K)/agg(R) aag(K)/aaa(K) atg(M)/ttg(L) aca(T)/gca(A) 
V R 
Substitution 
TS TS TS TS TR TS TS TS TS TR TS TS TS 
Type 
Allelic 
0.01 0.33 0.21 0.01 0.33 0.01 0.32 0.01 0.1 0.21 0.01 0.2 0.11 
frequency 
B) Nucleotide 













COS CDS CDS CDS 3UTR 3UTR 3IJTR 3'UTR 
Codon 98 Codon 136 Codon 168 Codon 226 
Alleles R R V V R CTFT Y S R 
acc(T)/gcc(A) gcc(A)/gct(A) cca(P)/tca(S) gag(E)/cag(Q) 
Substitution 
TS TS TS TS TS TS TS TS TR Indel TS TR TS 
Type 
Allelic 




3.2.4 	Genotypes and Haplotypes of the PrP gene 
Only 10 genotypes were identified for the 48 wapiti samples. No association was found 
between genotypes and disease. Genotypes W-9 and W-10 (Table 10) were only found in 
CWD,vE  animals, but this is likely to be due to the low frequency of these genotypes. The 
genotypic variability of red deer was higher, with 18 unique genotypes, although most of 
them were rare; they all had frequencies in the 0.02-0.08 range with the exception of R-6 and 
R-1 (Table 10). An analysis of the haplotypes identified 7 different haplotypes for wapiti and 
11 for red deer. For wapiti, two of the seven haplotypes represented 85% of the alleles (Wh-
1 and Wh-6) while for red deer the three most common haplotypes (Rh-lIRh4IRh-11) 
represented 73% of the alleles (Table 11). 
When the whole target area was taken into consideration, the level of similarity 
between the two most common alleles of wapiti and red deer was very high: 99.9%, a 
difference of only three nucleotides over the 2067bp of the target region. Surprisingly the 
two species do not share any haplotypes, when the whole target region is compared, but 
when the comparison is narrowed to the ORF only, then the two species share the two most 
common haplotypes. These two haplotypes, which include only sites within the ORF, 
represent 66.6% and 76% of the alleles of wapiti and red deer, respectively. In the case of 
wapiti the three most common haplotypes were found at very similar frequencies both in 
CWD+VE  and CWDVE animals. Wh-2, Wh-4, Wh-5 and Wh7 were only found in CWD VE 
animals but all of these haplotypes had frequencies of 0.01. 
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Table 10 - Wapiti and Red deer Genotypes (PrP) 
Genotypes identified through the direct sequencing of the target area of the PrP gene. A) 
wapiti B) red deer. Heterozygosity at a specific position is marked in red, homozygosity for 
the most common allele in white and homozygosity for the alternative allele in green. For 
more information on the specific variants see Table 9. The red deer consensus sequences 
(Appendix 2) was used as reference for the numbering of the nucleotides. The IUPAC code 
for ambiguous nucleotides was used to describe the non coding variants. The letter "W" is 
used to identify the wapiti's genotypes while the letter "R" is used for the genotypes identified 
for red deer. The nucleotides representing the most common alleles are given in W-1 and R-
1. In table B, "CTTT" in the column representing the 4-bp indel indicates the presence of the 
4 nucleotides in the most common allele. 
A) 
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Table 11 - Wapiti and Red deer Haplotypes (PrP) 
Haplotypes identified through T-vector cloning and the application of the PHASE v.2.1.1 
software. A) wapiti B) red deer. The most common allele is defined in white, while the 
alternative allele in green. For more information on the specific variants see Table 9. The red 
deer consensus sequences (Appendix 2) was used as reference for the numbering of the 
nucleotides. The IUPAC code for ambiguous nucleotides was used to describe the non 
coding variants. The letters Wh" are used to identify the wapiti's haplotypes while the letters 
"Rh" are used for the haplotypes identified for red deer. The nucleotides representing the 
most common alleles are given in Wh-1 and Rh-i. In table B, "CTTT" in the column 
representing the 4-bp indel indicates the presence of the 4 nucleotides in the most common 
allele. The nucleotide sequence of each haplotype was submitted to GenBank, the 
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Accession numbers: Wh.I = EU032288; Wh-2 = EU032289; Wh-3 = EU032290; Wh-4 = EU032291; Wh-5 = EU032292; 
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Accession numbers: Rh-I = Eu032277, Rh-2 = EU032278: Rh-3 = EU032279, Rh-4 EU032280, Rh-S = EU032281. 
Rh-6 = EU032282; Rh-i = Eu032283; Rh-8 = EU032284: Rh-9 = EU032285; Rh-10 = EU032288 1  
Rh-il = EU032287 
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3.2.5 	Genetic Variability of the PBGD Gene 
The target region (1840bp for both populations) was sequenced for 25 red deer and 32 wapiti 
(12 CWD,vE  and 20 CWD). This region of the PBGD gene (Figure 3) included exons IX 
to Xlv and a section of the 3'UTR as well as the introns separating the six exons. The 
amplicon was obtained using oligonucleotides PBGD-I-viii-ld and Cattle-Intergenic (Figure 
3 and Table 6). The PBGD gene was highly conserved in both species. The only variable site 
identified within the CDS was located in Exon IX (Codon 178) of the red deer PBGD gene: 
gac (N)/gat (N). Table 12 summarises the characteristics of the variants identified. Eight 
polymorphic sites were identified within the target area of the red deer locus, four of which 
were indels; two were located in the Intronic region and two in the 3'UTR (Table 12 and 
Figure 19). The wapiti locus was even more conserved and only three variable sites were 
identified (Table 12 and Figure 18). 
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Figure 18 - Variable Sites within the Target Region of the Wapiti PBGD Gene 
Positions 1448-Y and 1482-Y were sequenced bidirectionally while 1791-S was sequenced 
on a number of different PCR products and was confirmed through cloning. The sequencing 
primers are given. See Table 6 for more information on the primers. The red deer consensus 
sequence (Appendix 3) was used as reference for the numbering of the nucleotides. A and 
B: 3'UTR nucleotide 1448 (Y). Forward primer (A): PBGD-l.xii-654d; Reverse primer (B): 
Deer-lntergenic-16u. C and D: 3'UTR nucleotide 1482 (Y). Forward primer (C): PBGD-l.xii-
654d; Reverse primer (D): Deer-lntergenic-16u. E and F: 3'UTR nucleotide 1791 (S). 
Forward primers (E): PBGD-3'UTR-901d and (F): PBGD-l.xiii-810d. The IUPAC code for 
ambiguous nucleotides was used to describe the heterozygous positions, in yellow. 
C A C A 6 G6C C GC 	7 	G C T 66 :&C C 
B; 	Cc 	CA C & 	A C C 	& AG A AC rAG ACG 
C) C A CA G & AC C AC 	I TA CT AG IC CC - 	& CCC 





Figure 19 - Variable Sites within the Target Region of the Red Deer PBGD Gene 
All the alleles were sequenced bidirectionally with the exception of 1582-Y which was 
sequenced on a number of different PCR products and was confirmed through cloning. The 
sequencing primers are given. See Table 6 for more information on the primers. The red 
deer consensus sequence (Appendix 3) was used as reference for the numbering of the 
nucleotides. A and B: Intron IX nucleotide 155 (Y). Forward primer (A): PBGD-E.ix-ld; 
Reverse primer (B): PBGD-I.ix-128u. C and D: Intron IX Deletion nucleotides 158-162 (ctc). 
Forward primer (C): PBGD-E.ix-ld; Reverse primer (D): PBGD-E.xi-65u. E and F: Intron XII 
Deletion nucleotides 980-983 (Ct). Forward primer (E): PBGD-E.xiii-126u; Reverse primer 
(F): PBGD-E.xiii-126u. G and H: 3'UTR Deletion nucleotides 1452-1467 (ggtgcct or ctggtgc). 
Forward primer (G): PBGD-l.xiii-810d; Reverse primer (H): Deer-Intergenic-16u. I and K: 
3'UTR, nucleotide 1563 (R). Forward primer (I): PBGD-l.xiii-810d; Reverse primer (K): Deer-
Intergenic-16u. L and M: 3UTR nucleotide 1582 (Y). Reverse primer (L and M): Deer-
Intergenic-16u. N and 0: 3'UTR deletion nucleotide 1588-1595 (a). Forward primer (N): 
PBGD-I.xiii-810d; Reverse primer (0): Deer-lntergenic-16u. P and Q: Exon IX codon 178 
nucleotide 58. Forward primer (P): PBGD-E.ix-ld; Reverse primer (Q): PBGD-I.ix-128u. The 
IUPAC code for ambiguous nucleotides was used to describe the heterozygous positions, in 
yellow. The exact position of the four indels could not be identified due multiple repeats of 
the indels in the area. In the case of the 7bp indel (0 and H) the exact sequence of the indel 
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Table 12 - Genetic Variability of the PBGD gene 
Genetic variants identified during the sequencing of the target region of the wapiti (A) and 
red deer (B) PBGD gene. The exact position of the four red deer indels could not be 
identified due multiple repeats of the indels in the area. In the case of the 7bp indel in the 
3'UTR of the red deer PBGD gene, the exact sequence of the indel could not be identified 
due to the nature of the nucleotide sequence. For the only variable site located within the 
CDS the codon position is given together with the three nucleotides, and the encoded amino 
acid in brackets. The bovine amino acid numbering was used. The allelic frequency of the 
least common variants is given. The red deer consensus sequence (Appendix 3) was used 
as reference for the numbering of the nucleotides. The IUPAC code for ambiguous 
nucleotides was used to describe the non coding variants. TR = transversions and TS = 
transitions. 
Nucteotide N. 1448 1482 1791 
Position 3'UTR 3'UTR 3'UTR 
Alleles Y Y S 
Substitution Type TS TS TR 




58 155 158-162 980-983 1452-1467 1563 1582 1588-1595 
N. 
Position 
Exon IX Intron 









TS TS Indel lndel Indel TS TS Indel 
Type 
Allelic 




3.2.6 	Genotypes and Haplotypes of the PBGD gene 
The target region of the wapiti PBGD gene was highly conserved and only four haplotypes 
were identified (Wh-PBGD.1 to Wh-PBGD.4). The two most common haplotypes, Wh-
PBGD.1 and Wh-PBGD.2) represented 95.3% of the haplotype variation. Four genotypes 
were identified; two of which had a frequency below 0.1 (Table 13). The eight 
polymorphisms identified within the target region of the red deer PBGD gene resulted in 6 
haplotypes (Table 14), although the three most common ones represented 84% of the 
haplotype variation. Of all the possible genotypes, eleven were identified (Table 13). 
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Table 13 - Wapiti and Red Deer Genotypes (PBGD) 
Genotypes identified through the direct sequencing of the target area of the PBGD gene. A) 
Wapiti B) red deer. Heterozygosity at a specific position is marked in red, homozygosity for 
the most common allele in white and homozygosity for the alternative allele in green. For 
more information on the specific alleles see Table 12. The red deer consensus sequences 
Appendix 3 was used as reference for the numbering of the nucleotides. The IUPAC code for 
ambiguous nucleotides was used to describe the heterozygous positions. The letter W' is 
used to identify the wapiti's genotypes while the letter UR  is used for the genotypes identified 
for red deer. The nucleotides representing the most common alleles are given in W-PBGD.1 
and R-PBGD.1. In the case of the deletions, the absence of the deletion is represented by 
reporting the nucleotides involved in the indel in R-PBGD.1. In the case of the 7bp indel in 
the 3'UTR of the red deer locus, exact sequence of the indel could not be identified due to 
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Table 14 - Wapiti and Red Deer Haplotypes (PBGD) 
Haplotypes identified through T-vector cloning and the application of the PHASE v.2.1.1 
software. A) Wapiti B) red deer. The most common allele is defined in white while the 
alternative allele in green. For more information on the specific variants see Table 12. The 
red deer consensus sequences (Appendix 3) was used as reference for the numbering of the 
nucleotides. The IUPAC code for ambiguous nucleotides was used to describe the 
heterozygous positions. The letters "Wh" are used to identify the wapitis haplotypes while 
the letters "Rh" are used for the haplotypes identified for red deer. The nucleotides 
representing the most common alleles are given in Wh-1 and Rh-i. The nucleotide 
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Accession numbers: Rh-PBGD.1 = EU032306; Rh-PBGD.2 = EU032307, Rh-PBGD.3 = EU032308; 
Rh-PBGD.4 = EU032309 Rh-PBGD.5 = EU032310: Rh-PBGD.6 = EU032311 
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3.2.7 	PBGD Pseudogene 
The human and cattle genomes are PBGD-pseudogene free (Janssens et al. 2004). However, 
it appears that at least one pseudogene exists for the C. canadensis PBGD gene. The 
presence of the pseudogene was detected during the optimisation of the PCR reaction. When 
both PCR oligonucleotides were binding exonic DNA, two PCR amplicons were obtained 
(Figure 20). An analysis of the molecular weight of the smaller PCR band suggested that this 
could be a pseudogene lacking the introns. This suggestion was confirmed after the smaller 
band was gel extracted (Section 2.8) and sequenced. The two amplicons were obtained using 
four different sets of oligonucleotides: PBGD-E.xii-lOd - PBGD-E.xiv-41u; PBGD-E.xii-
lOd - PBGD-E.xiv-41u-2; PBGD-E.ix-14d - PBGD-E.xiv-41u-2 and PBGD-E.ix-ld - 
PBGD-E.xiv-41u (Figure 3 and Table 6). The lack of introns is one of the classic 
characteristics of retrotransposed genes. However, other common characteristics like the lack 
of expressed mRNA and the presence of a 3' poly(A) tract and flanking repeats were not 
investigated in this study. From the sequencing of the smaller PCR amplicon, the full 
sequence of Exons X - XIII was obtained while the first 13 codons of Exon IX and the last 
10 codons of Exon X1V were not sequenced due to their absence from the amplicons as a 
result of the position of the PCR oligonucleotides. 
In addition to the absence of the introns a number of mutations were identified in the 
pseudogene. Four of these mutations did not result in a change of amino acid; these include a 
cytosine to thymine transition at the first base of codon 238 (nucleotide = 604), a cytosine to 
thymine transition at the third base of codon 260 (nucleotide = 896), a cytosine to thymine 
transition at the first base of codon 343 (nucleotide = 1362) and a cytosine to adenine 
transversion at the third base of codon 346 (nucleotide = 1373) (Appendix 6). Five 
nonsynonymous mutations were also found, which resulted in the following changes in 
amino acid composition between the pseudogene and the functional gene (the changes are 
represented by the codon number followed by the amino acid encoded by the functional gene 
and then by the one possibly encoded by the pseudogene): codon 263 V to M, codon 264 p 
to L, codon 270 T to A; codon 321 R to H and codon 325 R to Q (Figure 21) (Appendix 6). 
No nonsense mutations were identified. The presence of the pseudogene in C. elaphus, as 
well as its distribution within the three wapiti populations was not investigated. The 
nucleotide sequence of the PBGD pseudogene was submitted to GenBank; the accession is 
EU0323 18. 
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Figure 20 - PCR Amplification of the PBGD Pseudogene 
The two amplicons shown in the image were obtained using oligonucleotides PBGD-E.ix-14d 
and PBGD-E.xiv41u-2. The size difference between the two PCR bands is due to the lack of 
introns in the pseudogene (smaller DNA band). The DNA Molecular Weight Marker VI 
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Figure 21 - Sequencing of the PBGD Pseudogene 
The PBGD pseudogene lacked the introns, the images compare the chromatograms 
obtained from the sequencing of the two PCR amplicons shown in Figure 20. It can be 
clearly seen that despite sharing the initial few nucleotides the sequences start differing at 
the points indicated by the orange arrows. These are the ends of the different exons. For 
more details on the sequences see the full consensus sequence obtained for wapiti PBGD: 
Appendix 6. A, C, E, 0, I) Functional gene, the chromatograms show the 3'end of an exon 
and the 5' end of the following intron B, D, F, H, K) Pseudogene, the chromatograms 
includes the 3'end of an exon followed without interruption by the 5' end of another exon, 
indicating the lack of introns. A) Exon IX and Intron IX, sequenced using oligonucleotide 
PBGD-E.ix-14d B) Exon IX and Exon X, sequenced using oligonucleotide PBGD-E.ix-14d C) 
Exon X and Intron X, sequenced using oligonucleotide PBGD-E.ix-ld D) Exon X and Exon 
XI, sequenced using oligonucleotide PBGD-E.ix-14d. E) Exon XI and Intron Xl, sequenced 
using oligonucleotide PBGD-E.xi-63d F) Exon XI and Exon XII, sequenced using 
oligonucleotide PBGD-E.ix-14d. G) Exon XII and Intron XII, sequenced using oligonucleotide 
PBGD-E.xi-63d H) Exon XII and Exon XIII, sequenced using oligonucleotide PBGD-E.ix-14d. 
I) Exon XIII and Intron XIII, sequenced using oligonucleotide PBGD-I.xii-654d K) Exon XIII 
and Exon XIV, sequenced using oligonucleotide PBGD-E.ix-14d. 
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3.2.8 	Genetic Variability of the Caprine Genes 
The target regions of the PrP and PBGD genes analysed for the two cervid species were also 
amplified and sequenced for one goat. The sample was utilised as an outgroup for the 
population genetic study described in Chapter 5. Four different oligonucleotide sets were 
used to amplify the PRNP target region: MP-540dITvIP+690u, MP-540d/MP+692u, MP-
534dIM1P+690u and MP-534d/MP+692u. The different oligonucleotide sets produced PCR 
fragments of slightly different sizes and the sequencing of these amplicons provided 
unambiguous data for 2014bp of the capt-inc PrP gene. 
Thirteen heterozygous sites were identified within the 2014bp region of the analysed 
sample, suggesting higher levels of genetic variability for caprine PRNP compared to the 
cervid PRNP. As for C. canadensis and C. elaphus, the number of nonsynonymous variants 
was higher than the number of synonymous ones. This goat sample was part of a study to 
establish the level of genetic variability of PRNP coding region in UK goats carried out by 
the TSE Genetics Group (Institute for Animal Health, Edinburgh). The study revealed high 
levels of variation in the caprine PrP gene and has been published (Goldmann et al. 2004). 
Three of the heterozygous positions were located in intron II: nucleotide 221(Y), nucleotide 
403 (R) and nucleotide 482 (S). Five variable positions were identified in the 3'UTR: 
nucleotide 1415 (S), nucleotide 1658 (S), nucleotide 1831 (K), nucleotide 1874 (K), 
nucleotide 1921 (R). The remaining five heterozygous sites were located within the ORF. 
Three of the variants resulted in amino acid changes: 1142M, R21 IQ and S240P. These three 
sites had been previously identified as polymorphic in goat: 1142M (Goldmann et al. 1996), 
R21 1Q (Wopfner et al. 1999) and S240P (Goldmann et al. 1996). The genotype of this 
sample is 1 142Q211 S240 / M 142 R211 P240, the association between the other identified variants was 
not established. The 1142M SNP has been shown to modulate disease incubation periods in 
goats experimentally infected with isolates of BSE and scrapie (Goldmann et al. 1996). 
Variation at human codon 208 (R208H), which corresponds to the caprine codon 211 has 
been associated with the development of CJD (Telling et al. 1996; Roeber et al. 2005). To 
date none of the goats carrying the R2 11Q polymorphisms have been diagnosed with 
scrapie. The two silent polymorphisms, both of which were transitions, were located at the 
third base of codon 42 (guanine or adenine) and at the third base of codon 138 (cytosine or 
thymine). As expected the rate of transitions was higher than the rate of transversions. 
The target region of the PBGD gene was amplified using the oligonucleotides 
PBGD-I.viii-ld and Cattle-hitergenic (Table 6). Sequencing data were obtained for 2125 
nucleotides. Two heterozygous positions were identified: a guanine to thymine transversion 
at nucleotide 324 (Intron IX) and a thymine to cytosine transition at nucleotide 682 (Intron 
XI). 
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As expected from the intraspecies variation, both the PrP and the PBGD genes show 
high levels of conservation between the two cervid species and goat in coding and non-
coding areas of the two genes. The level of identity between the PBGD target regions of the 
two cervid species and the caprine one was 92.0%, while a slightly higher level of identity, 
just under 95%, was found between the PrP genes. 
All the genetic variants identified were sequenced bidirectionally and the numbering 
of their position was based on the red deer PrP and PBGD consensus sequences (Appendix 2 
and Appendix 3). The nucleotide sequences of the two haplotypes obtained for each target 
region were submitted to GenBank; the accession numbers are: EU032304 and EU032305 
for the PrP gene and EU0323 16 and EU0323 17 for the PBGD gene. 
3.2.9 	Genetic Variability of the PrP Gene in Ruminants 
The open reading frame from samples of seven species of the order Artiodactyla (even-toed 
ungulates) (Table 4) was analysed as part of a genetic variability study of the mammalian 
PrP gene. Partial sequences of the PrP gene from some of these samples were available 
(Goldmann, W. 2003. Unpublished) and were used for the design of PCR and sequencing 
oligonucleotides. The nucleotide sequences obtained for each species were submitted to 
GenBank; the accession numbers are given in brackets: EU032xxx. 
Tragelaphus angasii (Nyala) belongs to the group of captive ungulates that were 
diagnosed with BSE-like spongiform encephalopathies, which probably resulted from 
exposure to BSE contaminated feed (Jeffrey and Wells 1988). Three TSE-free nyala samples 
were studied and a novel synonymous cytosine (EU032295) to thymine (EU032296) 
transition was detected at codon 69 in two of the samples. 
A single Bison bonasus (European bison) sample was analysed. This species is 
taxonomically very close to Bison bison (American bison), which was also diagnosed with 
BSE-like spongiform encephalopathies (www.defra.gov.uk ). The full coding region was 
successfully sequenced and a synonymous variant was identified: an adenine (EU032297) to 
guanine (EU032298) transition at the third base of the last codon of the sixth repeat. 
Two species of the genus Bos were analysed: Bos grunniens (Yak) (EU03 2299) and 
Bos frontalis (Gaur) (EU032300). No polymorphisms were identified. The yak sequence 
was very similar to sequences currently available on online database (AY367637, 
AY367636, AY367635 and AY327450): a comparison of the five sequences identified a 
synonymous SNP at codon 90 (ggtlggc) and a nonsynonymous SNP at codon 121: A 121 V. 
None of the two SNPs were identified in the current study. All yak PrP sequences had six 
octapeptide repeats. No sequences of the gaur PrP gene have been published to date. The 
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gaur PrP gene was shown to contain five octapeptide repeats and, as expected, it was very 
similar to the PRNP sequences available for other members of this genus. 
One sample was analysed for Gaze/la thomsonii (Thomson's gazelle) (EU03230 1), 
sequences were available for two other members of the subfamily Antilopinae: Gazella 
subgutturosa (AF1 17313) and Antilope cervicapra (AY720705 and AY720706). No 
differences were seen between the three species at the amino acid level. 
One Kobus ellipsiprymnus (Waterbuck) sample was analysed. The waterbuck PrP 
gene had six octapeptide repeats and a novel variant was identified at codon 106: T106N (the 
codon numbering does not take the sixth repeat into account) (EU032302). 
The full ORF of one Rangfer tarandus (caribou) sample was successfully 
sequenced. However, depending on the oligonucleotides utilised for the PCR,, different PrP 
haplotypes were identified. The use of a specific oligonucleotide (MPO1d) was associated 
with the lack of the dimorphisms at position 129 (G -* S), 169 (V - M) and 176 (N - D). 
The oligonucleotide in question was MPO1d (Table 6). When primer MPO1d was used for 
the PCR, only the G1291V1691N176 haplotype was detected. The use of different primers 
resulted in two haplotypes: G129N1691N176 and S1291M169/D176. This difference in 
detection of the haplotypes is thought to be due to a heterozygous site within the 
oligonucleotide-binding region: variation affects the annealing of the oligonucleotide, which 
as a result of this can only bind and amplif' the allele carrying the nucleotide region 
complementary to the oligonucleotide. This type of artefacts is dependent on factors such as 
the stringency of the PCR conditions and the level of variation within the binding site. This 
could not, however, be proven due to a lack of sample material. Only the nucleotide 
sequence of the G1291V169/N176 haplotype was submitted to GenBank: EU032303. 
Table 15 - Genetic Variability of the PrP Gene in Ruminants 
Genetic variation identified in the ORE of the seven ruminant species analysed. The number 
of octapeptide repeats is also given. The two yak SNPs were not detected in the current 
study. The synonymous variant identified in bison was located in the last codon of the 6th 
repeat (caa/cag). 
Species 
Samples Repeats SNPs synonymous SNPs nonsynonymous 
Waterbuck 1 6 None TI06N 
Gazelle 1 6 None none 
Nyala 3 5 Nucleotide 207 (clt) none 
Bison 1 6 6th repeat (a/g) none 
Gaur 1 5 None none 
Yak 1 6 Nucleotide 270 (tIc) A121V 
Caribou 1 5 None G129S / V169M / N176D 
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3.3 Discussion 
The levels of genetic variability identified in the PRNP of C. elaphus and C. canadensis 
were similar to the one published for unrelated populations of these two cervid species 
(Kaluz, Kaluzova, and Flint 1997; O'Rourke et al. 1999; Peletto etal. 2005). 
A genetic variability study of the Bos taurus PRNP gene showed that cattle, a 
species which has been subjected to high levels of selective breeding, has levels of genetic 
diversity similar to the one detected for C. elaphus and C. canadensis within the 2kb target 
region. The main difference between the cattle and the cervid genes appears to be the higher 
proportion of synonymous polymorphisms identified in the bovine ORF. Eleven SNPs have 
been identified in cattle and only one of them results in a change of amino acid (Clawson et 
al. 2006). In contrast to this, with the exception of mule deer, all the other cervid species 
have similar ratios of nonsynonymous to synonymous SNPs: white-tailed deer 5/8; moose 
1/2; wapiti 3/3 and red deer 5/4. Like cattle, mule deer seems to have a higher proportion of 
synonymous SNPs: 4/12. Mule deer and white-tailed deer seem to have a higher level of 
genetic variability, however many of these SNPs have frequencies which are less than 0.05 
(O'Rourke et al. 1998; Raymond et al. 2000; Heaton et al. 2003; Johnson et al. 2003b; 
Johnson et al. 2003a; O'Rourke et al. 2004; Jewell et al. 2005; Johnson et al. 2006). This, 
together with the higher number of animals analysed for these two species, could explain the 
higher number of SNPs identified. Clearly, variation in genetic variability could also be the 
result of demography or to the fact that for some species more than one population has been 
studied. The 48 elk samples analysed were obtained from two different populations from 
DAUs E-8 and E-9 (Section 2.1) however, as described in Chapter 5, these two populations 
do not differ significantly at the genetic level. A number of other studies have also shown 
low genetic variability in other genes for North American wapiti, presumably due to the 
demographic history of this species (Comincini et al. 1996; Talbot, Haigh, and Plante 1996; 
Wilson et al. 1997; Abel and Dessein 1998; Roed and Midthjell 1998; Polziehn et al. 2000). 
This suggests that the Colorado samples possibly provide a good representation of the C. 
canadensis genetic variability for the two studied loci. 
The red deer samples were obtained from the Isle of Rum (Section 2.1), which 
despite being an isolated island population, is considered to be genetically variable, as after 
extirpation in the 18th century, red deer were reintroduced to the island from at least four 
source populations across the UK. These populations were themselves probably quite 
variable due to the intense human translocation that red deer has been historically subjected 
to (Hartl, Zachos, and Nadlinger 2003; Nussey et al. 2006). This suggests that Rum deer 
99 
does provide a suitable representation of the genetic variability of C. elaphus PrP and PBGD 
genes 
A genetic study similar to the one carried out for this thesis analysed different 
regions of the ovine PRNF locus. Despite the analysis of only 90 sheep, 14 SNPs were 
identified within the ORF alone (Green et al. 2006). In addition to this, while all but one of 
the bovine SNPs were synonymous, the majority of the identified ovine SNPs were 
nonsynonymous. An excess of nonsynonymous polymorphisms was also identified in both 
the cervid species analysed in this study. However, a statistical analysis of this variation in 
Chapter 5 does not seem to indicate the action of a specific evolutionary force. On the other 
hand, while the bovine PRNP gene has been found to be under purifying selection (Seabury 
et al. 2004); the signature of balancing selection has been detected in the ovine locus. An 
excess of nonsynonymous SNPs has also been described in goats and it has been associated 
with the relaxation of purifying selection (Slate 2005). The identification of 13 caprine 
variable sites in this study, through the analysis of one single goat sample, corroborates the 
higher levels of genetic variability described by Slate (2005). It is however not known how 
representative this goat is with regard to the population it was derived from. It is worth 
noting that the PBGD gene sequenced for the same goat sample had only two variable sites, 
which is in accordance with the levels of genetic variability seen in the PBGD gene of the 
two analysed cervid species. This indicates the presence of species specific patterns of 
genetic variability, which could potentially result from selection on the basis of protein 
function or in the case of the ovine gene, disease. However, the effects of other factors such 
as demography and intensive selective breeding regimes should not be excluded. 
The current study identified a total of 16 polymorphic sites and one indel in the non-
coding regions of the 98 cervid samples. None of these variants eliminate the known motifs 
within FRNP such as the intron Il/exon III boundary (position 566) or the polyadenylation 
signal at positions 2099-2104 (Appendix 2). However, despite increasing the knowledge of 
the genetic composition of this cervid locus, the study does not provide definite data on the 
structure of the C. elaphus and C. canadensis genes and their mRNAs. 
No evidence was found of the presence of a PRNP pseudogene in any of the 
mammalian species sequenced for this study. However, in the case of the seven additional 
ruminant species this could have simply been the result of the low sample number while for 
red deer and wapiti it was probably the sequencing strategy, which was aimed at minimising 
the chances of pseudogene detection by using PCR oligonucleotides binding to non-coding 
regions of the target loci. To date, PRNP pseudogenes have only been identified in white-
tailed deer, mule deer, black-tailed deer and silky anteater (Section 1.10). This study 
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provides the first sequence for the cervid PBGD gene and the first report of a PBGD 
pseudogene. Due to its pseudogene-free status in humans (Janssens et al. 2004), the PBGD 
gene is often used as a reference gene in mRNA expression studies. The identification of a 
cervid PBGD pseudogene suggests the use of alternative housekeeping genes in studies of 
the mRNA expression of cervid genes. 
The mature PrP prion protein is composed of an unstructured and flexible N-
terminal tail (residues 25 to 128) and a structured C-terminal region (residues 129 to 234), 
which includes three a-helices and two short n-sheets (Section 1.6 and Figure 1). The current 
study identified 9 variable sites within the cervid ORF. Three of these were located within 
the N-terminus, five within the C-terminus (Table 9) and one in the signal peptide (residues 
1 to 24) (Table 9). An examination of the wapiti sequencing data shows an apparent absence 
of association between CWD and the identified variants, haplotypes or genotypes in the 
studied populations. An in-depth analysis of the modulatory role of codon 132 is given in 
Chapter 4. 
A novel nonsynonymous cervid singleton was identified at codon 25 (Section 
3.2.2.2) of the wapiti PRNP, which encodes the N-terminal amino acid of the mature protein. 
The lysine to arginine change is conservative and the two amino acids have similar n-sheet-
forming propensities. With the exception of this one wapiti sequence, all the other species of 
the family Cervidae studied to date encode lysine at codon 25. Studies using N-terminally 
truncated PrP constructs have shown that the 25-50 region of the PrP protein is involved in 
protein internalization: its deletion has a deleterious effect on PrP endocytosis and results in 
prolonged turnover of the prion protein. Deletions within the 25-95 region have also been 
shown to have detrimental effects on the secretory pathway and localization of PrP within 
lipid rafts (Nunziante, Gilch, and Schatzl 2003; Walmsley, Zeng, and Hooper 2003). Despite 
this, the nature of the amino acid change suggests no or very limited effects on the PrP 
function. A glycosaminoglycans (GAGs) binding motif is present at residues 25-29 
(KKRPK). The binding of PrPC  to GAGs is believed to be important in the potential cell—cell 
adhesion and signaling function of the PrP protein (Pan et al. 2002a; Yin et al. 2006) but it 
has also been hypothesized to affect disease mechanisms (Wong et al. 2000). However, the 
fact that both lysine and arginine have basic side chains prompts the speculation that there is 
no effect on the GAG binding ability of the motif. 
One of the main structural features of the PrP N-terminus is the presence of 
histidine-glycine-proline rich octapeptide repeats, which are believed to be involved in 
protein function and in the modulation of disease phenotypes (Brown et al. 1997; Flechsig et 
al. 2000). The number of repeats varies considerably within and between mammalian species 
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(Collinge 2001; Van Rheede et al. 2003) and in humans, specific expansions and 
contractions of the normal number of five repeats has been associated with TSE development 
(Schatzl et al. 1995; Beck et al. 2001). The current study shows that in species of the family 
Cervidae, the number of repeats is apparently constant, as all samples sequenced to date had 
five repeats. 
The K25R dimorphism is the only nonsynonymous cervid variation identified 
between the N-terminus and the octapeptide repeats; not many polymorphisms for this PrP 
region have been found in mammals. 
Another nonsynonymous SNP, T98A (Section 3.2.2.3), was identified in the region 
preceding the stop transfer effector region (STE region) (Yost et al. 1990). To date this SNP 
has been identified in a number of European populations of C. elaphus (Peletto et al. 2005). 
Codon 98 encodes threonine in all cervid species studied to date (Section 1.26) with the 
exception of Indian muntjac (Schatzl et al. 1995) which encodes serine. In addition to T98A 
in C. elaphus, three additional nonsynonymous cervid SNPs have been identified to date 
within this region: Q95H in white-tailed deer and G96S and Gi 16A in both mule deer and 
white-tailed deer (O'Rourke et al. 1998; Heaton et al. 2003). The G96S SNP, together with 
Q9511 that is located on the last residue of the octapeptide repeat region, have been shown to 
be associated with reduced likelihood of CWD infection in white-tailed deer (Johnson et al. 
2003a; Acin et al. 2004; O'Rourke et al. 2004; Johnson et al. 2006) (Section 1.27) and this is 
probably also true for mule deer although this remains to be shown. 
Possible pathogenic or modulatory roles of polymorphisms situated in the C-
terminal part of the unstructured N-terminal domain of the PrP protein have been 
demonstrated for five pathogenic human SNPs: P102L (codon 105 in cervid PrP) (Hsiao et 
al. 1989), P105L (Kitamoto et al. 1993), P105T (Mead 2006) (codon 108 in cervid PrP), 
GI 14V (codon 117 in cervid PrP) (Rodriguez et al. 2005) and Al 17V (codon 120 in cervid 
PrP) (Tranchant etal. 1992). With the exception of the human SNPs at codons 117 and 120 
(numbering based on elk PrP), which are located in the highly conserved hydrophobic 
membrane-spanning region of PrP (residues 115 to 139), the other pathogenic human SNPs 
are located within the hydrophilic STE region (residues 99 to 114). It is also worth noting 
that one of the two major determinants of prion disease incubation time in mice, codon 108 
(codon 112 in elk) (Westaway etal. 1987) is also located in this hydrophilic region. The STE 
region has been linked to the control of PrP translocation as well as directing the biogenesis 
of different PrP topological variants (Yost et al. 1990; Hegde and Lingappa 1999). Removal 
of the STE region has also been shown to prevent PrP sr formation (Muramoto etal. 1996). 
The high evolutionary conservation of the N-terminus observable in the studied 
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species, as well as throughout the class Mammalia, supports the idea that this region is 
important for the function of the prion protein. As a result of this, both variation in the 
structural composition and in the amino acid sequence of the PrP N-terminus could have an 
impact on the function and structural features of the PrP protein. While variation in the 
region preceding the octarepeats only seems to affect the structure and function of PrP, 
variation in the repeat region and in the remainder of the N-terminus seem to also affect the 
development and phenotype of TSEs. However, the nature and the position of genetic 
variants, rather than variation per se, are the actual determinants of the effects on function 
and disease. 
The lack of variability at position 132 in the C. elaphus population analysed in this 
study, together with previous studies in other cervid species (Section 1.26), support the 
hypothesis that variation at codon 132 within the family Cervidae is unique to C. canadensis. 
This position is significant, as it corresponds to the human codon 129, which has been shown 
to have disease susceptibility and phenotype modif'ing effects in all human prion diseases 
(Wadsworth et al. 2004; Mead 2006). Despite the clear involvement of this SNP in human 
disease, the under-lying molecular mechanisms are still unknown. The potential disease 
association of the 132 polymorphism in C. canadensis is discussed in Chapter 4. 
The identification of heterozygosity at codon 168 in Rum deer (P168S) is of 
considerable interest. This position had been previously identified as polymorphic in sheep 
(P168L) and goats (P168Q) (Billinis et al. 2002; Goldmann et al. 2006b). In sheep, the SNP 
was shown to be associated with susceptibility to experimentally inoculated BSE: the leucine 
allele is associated with increased resistance to intravenous inoculation with the BSE agent 
(Goldmann et al. 2006b). No cases of scrapie have been reported in sheep carrying the L 168 
allele (Goldmann, W., 2006. Personal communication). It is therefore possible that the 
P168S change is also associated with TSE (CWD) disease susceptibility. However, scrapie 
has been diagnosed in goats carrying the variant allele Q168  (Acutis et al. 2006; Papasavva-
Stylianou et al. 2007), thus suggesting that the type of amino acid change could be crucial to 
the degree of disease modulation. 
Not only is codon 168 implicated in disease, it is also very close to codon 171 
(Goldmann et al. 1990; Belt et al. 1995; Abel and Dessein 1998), which is polymorphic in 
sheep and associated with scrapie susceptibility. The importance of the amino acid loop 
connecting p2-sheet and a2-helix (codons 168-175) in the mechanisms of TSEs has been 
recognized for a long time and the S 168 allele in red deer may represent a significant 
discovery. 
Minor changes in the amino acid sequence of the 168-175 loop have been shown to 
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have very significant effects on its structure. Nuclear magnetic resonance (NMR) studies of 
different mammalian PrP proteins showed that, while the structure of the wapiti PrP loop is 
very well defined and positionally fixed, this region is relatively flexible in PrP from other 
species such as mouse and cattle. Their loop sequences only differ from the wapiti at two 
positions, when residues 176-178 are also considered: both mouse and cattle differ from elk 
at position 173 and 178 (Gossert et al. 2005). This study suggests that different amino acid 
changes in this loop, like codon 168, can have significant effects on the stability of the loop 
and consequently on its role on disease and PrP function. The only other variation identified 
within the cervid 168-175 loop was the presence of methionine instead of valine at position 
169 in the Rang jfer tarandus PrP protein (Section 1.26 and Table 3). In addition to being 
identified in the current study, variation at this position had been previously detected during 
the analysis of PRNP in Alaskan caribou (Section 1.26) (Huson and Happ 2006). The coding 
of methionine at position 169 makes the loop more similar to the one present in humans; this 
could possibly increase the structural disorder of the loop. With the exception of species of 
the Hominidae and Hylobatidae families, caribou is the only other mammalian species 
encoding methionine at this position. Caribou is currently considered TSE free (Lapointe et 
al. 2002) despite the fact that it overlaps the geographical range of Odocoileus species 
(1-luson and Happ 2006). This structural variant could potentially be one of the many 
possible factors contributing to the current TSE free status of caribou. 
The role of the 168-175 loop in disease is still unclear; however, intriguing results 
have been obtained in transgenic mice expressing mouse PrP proteins containing the 
structured wapiti loop. These mice developed a spontaneous neurologic disease with features 
similar to CWD and vCJD. The authors of the study theorized a possible link between the 
structured 168-175 loop and an increase in the risk of sporadic CWD (Sigurdson and Aguzzi 
2006). In addition to this, the amino acid sequence of the wapiti loop has also been shown to 
have long-range effects by increasing the structural definition of the u3-helix. Although this 
long-range effect and its possible functional repercussions are not clear, it may not be 
groundless to speculate that such an effect could neutralize the TSE promoting effects of the 
structured loop described by Sigurdson and colleagues in 2006. 
Red deer are currently classified as a TSE-free species and this status is supported by 
surveillance studies of free-ranging C. elaphus in Belgium and Germany (Schwaiger et al. 
2004; Roels et al. 2005). As a result of this, the possible effects of the proline (P) to serine 
(S) change on the underlying mechanisms of TSE disease in the natural environment cannot 
be determined. The variant allele was only identified in one Rum deer, suggesting a low 
frequency in this population. To verify the allele frequency, a larger proportion of the 
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population could be screened through genotyping using the restriction enzyme Bsr I in a 
PCR-based RFLP assay. Animals carrying the desired genotypes could then be used for in 
vivo studies. As this would be expensive, alternative in vitro conversion studies could be 
used to test how the serine allele affects PrPTCs  formation. 
Heterozygosity was identified at codon 191 (TI9IA) in a single CWD. VE wapiti 
(Figure 14 and Table 9). This site corresponds to the human codon 188 and it is of particular 
interest since three human SNPs at this position have been identified as pathogenic and are 
believed to result in the development of CJD: T188K (Finckh etal. 2000); T188A (Collins et 
al. 2000); TI 88R (Windl et al. 1999). The question whether the 191 polymorphism could 
have a similar effect on disease onset in deer cannot be answered as yet. The wapiti sample 
was CWD..v1., but the possibility of it developing CWD at a later stage, if the animal had not 
been culled, cannot obviously be excluded. It appears that the threonine to alanine mutation 
in the human PrP protein resulted in CJD only when the patient reached the age of 82 
(Collins et al. 2000) and if such a long lifespan is needed to result in disease in humans then 
prolonged incubation times may also be necessary in wapiti. The fact that three different 
amino acid changes can be associated with the development of CJD, and that all the variant 
amino acids have I-sheet-forming propensities much lower than threonine, may suggest that 
in this case the crucial factor is the location of the substitutions rather than the amino acid 
change. 
Residue 191 is located within the a2-helix (residues 176 to 198) of the PrP protein; 
to date four additional human pathogenic SNPs have been identified in this region (Mead 
2006). Variation within the a2-helix has also been associated with disease in other species: 
codon 176 (N 176K) in sheep is suspected of having a modulatory effect on scrapie (Vaccari 
et al. 2001; Baylis and Goldmann 2004) and in mouse variation at codon 189 (elk codon 
193) is a major determinant of TSE incubation times (Westaway etal. 1987). 
Residue 191 is the first of a highly conserved amino acid sequence comprising 
residues 191 to 204 (TVTTTTKGENFTET), which due to its structural plasticity is believed 
to play a role in PrP structure and to potentially act as a conformational switch from a-helix 
to n-sheet (Haire et al. 2004; Ronga et al. 2006; Ronga et al. 2007). The first three turns of 
a2-helix have been shown to be closely packed against a-3helix. This, together with the N-
linked glycan at residue 184 stabilises the helix up to around residue 192. Therefore, 
variation at codon 191 could also affect the stability of a2-helix and thus lead to structural 
rearrangement into n-sheet and possibly protein aggregation (Bosques and Imperiali 2003b; 
Bosques and Imperiali 2003a; Ronga et al. 2006). Structural studies of the amyloid fibrils 
formed by the recombinant human PrP 90 . 231 (elk residues 94 to 234) also identified a2-helix 
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as part of the f3-sheet core of PrP amyloid (Lu, Wintrode, and Surewicz 2007). However, 
these studies are at odds with data supporting a preservation of the native structure of a2-
helix during the conversion of PrPC  into PrPSC  (DeMarco and Daggett 2004; Eghiaian et al. 
2004; Govaerts et al. 2004). Due to a lack of confirmed molecular models of PrPSC  structure 
and formation, it is difficult to appreciate the role of variation at codon 191 and other 
residues of a2-helix on disease mechanisms and PrP structure and function. 
One nonsynonymous SNP was identified in the a3-helix of the C. elaphus PrP 
protein: E226Q. Variation at this position had previously been seen in a number of other 
cervid species (Section 1.26). Residue 226 is adjacent to codon 225 which has been shown to 
be involved in CWD modulation in mule deer: heterozygosity at codon 225 is believed to 
have a protective effect against CWD (Jewell etal. 2005; Williams 2005; Fox et al. 2006). 
As in the a2-helix, clustering of human pathogenic mutations is also clearly visible 
in the a3-helix (Mead 2006). A number of caprine SNPs have also been identified within this 
region (Baylis and Goldmann 2004) and the Q222K SNP is potentially associated with 
scrapie resistance (Agrimi et al. 2003) as is the same change in this position (E219K) in 
human PrP which is associated with partial resistance to CJD. In addition to codon 225 and 
226, nonsynonymous SNPs have also been found at codons 208 and 209 of the cervid PrP 
protein: M2081 [C. elaphus, (Kaluz, Kaluzova, and Flint 1997)] and M2091 [A ices alces, 
(Jewell et al. 2003)]. To date, variation at these two positions has not been associated with 
disease in any of the species affected by TSEs. 
Despite lacking the 3-sheet propensity of a2-helix, the a3-helix is still believed to 
play a critical role in the folding and stability of the PrP protein (Gallo et al. 2005). 
Therefore, variation within this region could affect the conformation of the helix and thus 
disrupt its natural role in PrP structure and function. However, as previously mentioned for 
the N-terminus, not all the mutations identified within a2-helix and a3-helix are linked to 
disease development or modulation (Baylis and Goldmann 2004; Mead 2006). 
3.4 Conclusions 
The PrP protein is a complex entity and each region of this protein appears to have its own 
functional and disease modulating role. Variation at the amino acid level may result in 
structural changes in PrP that would then potentially affect the function of the protein and its 
role in TSE mechanisms. 
The N-terminus of the PrP protein appears to be less variable than the C-terminus, 
and variation within this area of the protein appears to affect its structure and its potential 
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function. However, variation in the repeat region and in the C-terminal part of the 
unstructured PrP tail seems to also affect the development and phenotype of TSEs. 
Variation within the globular domains of the PrP C-terminus plays a more 
significant role in disease development and modulation in many of the mammalian species 
susceptible to TSEs, including cervids. Nevertheless, the characteristics and properties of the 
variant amino acids as well as their position, rather than variation per se, are the true 
perturbants of PrP structure and function. 
The low levels of genetic variability identified in both the PrP and PBGD genes of 
the two studied cervid species could be the result of functional constraints, TSE specific 
selection, human management of the cervid populations, the demographic history of the 
species or a combination of these and other factors. The sequencing effort described in this 
chapter provided the necessary data to address these issues (Chapter 5). 
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Chapter IV: Codon 132 and CWD Modulation in 
Wapiti 
4.1 	Introduction 
Variation in the primary amino acid sequence of the PrPC  protein has been associated with 
the development and modulation of disease in many species. In humans, between 10 and 
15% of diagnosed prion diseases are associated with over 30 pathogenic mutations of PRNP 
and two SNPs have been associated with disease susceptibility. The M129V polymorphism 
in the human PrP gene, although not pathogenic, has been shown to have a major effect on 
susceptibility to, and phenotypic expression of, human prion diseases (Section 1.15) (Windl 
et al. 1999; Mead 2006). The influence of PrP genetics on disease susceptibility and 
pathology has also been described for scrapie, BSE and CWD (Johnson et al. 2003b; Baylis 
and Goldmann 2004; Sander et al. 2004; Jewell et al. 2005). 
Wapiti PrP (Cervus canadensis) is polymorphic at codon 132, which corresponds to 
codon 129 in humans. The amino acid change in wapiti is from methionine to leucine 
whereas in humans it is to valine. Association with CWD susceptibility in free-ranging and 
farmed wapiti has been suggested: animals homozygous for methionine at codon 132 
(MM 132) have been shown to be over-represented in both free-ranging and farmed CWD + 1 
wapiti (Table 17), when compared to healthy control groups (O'Rourke et al. 1999). 
Additional transmission studies seemed to indicate that incubation time rather than 
susceptibility are modulated by variation at codon 132 (Spraker et al. 2004a; Kreeger et al. 
2005; Hamir et al. 2006). 
As part of this thesis, codon 132 was genotyped for 171 samples from free-ranging 
wapiti to investigate the disease-related patterns of genetic variation. The study focussed 
uniquely on free-ranging wapiti to better understand the role of genetics in wild populations, 
where CWD is more difficult to control and to avoid unusual genotype frequency patterns 
often found in farmed herds. Forty-seven samples were from confirmed CWD cases and 124 
from healthy animals. The animals were initially screened using enzyme-linked 
immunosorbent assay (ELISA) for abnormal PrP. Samples identified as positive through 
ELISA were then analysed by immunohistochemistry (IHC), using antibody F99/97.6.1, to 
confirm their disease status (Hibler et al. 2003) (Miller, M. W., 2006. Personal 
communication). Samples that were negative on ELISA were regarded as CWD and were 
not examined by 11-IC. Compared to previous studies, the larger number of genotyped 
CWD+VE samples coupled with the analysis of affected and control animals from three 
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independent populations (Figure 2) provided more robust results. 
4.2 Results 
A total of 171 samples were genotyped for codon 132: the full open reading frame was 
sequenced in 48 of the samples (Chapter 3) while partial ORF sequences (Figure 3) were 
obtained for the remaining 123 samples. Three free-ranging populations from Colorado were 
analysed for this thesis (Table 16): DAU E-6, E-8 and E-9. While E-6 is completely 
independent, some overlap occurs on summer ranges between populations E-8 and E-9 
(Miller, M. W., 2006. Personal communication). The three populations were found to be at 
Hardy-Weinberg Equilibrium (Table 16). 
Table 16 - Codon 132 Genotype Frequencies 
The table gives the number and percentage of animals per genotypic group as well as the 
Hardy-Weinberg Equilibrium test per population. 
Group n. DAU and CWD status Met/Met MetiLeu Leu/Leu HWE 
I E9, E6 & E8 (CWD. VE) 81(65.3%) 40 (32.3%) 3 (2.4%) P = 0.753 
2 E-6 (CWDVE) 27 (79.4%) 7 (20.6%) 0 (0%) P = 0.799 
3 E-8 (CWDVE) 26(61.9%) 15(35.7%) 1(2.4%) P= 0.789 
4 E-9 (CWDVE) 28(58.3%) 18(37.5%) 2(4.2%) P= 0.913 
5 E-9, E6 & E8 (CWD+VE) 33(70.2%) 13(27.7%) 1(2.1%) P= 0.977 
6 E-6 (CWD +VE) 16(94.1%) 1(5.9%) 0(0%) P= 0.992 
7 E-8 (CWD+VE) 7 (63.6%) 4 (36.4%) 0 (0%) P = 0.762 
8 E-9 (CWD+VE) 10(52.6%) 8(42.1%) 1(5.3%) P= 0.932 
The only other genetic study which had analysed the frequency of codon 132 in free-ranging 
wapiti was carried out by O'Rourke and colleagues in 1999; they genotyped CWD +1 and 
CWD vE  free-ranging animals (Groups A and B - Table 17) that were collected in GM1J 20 
(DAU E-9) in Colorado (Figure 2), as well as hunter-harvested CWD VE wapiti from two 
other free-ranging populations (Groups C and D - Table 17) (O'Rourke etal. 1999). There is 
therefore an overlap between both studies in area but not in sampling years. 
In this study, the Freeman-Halton extension of Fisher's exact probability test was 
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used to compare genotype frequencies of different groups of animals. The dataset analysed, 
eliminated the need of pooling and analysing the heterozygotes together with the leucine 
homozygotes; thus making the analysis more robust. O'Rourke and colleagues used the chi-
square test. 
Table 17 - Genotype Frequencies of Wapiti from Published Studies 
The data were obtained from three published studies; Reference 1 = (O'Rourke et al. 1999), 
Reference 2 = (Spraker et al. 2004a) and Reference 3 = (Balachandran et al. 2002). Both 
the number and percentage of animals per genotypic group are given. The genotypic 
frequencies of the CWftve  samples were not available for references 2 and 3. Group E is 
equal to the sum of groups B, C and D. 
Group Reference Natural Status CWD Status Met/Met Met!Leu Leu!Leu 
A 1 Free-ranging +VE 20 (100%) 0 (0%) 0 (0%) 
B 1 Free-ranging -yE 60 (68.2%) 26 (29.5%) 2 (2.3%) 
C 1 Free-ranging -yE 44 (80.0%) 11(20%) 0 (0%) 
D 1 Free-ranging -yE 35 (83.3%) 7(16.7) 0 (0%) 
E 1 Free-ranging -yE 139(75.1%) 44(23.8%) 2(1.1%) 
F I Captive +VE 17 (73.9%) 6 (26.1%) 0 (0%) 
G 1 Captive -yE 20 (35.7%) 30 (53.6%) 6 (10.7%) 
H I Captive -yE 13 (50.0%) 12 (46.2%) 1 (3.8%) 
1 Captive -yE 29 (61.7%) 15 (31.9%) 3 (6.4%) 
L I Captive -VE 29 (96.7%) 1 (3.3%) 0 (0%) 
M 2 Captive +VE 178 (95.7%) 7 (3.8%) 1 (0.5%) 
N 3 Captive +VE 31(96.9%) 1(3.1%) 0 (0%) 
4.2.1 	Spatial and Temporal Variation in Genotypic 
Frequencies 
The samples genotyped by O'Rourke and colleagues were harvested prior to 1999, while all 
the samples analysed in the present study were collected after 2002. To determine if the 
genotypic frequencies of the CWD_ vE  samples had changed significantly in DAU E-9 since 
the previous study, samples from Group B (Table 17) were compared with the samples from 
Group 4 (Table 16 and Figure 22). No significant difference was found (P = 0.499) 
indicating stability in the genotypic frequencies over time. 
The genotypic frequencies of the CWD vE samples from the three studied DAUs 
(Table 16 and Figure 22) were compared to test if significant differences were present 
between different DAUs. None of the comparisons gave statistically significant results: E-6 
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statistical significance, as expected, the difference between the genotypic frequencies of the 
three wapiti populations increased with an increase in distance between the DAUs (Figure 
22); with E-6 and E-9 having the highest level of divergence. These data indicate stability of 
the genotypic frequencies within the area investigated. 
Figure 22 - Spatial and Temporal Variation in the Genotypic Frequencies 
The genotypic frequencies of the three DAUs analysed are compared. The samples 
collected in DAU E-9 and analysed by ORourke and colleagues in 1999 are also shown. 
Codon 132 Genotypes 
4.2.2 	Association of M132L with CWD 
O'Rourke and colleagues (1999) proposed a modulatory role for the SNP at codon 132 by 
comparing the genotype frequencies of 20 CWD± VE and 185 control animals. 
The data presented here are based on samples derived from 47 CWDVE positive 
animals and 124 healthy control animals. These samples were collected in three 
neighbouring DAUs in Colorado: DAU E-6 (34 CWD1 and 17 CWD+ VE), E-8 (42 CWD 1 
and 11 CWD VE) and E-9 (48 CWD and 19 CWD vE). Overall genotype frequencies for 
healthy animals in the three DAUs were 65.3% (n = 81) MM 132 homozygotes, 32.3% (n = 
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40) ML 132 heterozygotes and 2.4% (n = 3) LL 132 homozygotes (Group 1, Table 16, Figure 
23). For the CWD vE  animals these frequencies were 70.2% (n = 33) MM 3 32, 27.7% (n = 13) 
ML 332 and 2.1% (n = 1) LL 132 (Group 5, Table 16, Figure 23). A comparison of these 
frequency patterns using the Freeman-l-lalton extension of Fisher's exact test, showed that 
methionine homozygous animals were not over-represented in CWD* VE animals: P = 0.823 
(Table 16, Group I vs. Group 5). The same was also true when CWD± VE and CWD 
samples from the same DAU were compared: E-6 (Group 2 vs. Group 6), P = 0.242, E-8 
(Group 3 vs. Group 7), P = 1, E-9 (Group 4 vs. Group 8), P = 0.902 (Table 16). These data 
also confirm that all three diploid genotypes are susceptible to naturally acquired CWD as 
one CWD+VE leucine homozygous wapiti was detected in E-9. Diseased animals carrying this 
genotype had previously only been reported in captivity (Spraker et al. 2004a). The result 
was surprising as the expectation based on O'Rourke el al. 1999 was of an over-
representation of methionine homozygotes in CWD vr wapiti. 
Figure 23 - Codon 132 Genotype Frequencies and CWD Modulation 
The genotypic frequencies of the CWD +VE and CWD VE wapiti samples analysed in each 
DAU are compared. The sum of the genotypic frequencies of all the CWD +VE and CWD VE 
samples is also given (E-6 + E-8 + E-9). These frequency patterns showed that methionine 



















MM ML LL MM ML 	LL MM ML 	LL MM ML LL 
E 6 E-8 E-9 	 E-6 	 E-8 	 E-9 
Gennotype I DAU 
112 
The prevalence of CWD in cervid species has been shown to vary between different 
age classes and sexes, with the highest disease prevalence in 5- to 6- year old males. This is 
believed to be the result of increased exposure to sources of infection due to mating rituals 
and reproductive habits (Miller and Conner 2005). Most of the animals genotyped in this 
study were adults (155 out of 171) and only two CWD +VE yearlings were available, thus 
preventing an analysis of the genotypic frequencies in relation to different age groups. 
Despite this, a practically equal number of males and female (females = 54.4%; males = 
45.6%) enabled the analysis of the genotypic frequencies in relation to the sex of the 
animals. The frequencies of the three genotypes did not differ significantly among CWD+1 
and CWD13 samples (Table 18): E-6 males (P = 1), E-6 females (P = 0.123), E-8 males (P = 
0.28), E-8 females (P = 0.5), E-9 males (P = 1) and E-9 females (P = 0.999). This indicated 
that even males, which are potentially subject to higher exposure to the CWD agent, do not 
show signs of CWD-related patterns of genotypic frequency. 
Table 18 - Genotypic Frequencies in Relation to DAU of Origin Sex and CWD Status 
The table gives the number and percentage of animals per genotypic group in relation to sex 
and CWD status. 
DAU/SexICWD status Met/Met MetlLeu LeulLeu 
E-6 Male (CWDVE) 18( 90%) 2 (10%) 0 
E-6 Male (CWD+VE) 9 (90%) 1 (10%) 0 
E-6 Female (CWDVE) 9 (64%) 5 (36%) 0 
E-6 Female (CWD+VE) 7 (100%) 0 0 
E-8 Male (CWD VE) 14 (64%) 8 (36%) 0 
E-8 Male (CWD+VE) 5 (100%) 0 0 
E-8 Female (CWD. VE) 12(60%) 7 (35%) 1(5%) 
E-8 Female (CWD+VE) 2 (33%) 4 (67%) 0 
E-9 Male (CWDVE) 9(56%) 6 (37.5%) 1(6.5%) 
E-9 Male (CWD+VE) 3 (60%) 2 (40%) 0 
E-9 Female (CWD) 19 (59%) 12 (37.5%) 1(3.5%) 
E-9 Female (CWD+VE) 7(50%) 6 (43%) 1(7%) 
4.3 Discussion 
Variation at codon 129 in human PRNP has been linked to disease susceptibility and 
modulation (Mead 2006), and for this reason much interest was raised by the discovery that 
the corresponding codon (codon 132) was involved in disease susceptibility in C. canadensis 
(O'Rourke et al. 1999). 
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In their 1999 study, O'Rourke and colleagues showed that wapiti homozygous for 
methionine at codon 132 were over-represented in farmed and free-ranging CWD +VE 
animals. All the free-ranging CWD +VE animals were MM 132 homozygotes but CWD+VE 
M1L 132  heterozygotes were identified in the captive animals (Table 16 - Group F). 
Overrepresentation of methionine homozygotes was also identified in a game farm from 
Saskatchewan (Balachandran et al. 2002). The CWD susceptibility of the LL 132 genotype 
was described in captive wapiti from the USA and Canada (Spraker et al. 2004a) thus 
showing that at least in captive animals all the genotypes are susceptible to disease. The lack 
of CWD diagnosis in any of the free-ranging wapiti carrying the 132L allele was believed to 
be either the result of small sample size or of factors such as dose, route of infection or strain 
type (O'Rourke et al. 1999). The genotyping data of the three studies mentioned above, 
together with the analysis of PrPSC  deposition by Spraker et al. (2004) suggested that 
heterozygosity at codon 132, like 129 in human TSEs, could have a protective role, although 
incomplete, against CWD and that the low number of CWD +VE LL 132 homozygotes was 
probably simply due to the rarity of this genotype (Spraker etal. 2004a). 
Experimental challenges of wapiti support variation in incubation times in relation to 
the codon 132 genotype: oral challenges of wapiti showed that M1, 132 animals died on 
average 16.4 months after MM 132 wapiti (Hamir et al. 2006) and that LL 132 animals had the 
longest incubation times. However, additional challenges, despite providing similar results 
showed that genotype ML 132 rather than LL 132  had the longest incubation time (Kreeger et al. 
2005). The results of the latter study should nevertheless be treated with caution due to the 
development of clinical CWD by 80% of the uninoculated controls. Extended incubation 
times for ML 132  were also seen when wapiti were intracerebrally inoculated with sheep 
scrapie (Hamir et al. 2004). 
The current study, despite challenging the results of the genotyping study carried out 
by O'Rourke et al. in 1999 by showing a lack of overrepresentation of MM 132 in CWD+v1 
wapiti and the susceptibility of all genotypes in free-ranging animals, does not rule out the 
possibility that heterozygosity at this position modulates CWD incubation time. The 
CWD,1 sample sizes for DAU E-9 were comparable between the current study and the 
previous study. However, O'Rourke et al. collapsed the ML 132 and LL 1 32 groups and ran 2 
2 tables to handle the small sample sizes, while due to the genotypic patterns identified, this 
was not necessary in the current study, making implementation of the the Freeman-Halton 
extension of the Fisher exact test possible and the analysis more reliable. In addition to this, 
the genotyping carried out for this thesis had sampled three different wapiti populations, thus 
excluding the possibility of a geographical or population artefact. 
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The analysis of samples from the three different DAUs (Figure 22) also enabled the 
analysis of the variation in genotypic frequencies between healthy animals, which showed 
that different populations in the target areas have similar codon 132 frequency patterns. This 
lack of difference, as well as the fact that all the studied populations are at Hardy-Weinberg 
Equilibrium (Table 16), could be seen as indications that CWD is not targeting a specific 
genotype as over the years the different disease prevalence between DAUs would result in 
different genotype frequency patterns. However, it is important to remember that CWD 
prevalence is low in most free-ranging wapiti populations and for this reason it may not be 
able to have a significant effect on PRNP genetics. 
Studies of variation of CWD prevalence in relation to the age and sex of animals 
showed that the highest disease prevalence is found in adult males, probably due to mating 
rituals and reproductive habits (Miller and Conner 2005). The genotypic patterns of CWD +VE 
and CWDVE males and females within the three target DAUs were compared to assess if the 
variation in CWD prevalence between sex groups, especially the higher prevalence in adult 
males, would result in the identification of CWD related frequency patterns. However, no 
significant results were obtained, once again demonstrating the lack of CWD related effects 
on PRNP genetics. 
In relation to prolonged incubation times, it is of particular interest that one of the 
CWD,VE ML132  animals genotyped in this study was less than 2 years old (DAU E-9) when 
diagnosed. The full 2kb PRNP target region was available for this animal but no unusual 
genotype or haplotype was associated with this sample. CWD had also been diagnosed in 
two 2 years old ML 132 animals by O'Rourke et al. in 1999. However, only the ORF was 
available for these two samples. Comparing these data with an average P1 incubation period 
of 39.2 months for ML 32 wapiti orally challenged with CWD (Hamir et al. 2006) indicates 
that heterozygosity is not invariably associated with prolonged incubation times. This 
discrepancy could be explained by the action of different strains, the dose of the agent, the 
route of infection, additional PRNP polymorphisms and also by epistatic effects of other 
genes. In support of the latter possibility, a number of loci which could be possibly 
associated with TSEs have been proposed in humans (Chapman et al. 1998; Jackson et al. 
2001; Van Everbroeck et al. 2001; Croes et al. 2004; Jeong et al. 2005); however, 
inconsistent findings and the rarity of TSEs make these associations uncertain. In addition to 
this, polymorphisms outside the coding region of PRNP have also been associated with 
disease in cattle (Sander et al. 2004; Juling et al. 2006) and humans (Mead et al. 2001; 
McCormack et al. 2002; Vollmert et al. 2006); indicating that mechanisms other than 
variation of the primary sequence can control disease susceptibility. The epistatic effects of 
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codon 129 on the phenotypes resulting from pathogenic mutations in humans have been 
described: the 178N allele results in FF1 when linked with methionine at codon 129 while it 
results in familial CJD when associated with 1 29V (Goldfarb et al. 1991; Goldfarb et al. 
1992). None of the variants identified within the coding and non-coding areas of the target 
region of the wapiti PRNP gene showed an association with disease and no studies of the 
role of other loci in the disease mechanisms of CWD have been described in cervids. 
However, the human examples described above, together with the complex links between 
genetics and TSEs which are being uncovered in different mammalian species, make the 
presence of such mechanisms in CWD a realistic hypothesis. 
The existence of multiple strains or the adaptation of existing strains to animals with 
different PRNP genotypes could also explain the differences in the genotypic frequencies 
seen between the current study and the one carried out by O'Rourke and colleagues (1999). 
However, to date, most data on CWD support the existence of only one strain, which is able 
to cause disease in different cervid species (Race et al. 2002; Browning et al. 2004; 
Tamguney et al. 2006). Despite this, the lack of variation between the genotypic patterns of 
the CWD animals (Figure 22) indicated that the frequencies of the codon 132 genotypes in 
DAU E-9 have remained constant during the time separating the two studies. One could 
speculate that the prion strain that was affecting the wapiti population in E-9 adapted over 
time to infect ML 132 and LL 132 animals. However, it is hard to see how the low CWD 
prevalence within E-9 (1.7% - 95% confidence interval: 0.9% - 2.5%) could support this 
form of selection over such a short period of time. 
Despite its importance in human and animal TSEs, the molecular mechanisms by 
which variation at codon 129/132 affects disease remains unclear. Residue 132 lies within 
the first fl-strand (cervid PrP residues 13 1-134), which forms an antiparallel fl-sheet with a 
second fl-strand (cervid PrP residues 164-167). This fl-sheet has been proposed as a 
nucleation site for the conformational transition from PrPC  to PrPSC  (Riek et al. 1996). 
Studies on synthetic peptides seem to indicate that the polymorphism at human codon 129 
affects the kinetics of oligomerization that lead to the formation of PrPS  (Petchanikow et al. 
2001; Tahiri-Alaoui et al. 2004). The in vitro analysis of the different folding pathways 
resulting in the formation of oligomers and amyloids by recombinant human PrP have been 
investigated to try to identify the possible role of codon 129 in disease mechanisms. The 
formation of fl-oligomers has been shown to be favoured by the presence of methionine at 
codon 129 (Tahiri-Alaoui et al. 2004), while valine seemed to favour the formation of 
amyloid when the reaction involved unfolded PrP (Baskakov and Bocharova 2005), although 
the results of the latter study have since been questioned (Lewis et al. 2006). Variation at 
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codon 129 was shown to have no effect on the nucleation or growth rate of PrP amyloid, 
when the reaction was initiated from a-monomeric PrP (Tahiri-Alaoui et al. 2004) although 
this type of amyloid fibres have been shown to be infectious and to produce transmissible 
disease (Legname et al. 2004). Despite the fact that these data do not provide a clear 
explanation of the exact molecular mechanisms of the modulatory role of codon 129/132 in 
TSEs they seem to indicate that polymorphisms at this position do have an effect on the 
pathways that lead to the formation of PrPSC  (Baskakov and Bocharova 2005). 
Despite having significant effects on disease susceptibility in humans and an 
apparent modulatory role in CWD incubation time, in vitro folding studies which analysed 
the misfolding pathways resulting in the formation of fl-oligomers and amyloids did not 
show any significant effect associated with heterozygosity (Tahiri-Alaoui et al. 2004; 
Baskakov and Bocharova 2005). Kinetic studies have suggested that the fl-oligomers cannot 
form amyloids unless they first dissociate into monomers and an analysis of this pathway of 
amyloid formation showed that heterozygosity results in a five-fold reduction in the 
formation of amyloid. The authors speculated that this mechanism, if it were to occur in vivo, 
could result in a reduced incidence of disease (Tahiri-Alaoui et al. 2004). 
From the synthetic peptide studies described above and the modulation of human 
and cervid TSEs by the polymorphism at codon 132, it appears that it is the presence of the 
two PrP variants within a heterozygous individual, rather than the action of the variant allele 
that results in the disease modulatory effects of variation at this residue. The change of 
methionine into valine or leucine is very similar in type; however, it is possible that minor 
changes in the amino acid properties of valine and leucine (e.g. volume of side chains, ,5-
sheet propensity) result in the different phenotypic effects that heterozygosity has in humans 
and cervids. 
In addition to affecting the kinetics of PrPC  oligomerization, other possible factors 
should be considered when trying to understand the exact molecular mechanisms of the 
modulatory role of codon 132 in TSEs. These include possible alterations of the ways in 
which PrPC  interacts with different molecules within a complex cellular environment as well 
as the processes of PrP trafficking and sorting (Jones, Surewicz, and Surewicz 2006b). 
Codon 132 is highly conserved and the analysis of this position in 134 different 
mammalian species showed that with the exception of Erinaceus europaeus (Western 
European hedgehog - AY133043) and Cyclopes didactylus (Silky anteater - AY133062) all 
the other species encode methionine at this position. Both the hedgehog and the anteater 
encode leucine at this position. Obviously there are no data available on TSEs in these two 
species. This high level of conservation, which is in line with high levels of conservation 
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throughout the mammalian PrP gene, supports an essential role for this position and the 
surrounding residues in the cellular function of PrP. In addition to this, a study of the genetic 
variability of bovine PRNP showed very strong purifying selection throughout the gene and 
especially in regions believed to be important for the function and structure of the PrP 
protein, which included the first fl-sheet (Seabury et al. 2004). 
Mead and colleagues suggested that recurrent prion disease epidemics are 
responsible for the maintenance of the codon 129 polymorphism during the evolution of 
modern humans (Mead et al. 2003) and although this theory has been challenged (Kreitman 
and Di Rienzo 2004; Soldevila et al. 2005; Soldevila et al. 2006), there is undeniably strong 
evidence for this, at least in the recent Kuru epidemic in Papua New Guinea (Mead et al. 
2003). On the basis of this hypothesis and the fact that C. canadensis is the only other 
species which shows variation at codon 132, it could be tempting to hypothesise the 
occurrence of ancient CWD epidemics in wapiti. However, a population genetics study of 
the genetic variability of the wapiti PRNP carried out as part of this thesis (Chapter 5) does 
not support balancing selection at this locus. This could be due to the low prevalence of 
CWD in wild populations or to the fact that the increase in incubation time resulting from 
heterozygosity at codon 132 is not enough to drive selection for this genotype. When present 
in farmed cervids, CWD usually affects a high proportion of the animals within the affected 
population (Williams and Young 1992; Miller, Wild, and Williams 1998; Peters et al. 2000; 
Spraker et al. 2002b; Wild et al. 2002; O'Rourke et al. 2004). An analysis of the codon 132 
genotypic patterns of the survivors of such CWD outbreak in farmed animals could provide a 
better insight on disease related selection. 
The MM132  overrepresentation identified by O'Rourke and colleagues in captive 
wapiti could simply be the result of an artefact related to the timing of the sample 
collections: the CWD 1  controls were animals penned together with the CWD + (O'Rourke 
et al. 1999) animals and for this reason these animals could have died of CWD if they had 
not been culled for the study. The same could be true in the studies carried out by Spraker et 
al. (2004) and by Balachandran et al. (2002). In addition to this, as it can be seen in Group L 
(Table 17), captive populations can have extreme frequency patterns even when obtained 
from CWD VE  areas: 96.7% of the animals in Group L were methionine homozygotes. Both 
studies failed to provide the genotypic frequencies of the CWD VE animals and it is thus 
possible that the genotypic patterns identified in the CWD,1 samples could be the result of a 
pre-existing skew of the population genotypic frequencies. 
Personal communications with Professor T. R. Spraker and Dr. K. I. O'Rourke 
confirmed that although the diagnostic methods had been changed between the 1999 study 
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(O'Rourke et al. 1999) and the collection of the samples utilised for the current analysis, this 
should not have had a significant effect on the quality of the test results and could certainly 
not account for the overrepresentation of the MM 132 in the first study. In addition to this, the 
CWD,vE  wapiti studied by O'Rourke and colleagues in 1999 either showed clinical signs at 
the time of death or were found dead and submitted as "suspects" (Miller, M. W., 2006. 
Personal communications) thus suggesting that the longer incubation times of the M1L 132 
animals would not have biased the collection process. 
4.4 Conclusions 
The results observed in this study indicate that no CWD related genotypic patterns can be 
identified in recently collected free-ranging wapiti from Colorado, and that all the codon 132 
genotypes are susceptible to the disease. Despite this, a modulatory role of this residue in the 
incubation time of CWD in wapiti cannot be excluded. The discrepancies between the 
current investigation and data from a genotyping study carried out on free-ranging wapiti at 
the end of the 1990s (O'Rourke etal. 1999) could be the result of small sample size, although 
other biological and experimental factors cannot be completely excluded. Due to the analysis 
of a larger number of CWD +VE  animals harvested in three different wapiti populations, the 
current analysis and resulting data can be considered to be more robust and reliable. The 
exact modulatory effect of the variation at codon 132 in wapiti PrP remains therefore open 
for further investigations. This study has highlighted the importance to study genetic 
association under various conditions and at different time points of a TSE epidemic. 
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Chapter V: Molecular Evolution of the PrP and 
PBGD Genes 
5.1 	Introduction 
Variation in the primary structure of the PrP gene has been linked to TSE development and 
modulation in a number of mammalian species (Section 1.13 to Section 1.15), indicating its 
key role in the genetics of these diseases. As a result of this and the ability of TSEs to 
naturally and experimentally infect a wide range of animal species, the genetic structure and 
variability of this gene has been investigated in a variety of mammalian species (Schatzl et 
al. 1995; Wopfner et al. 1999; Zhang et al. 2002; Van Rheede et al. 2003). The open reading 
frame has been the main target of such studies. This is because it is the region encoding the 
PrP prion protein, which is where most disease associated variation has been identified, and 
also because of features such as limited interspecies variability and a genetic structure 
(Section 1.9) that makes it very amenable to PCR amplification. As a result of this, the 
sequence of the PrP ORF is now available, although in some cases not in its entirety, for over 
130 mammalian species. 
Despite this, until recently the evolutionary history of this gene and the possible 
effects of disease on its genetic variability patterns had not been investigated. To date, most 
of the studies carried out have focussed mainly on the information carried by the genetic 
variability of the ORF in humans, cattle and sheep (Section 1.12). A strong signature of 
balancing selection was identified in human populations in Papua New Guinea, which is 
believed to be the result of the selective pressure exerted by the Kuru epidemic (Section 
1.12). A worldwide signature of balancing selection in humans was also proposed (Mead et 
al. 2003). Additional studies in humans focused on challenging the latter hypothesis and they 
described a complex history of selection dominated mainly by positive selection, although 
temporally and spatially localized balancing selection (Hardy et al. 2006) and/or weak 
purifying selection could not be excluded (Kreitman and Di Rienzo 2004; Soldevila et al. 
2005; Soldevila et al. 2006; Zan et al. 2006a). 
Studies of the ruminant PrP concluded that the evolution of PRNP in these species 
has been dominated by purifying selection, with the exception of sheep and goats: the sheep 
PRNP gene is believed to be under balancing selection while evidence for relaxation of 
purifying selection was described in goats (Seabury et al. 2004; Slate 2005). 
The current lack of knowledge on the functional role of the PrP protein has made the 
interpretation of these data very challenging and the driving forces behind these evolutionary 
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scenarios, whether functional or disease-related, are still unknown. However, it is tempting 
to hypothesise the direct involvement of TSEs in the shaping of the genetic variability of the 
PRNP gene in species other than humans. 
All the artiodactyl species studied to date have been livestock populations and no 
information is currently available on the evolutionary forces acting on PRNP in free-living 
wild populations. Chronic Wasting Disease (Section 1.17) is the only known TSE that affects 
both captive and free-ranging populations (Williams and Young 1982). The evolutionary 
forces acting on the genetic variability of coding and non-coding regions of the PRJ'JP gene 
of CWD+vE (n. = 23) and CWD VE (n. = 25) wapiti from two North American populations 
(Section 2.1) were investigated through the analysis of the data described in Chapter 3, using 
population genetics methods. To better understand how PRNP has evolved in natural 
populations which are completely devoid of the disease, 50 samples from a deer population 
from the Island of Rum (Scotland) were also analysed. Although red deer are currently 
considered CWD free, to date CWD surveillance has been limited (Schwaiger et al. 2004; 
Roels et al. 2005; Schettler et al. 2006). On the other hand, the Rum population has been 
intensively studied since the late 1960s (Nussey et al. 2006), which should guarantee the 
TSE-free status of this population. 
Reports have been published on the role of genetics in the modulation of CWD 
susceptibility and incubation (O'Rourke et al. 1999; Spraker et al. 2004a; Kreeger et al. 
2005; Hamir et al. 2006) through variation at codon 132, which corresponds to the site under 
selection in humans (codon 129) (Mead et a! 2003). The effects of this variation on CWD 
susceptibility are challenged in Chapter 4 through a genotyping study of codon 132 in 
CWD+VE and CWD VE  wapiti. However, the presence of disease related selection cannot be 
excluded, especially as prehistoric epidemics of CWD cannot be ruled out. Investigating the 
evolutionary forces acting on the wapiti PRNP gene could possibly further the knowledge of 
CWD genetics as well as providing an insight in the functional role of this locus. 
To test for the possible effects of the demographic history of the different 
populations investigated, the variability patterns of the porphobilinogen deaminase (PBGD) 
housekeeping gene (Section 1.29) were investigated and utilized as controls in the PRNP 
evolutionary study. Housekeeping genes are required for the long-term evolutionary survival 
of the organisms and are often constitutively and ubiquitously expressed. For this reason, 
they have slower evolutionary rates than tissue-specific genes and are under strong purifying 
selection (Tu et al. 2006). The comparison of the data obtained for the target locus with the 
patterns of variation at the PBGD gene, which was expected to be under purifying selection, 
was aimed at the identification of exceptional patterns of variation: while selection only 
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targets a specific locus, demography produces a genome-wide effect on the patterns of 
variation (Beaumont and Nichols 1996). 
To date, efforts to identify genes affected by selection in animals have concentrated 
mainly on species with well-characterized genomes, such as Drosophila and humans (Zigas 
and Gajdusek 1957; Wall, Andolfatto, and Przeworski 2002; Glinka et al. 2003; Stajich and 
Hahn 2005) or on agriculturally important traits of livestock populations (Cheong et al. 
2006; Hayes etal. 2006; Roy etal. 2006). For this reason, the study of the patterns of genetic 
variation and selection in the PRNP and in the PBGD gene in nonmodel wild populations, 
which have not been subjected to intensive breeding regimes, provides a better insight into 
the genetic variability of autosomal genes in ruminant species. 
One of the main approaches utilized was to test for the departure of the genetic 
variability patterns obtained for the target loci from the one expected under the neutral 
theory of evolution (Section 2.20). Departure from neutrality can indicate the presence of 
natural selection acting either at the site under investigation or at linked sites. Due to the 
detrimental effects of low levels of sequence variation and demography on the power of the 
neutrality tests, the analyses of LD patterns within the target regions of the PrP and PBGD 
genes were also investigated. 
5.2 Results 
5.2.1 	Nucleotide and Haplotype Diversity 
The target regions for the selected loci were amplified and sequenced (Chapter 3) and the 
genetic variability (Table 9 and Table 12) was analysed using population genetics methods. 
The main characteristics of the sites forming the two target regions are given in (Table 19). 
The average number of nucleotide substitutions per site between two sequences (2r) 
(Nei 1987) was estimated for the nonsynonymous, the synonymous and the silent sites. The 
latter includes both the synonymous and the non-coding sites. The pairwise nucleotide 
diversity was low for both genes although it was especially low for the PBGD gene, with the 
overall (nonsynonymous plus silent sites) ir equal to 2x 10 4 for both red deer and wapiti. The 
overall ir for the PR/VP gene was 1.0x10 3  for both cervid species and no difference was seen 
between the CWD +VE and the CWD VE  samples. The nucleotide diversity of cervid PR/VP was 
comparable to the one estimated in North American cattle: 1.25 x  1 0 (Seabury et al. 2004). 
The 'r values obtained for bovines and cervids are high compared to the one obtained for the 
humaii PR/VP gene: a value of 3.1 x 104 , which is comparable to the one obtained in this 
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study for PBGD, was obtained from the sequencing of a 2.4kb region of the PrP gene by 
Soldevila and colleagues in 2006. The authors also pointed out that such a value is low 
compared to other human genes (Soldevila et al. 2006), and the possible presence of positive 
selection acting on the human PrP gene was suggested. As expected, for both genes, ir was 
lower in nonsynonymous sites than in synonymous or silent sites (Table 21), thus indicating 
the effect of functional constraints on these two loci. 
The values of Watterson's estimator (Ow)  obtained for the PRNP target region were 
low when compared to the one obtained for PRNP in other cervid species and in species of 
the family Bovidae: sheep (0.0062), goat (0.0046), cattle (0.0028), mule deer (0.0070) and 
white-tailed deer (0.0038). These latter values of O y were obtained for the ORF 
(synonymous and nonsynonymous sites); the values obtained for the ORF of the wapiti and 
red deer PrP gene in this thesis were 0.0013 and 0.0010, respectively. The value obtained for 
wapiti was also very similar to the previously published one: 0.00 11 (Slate 2005); thus 
suggesting, that despite a difference in sample size, the values for the two studies are 
comparable. This estimator of 0 is based on the number of polymorphic sites in the sampled 
sequences, and the low values identified provide additional confirmation of the low levels of 
genetic variability present in the PrP gene of C. elaphus and C. canadensis. A very low value 
of Ow  was obtained for the PBGD target region in red deer (0.0004), while no 
polymorphisms were identified in the ORF of the wapiti PBGD gene. Another aspect of the 
data worth noting was the presence of a number of low frequency variants in both loci. In the 
PRNP target region, five out of the 12 and 13 variable positions identified in red deer and 
wapiti, respectively, had a frequency of less than 0.05 (Table 9). The same was true for the 
PBGD gene target region: two out of the four variants of red deer and two out of the three 
identified for wapiti had a frequency of less than 0.05 (Table 12). 
The lack of diversity, coupled with the presence of low frequency variants may 
indicate population expansion after a bottleneck or the action of selection. These patterns of 
variation were analysed using neutrality tests to identify significant departure from the 
patterns expected under neutral evolution (Section 2.20). 
The haplotype diversity of the PrP gene was: 0.703 (10 haplotypes) (Table 11) for 
red deer and 0.524 (7 haplotypes) for wapiti (Table 11). Two of the seven wapiti haplotypes 
represented 85% of the alleles (Wh-1 and Wh-6) (Table 11) and four out of the remaining 
five had a frequency of 0.01. For red deer, 5 of the 10 haplotypes had a frequency lower than 
0.05 and the three most common haplotypes (Rh-lIRh4fRh-11) represented 73% of the 
alleles. The haplotype diversity obtained for the target region of the wapiti PrP gene was 
relatively low and very similar to the one detected in the human gene: 0.551 (Soldevila et al. 
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2006). Low levels of haplotype diversity were also obtained for PBGD in deer (0.288; 4 
haplotypes) (Table 14) and wapiti (0.345; 4 haplotypes) (Table 14). One of the four wapiti 
haplotypes (Wh-PBGD. 1) represented 80% of the alleles (Table 14) and 2 of the three 
remaining haplotypes had a frequency of less than 0.05. If the indels were not taken into 
account, haplotype Rh-PBGD. I represented 84% of the alleles and two of the remaining four 
haplotypes had a frequency below 0.05. The estimation of the haplotypes diversity did not 
take into consideration indels, as these are excluded by DnaSP 4.0. When indels were 
included the number of hap lotypes increased to 11 and 6 for red deer PrP and PBGD genes, 
respectively. 
The presence of a few main haplotypes in both genes together with low diversity fits 
a bottleneck model, which may represent the demographic history of the populations 
investigated. Reduction in diversity, together with the lower levels of nucleotide diversity at 
nonsynonymous sites may also suggest strong functional constraint, which is expected to 
play a significant role, especially in the housekeeping locus but possibly also in the PrP 
gene; on the basis of previous reports for ruminant PRNP (Slate 2005) and the hypothesised 
key role of PrP in cellular metabolism. The action of natural selection, however, cannot be 
excluded. 
A number of tests of neutrality were used to examine the variability identified in 
more detail and thus better understand the forces shaping the genetic patterns of these 
regions. However, as population structure has been shown to affect the results of neutrality 
tests (Przeworski 2002) and as the wapiti samples are known to originate from two different 
populations (Section 2.1), the genetic distance between these two populations was estimated 



















































Wapiti 	1298 	768 	 180.81 587.19 	 1252 588 	146.33 438.67 
Red deer 	1299 	768 	 180.7 587.33 	 1252 588 	146.33 438.67 
5.2.2 	Genetic Divergence between Populations 
Haplotype and sequence divergence statistics (Section 2.20) were implemented to determine 
whether the two independent but partially overlapping wapiti populations studied (E-8 and 
E-9) were genetically differentiated (Table 20). The analysis of both PrP and PBGD data 
does not indicate genetic subdivision as none of the permutation tests carried out gave 
significant results thus the null hypothesis that the two populations are not genetically 
different could not be rejected. All the test statistics for which significance was not tested 
also had values very close to zero (Table 20). The lack of significant genetic divergence 
between the two populations eliminates the possible effects that genetic structure within the 
populations could have on the results of the neutrality tests. 
As mentioned in (Section 1.28), there is still disagreement on whether red deer (C. 
elaphus) and wapiti (C. canadensis) should be considered as two independent species, and 
for this reason the genetic subdivision tests were also applied to the PrP and PBGD data 
obtained for the two cervid species. All the permutation tests carried out for haplotypes (HST) 
and sequence statistics (Snn) gave statistically significant results, with P values lower than 
0.001 for both the PrP and PBGD genes (Table 20) indicating genetic difference between 
these two closely related species. These results were also supported by the other genetic 
differentiation tests (GST  and FST)  with the exception of dA.  The values of dA obtained for the 
two cervid species were very close to zero: 8.8x10 and 3.6 x 104 in PRNP and in the PBGD 
gene respectively. Such values indicate low levels of divergence between the two species. If 
only silent sites were considered (dy), the values remained practically unchanged: PrP (d = 
1.17x10) and PBGD gene (d5 = 4.75x10) (Table 20). 
The different results obtained for dA and the other test statistics could be related to 
the different type of information used for their estimation. The haplotype and sequence 
statistics (Section 2.20) utilise information on the haplotype frequencies and on the numbers 
of differences between haplotypes while dA (Section 2.20) uses information on the pairwise 
nucleotide diversity (it) of the two populations and the average number of nucleotide 
substitutions per site between the populations. A possible interpretation of the data is that the 
low genetic diversity identified for the two species, together with the very low values 
obtained for dA, may suggest that, although the two species have diverged since they 
separated around 0.6 million years b.p. (Polziehn and Strobeck 2002), as suggested by the 
significance of the haplotype statistics, the divergence is not actually very large. 
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Gene 	Data Groups 	 Hsr 	 Snn 	 GST 	 FST 	 dA 	d5 
Wapiti (E-8 / E-9) -0.008 	P = 0.822 0.486 	P =0.868 -0.008 -0.013 1.5xl0 -2.5x10 5 
PrP 
Wapiti/Red deer 0.239 	P0* 0.995 	P0 0.239 0.397 8.8x10 1.17x10 
Wapiti (E-81E-9) 0.018 	P0.155 0.543 	P0.162 0.025 0.076 1.5x10 5 2.5x1O 
PBGD 
Wapiti/Red deer 0.461 	P0* 0.847 	P0 0.459 0.589 3.6x10 4.75x10 
5.2.3 	Testing for Departure from Neutrality 
The Tajima's D (Dr) test was applied to investigate possible departures from neutrality. 
None of the DT values obtained for the PrP gene were significant (Table 21). The wapiti 
samples were also divided into CWDve and CWD+ve samples to test for the possible 
presence of a CWD-related variability pattern which could suggest the presence of natural 
selection. Although not significant, the CWD+e samples produced a much higher DT (1.650) 
compared to the other groups, which had DT  values that ranged between -0.113 and 0.104. 
This increase in the Taj ima' s D was the result of the absence of one of the elk samples from 
the CWD+ve  dataset: this CWD sample carried four singletons unique to the sample. Its 
absence resulted in a marked reduction in the number of low frequency polymorphisms and 
thus a sharp increase in the value of DT.  Fu and Li's F*  and D*  also gave nonsignificant 
results. These data suggest that there is no significant evidence of a departure from neutral 
expectations. Similar results were obtained for the target region of the PBGD gene; none of 
the neutrality tests, despite giving values close or smaller than -1, were significant (Table 
21). D, F* and D* were also estimated for silent sites only (Table 21); this did not have a 
significant effect on the results obtained for the two genes, indicating that the 
nonsynonymous SNPs are not biasing the results. On the basis of the data obtained for the 
two genes, there seem to be no evidence for the action of selection or, as mentioned in the 
previous section, evidence indicating a recovery from a bottleneck. However, the low 
number of variants identified for both genes could significantly affect the power of the 
neutrality tests thus resulting in the lack of significance and in the latter case the age of the 
bottleneck would also play a significant role in the ability of the tests to detect it. 
The Fay and Wu's H test, which focuses on a genetic signature specific to selective 
sweeps, was also implemented. Sequences obtained from the target regions of a goat sample 
(Section 3.2.8) were used as outgroups. The outgroup is necessary to distinguish derived and 
ancestral variants, which is the main focus of the test statistic. However, the results obtained 
for both the PRNP and PBGD target regions were not significant, thus suggesting the 
absence of the signature of a selective sweep. The only exception was when the test was 
applied to the PBGD target region of the CWD, VE wapiti. However, once again, the 
extremely low genetic variability identified in the wapiti PBGD target region as well as the 
low number of CWD+1 wapiti analysed (n. = 12) could have influenced the test statistics. 
The H-test and the K-test (Section 2.20) were not significant for the two red deer loci 
(Table 22); while the same was true for the wapiti PBGD target region, a lower than 
expected haplotype diversity was detected for the wapiti PRI'JP target region (P = 0.045). 
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This significantly low value for H, together with a fairly low although not significant K (P = 
0.094), could indicate a population expansion scenario where the population is in the early 
stage of recovery from a bottleneck: although the number of haplotypes has already 
recovered thanks to low frequency polymorphisms arising after the bottleneck, the haplotype 
diversity is still in the process of recovery. If the haplotype patterns described were the result 
of the described scenario, similar results would be expected from the PBGD gene due to the 
genome wide effect of bottlenecks. The lack of significance for the estimates of H and K for 
the wapiti PBGD haplotypes, although possibly indicative of an alternative scenario could 
also be the result of the very low number of variants available for analysis. 
Table 21 - Nucleotide Diversity of the PRNP and PBGD Loci 
The ,r is given for the nonsynonymous (nonsyn.), the synonymous (syn.) and the silent sites. 
The latter include both the synonymous and the non-coding sites. The Owas also estimated 
for the three groups of sites. The 95% Cl of DT, F* and  D*  were identified using coalescent 
simulations (10,000 replicates). Statistical significance for DT, F*and D* was assessed using 
a two-tailed test. None of tests applied was significant. 
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0w Tajima's DT Fu and Li's 
D* Fu and Li's F* 
Gene Species CWD 
Nonsyn. Syn. Silent Nonsyn. Syn. Silent All sites All sites All sites 
Sites Sites Sites Sites Sites Sites 
0.104 0.841 0.688 
PRNP Red deer N/A 0.0010 0.0020 0.0013 0.0010 0.0011 0.0013 95% CI, -1.593 to 1.871 95% CI, -2.293 to 1.467 95% Ct, -2.170 to 1.701 
0.315 -1.442 -0.968 
PRNP Wapiti +/-ve 0.0006 0.0035 0.0017 0.0010 0.0022 0.0013 95% CI, -1.634 to 1.981 95% CI, -2.033 to 1.510 95% CI, -2.279 to 1.740 
1.650 1.304 1.662 
PRNP Wapiti +ve 0.0006 0.0037 0.0017 0.0004 0.0025 0.0011 95% CI, -1.681 to 1.922 95% CI, -2.201 to 1.304 95% CI, -2.335to 1.679 
-0.113 -1.040 -0.862 
PRNP Wapiti -ye 0.0006 0.0034 0.0016 0.0011 0.0025 0.0015 95% CI, -1.660 to 1.898 95% CI, -2.571 to 1.511 95% CI, -2.358 to 1.684 
PBGD Red deer N/A 0.0000 0.0003 0.0003 0.0000 0.0015 0.0006 
-1.035 
95% CI, -1.667 to 2.006 
-0.098 
95% CI, -2.302 to 1.004 
-0.450 
95% CI, -2.430 to 1.532 
PBGD Wapiti +1-ye 0.0000 0.0000 0.0003 0.0000 0.0000 0.0004 
-0.657 
95% CI, -1.575 to 2.081 
-0.478 
95% CI, -1.823 to 0.867 
-0.622 
95% CI, -2.040 to 1.447 
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DT D* Fay and Wu's H H-test K-test 
Gene Species CWD tee1 Iteet All Sites All Sites All Sites 
Red -1.324 0.703 10.00 
PRNP deer 
N/A 0.099 1.318 1.064 95% CI, -4.381 to 1.755 95% CI, 0.445 to 0.862 95% CI, 6.00 to 13.00 
9H 	-1.324]: 0.147 P[Hs 0.703]: 0.362 P[Hs 10.00]: 0.638 
-0.938 0.524 7.00 
PRNP Wapiti +1-ye 0.665 -0.721 -0.283 95% CI, -4.814 to 1.88 95% CI, 0.475 to 0.870 95% CI, 6.00 to 14.00 
P[H. -0.938: 0.192 9I-1 	0.5241: 0.045 P(H5 7.001: 0.094 
-0.765 
PRNP Wapiti +ve 1.585 1.247 1.589 95% CI, -3.691 to 1.422 N/A N/A 
9Hs -0.7651: 0.187 
-1.149 
PRNP Wapiti -ye 0.229 -0.262 -0.443 95%CI,-5.084to2.077 N/A N/A 
P[!-1 	-1.149]: 0.175 
Red 0.441 0.288 4.00 
PBGD deer 
N/A -1.035 -0.098 -0.450 95% CI, -2.335 to 0.813 95% CI, 0.187 to 0.749 95% CI, 3.00 to 5.00 
P[H5 0.441]: 0.147 P[H5 0.288]: 0.094 9H:g 4.001: 0.438 
-0.871 0.345 4.00 
PBGD Wapiti +/-ve -0.657 -0.478 -0.622 95% CI, -1.756 to 0.637 95% CI, 0.121 to 0.695 95% CI, 2.00 to 4.00 
9H 	-0.871]: 0.109 P[hIS 0.345]: 0.295 P(H5 4.00]: 1.000 
1 . 833* 
PBGD Wapiti +ve -1.159 -1.606 -1.704 95%CI, -1.369 to 0.261 N/A N/A 
P[Hs -1.833]: 0.009 
-0.433 
PBGD Wapiti -ye -0.393 -0.350 -0.422 95% CI, -1.759 to 0.656 N/A N/A 
PEH5 -0.4331: 0.197 
The McDonald-Kreitman test, which compares the ratio of replacement to 
synonymous fixed differences with the ratio of replacement to synonymous polymorphisms, 
failed to show any evidence of selection in both loci (Table 23), consistent with the results of 
the other neutrality tests. The test could not be carried out for the PBGD gene using the 
wapiti and goat sequences, due to a lack of variable positions in the coding region of the 
wapiti gene. Divergence from the patterns of nucleotide variation expected under a neutrality 
model were also tested using the 1-IKA test (Section 2.20), which determines if the relation 
between intraspecies variation and interspecies divergence at the tested loci is consistent 
with the one expected for neutrally evolving loci (Hudson, Kreitman, and Aguade 1987). 
The 1-IKA test was carried out using sequencing data obtained from the PrP and the 
PBGD genes of red deer, wapiti and domestic goat; the latter species was used for the 
quantification of interspecific variation. Divergence was calculated as the average number of 
pairwise differences between goat and the cervid sequences. Departure from the neutral 
model is tested using the chi square distribution of the sum of the deviations obtained for 
intraspecific and interspecific variation (Table 24). 
The sum of the deviations was not significant for red deer when all substitutions 
were considered (j = 3.004; P = 0.083) or if the HKA test was carried out using only silent 
positions (y = 1.913; P = 0.167). On the other hand, a significant result was obtained for 
wapiti through the analysis of all silent and nonsynonymous sites (J = 4.933; P = 0.026); the 
largest deviations came from the higher-than-expected number of SNPs in PRNP (2.30 1) and 
the lower-than-expected number of SNPs in the PBGD gene (2.05 1). However, the 
application of the test to silent positions resulted in a reduction of the sums of deviations ( 
= 3.73 8), which was just below the significance level: P = 0.053. This suggests that the 
patterns of variation are not the result of directional selection. The excess of SNPs detected 
in wapiti seems to be the result of the nonsynonymous changes identified in wapiti; these 
could be the result of a slight relaxation of purifying selection within the C. canadensis 
PRNP. The nonsignificant result of the FIKA test also suggest that the low levels of 
variability detected for the PBGD gene are not the result of a selective sweep. 
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Table 23 - McDonald-Kreitman test 
Capra hircus (Appendix 5) was used as outgroup. N/A indicates that the statistical 
significance of the test could not be estimated due to the lack of variable sites. 
Gene 
Fixed Differences between 
Søecies 	
Polymorphic Sites 
Synonymous Nonsynonymous I Synonymous I Nonsynonymous P 
Red I PRNP 16 3 I 	I I 	3 0.260 
deer I PBGD 17 2 I 1 I 0 1.000 
Colorado I PRNP 13 7 I 2 I 3 0.358 








Loci PRNP PBGD PRNP PBGD PRNP PBGD PRNP PBGD 
Sequence length 1958 1803 1370 1364 2022 1816 1425 1377 
N. of sequences 100 50 100 50 96 64 96 64 
Polymorphisms 











Observed 12 4 
_______ 
9 4 13 3 10 3 
Deviation(poIymohIsm) 1.400 1.238 0.958 0.762 2.301 2.051 1.881 1.492 
Divergence 
between species 
(n. of sites) 
Expected 81.10 95.20 73.00 93.91 83.99 95.67 75.54 94.39 
Observed 77.04 99.26 70.15 96.76 78.82 100.84 71.59 98.34 
Sequence length for species 
comparison 
1958 1803 1370 1364 2013 1816 1425 1377 
Deviation(dIveoflce ) 0.198 0.168 0.109 0.084 0.310 0.271 0.203 0.162 
x2  (Sum of deviations) (P) = 3.004 (P = 0.083) x2 = 1.913 (P = 0.167) x2 = 4933 (P 0.026) x2 = 3.738 (P 	0.053) 
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5.2.4 	LD Pairwise Methods 
The levels of LD in the target regions of the PrP and PBGD genes were investigated, in order 
to complement the results of the nucleotide site neutrality tests (Section 5.2.3). The 
population recombination rate per locus was also estimated, as it provides a numerical 
summary of the extent of LD and also because knowledge of the levels of recombination in 
the target area is useful in relation to the sensitivity of some neutrality tests to recombination. 
Low frequency SNPs (0.05) were excluded from the LD analyses (Table 9 and 
Table 12) as they have been shown to have little power for detection of LD (Lewontin 1995; 
Goddard et al. 2000). This, together with the fact that indels were not included in the 
analysis, resulted in not enough sites being available for a meaningful investigation of LD in 
the PBGD gene: only one site for wapiti and two for red deer would have been suitable for 
such analysis, and the latter were in complete LD. 
LD patterns were investigated for the target region of the PrP gene (Figure 24) in red 
deer and wapiti using r2 and Fisher's exact P-values. Linkage disequilibrium measurements 
were generated from haplotype data. Both statistics were plotted using the GOLD software 
to obtain a visual representation of the intensity of LD across the investigated genomic 
regions. 
Relatively low levels of LD were identified in the target region of the red deer PrP 
gene, and the highest level of LD was found within the central region of the ORF (r2 = 0.59 
to 0.3). This pattern of LD could be a reflection of the history of the Rum population, which 
is known to have originated from numerous introductions between the 1840s and the 1920s 
from at least four UK populations which were probably themselves mixed, and thus quite 
variable populations, due to the extensive translocation to which deer have been subjected to 
by humans, over the centuries (Nussey et al. 2006). 
High levels of LD were found in the target region of the wapiti PrP gene (Figure 24) 
with some SNPs showing complete LD (r2 = 1). LD was identified between SNPs located 
within the coding and non-coding regions of the gene. The higher LD could be the result of 
many different factors. However, the fact that the LD did not seem to decrease as the 
distance between sites increased provides support for a possible population bottleneck. 
The levels of LD are also related to the effective population size; as populations with 
large Ne are expected to show less LD. Thus difference in the Ne between the deer and wapiti 
populations analysed could be the cause of difference in the levels of LD within the same 
genomic regions; however, no such difference was identified from the estimation of Ne from 
the two loci (Section 5.2.5). The mutation rates identified for both the red deer and wapiti 
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target loci were similar, while a notable difference was identified between the estimates of 
the effective population size obtained from the two loci (Section 5.2.5 and Table 26). 
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Figure 24 - LD Intensity Across the PrP Locus 
LD was measured for the target region of the PrP gene using r2 . P-values from the Fisher's 
exact test were also calculated to determine the significance level of the associations 
between polymorphic sites. A and B = Red deer PRNP. C and D = Wapiti PRNP. 
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The level of LD within the target regions was also investigated using a model-based LD 
measure which estimates the population recombination rate per locus (p) (Section 2.22). 
Very low values of p were obtained for the red deer and wapiti PrP datasets and a value of 0 
for red PBGD. On the other hand, a value of 3.061 was obtained for the wapiti PBGD target 
region (Table 25). The higher levels of p detected could however be the result of the low 
number of SNPs available for analysis and of the low sample number. In support of this, if 
only the samples from population E-8 were analysed, the value of p increased to 6.12 1. 
Rm is a conservative estimate of the minimum number of recombination events that 
have occurred in the history of the analysed sequences (Hudson and Kaplan 1985; Stumpf 
and McVean 2003). Low or no recombination for the PrP locus was also supported by the 
fact that all the datasets gave a value of zero for the minimum number of recombination 
events (Rm). This was expected in PrP, due to fewer haplotypes than SNPs (Table 9 and 
Table 11): the number of haplotypes (Al) minus the number of segregating sites (N) indicates 
the minimum number of recombination events that should have taken place (Myers and 
Griffiths 2003). The PBGD gene gave slightly different results: for red deer M = N while for 
wapiti M-N is equal to 1. Despite higher values of p and a positive value for M-N, Rm was 0 
for the wapiti PBGD. 
The significance of the population recombination rate was tested using a permutation-
based method (McVean, Awadalla, and Fearnhead 2002) which provided very low support 
for the presence of recombination in the tested genomic areas. Lack of recombination fits 
well with the high levels of LD identified through the pairwise methods for wapiti PRNP but 
is in contrast to the data obtained for red deer PRNP. However, other phenomena such as 
mutation, genetic drift, population history, breeding systems and selection can also have an 
effect on LD (Nei 1987; Stumpf and McVean 2003), which could thus explain the low levels 
of recombination detected in deer. 
Low sample size can also prevent the detection of recombination as small datasets do not 
fully represent the genetic variability of the target region. Thus the possibility that the 
studied datasets do not provide a significant representation of the genetic variability of the 
target regions cannot be excluded. 
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Table 25 - Testing for Recombination 
The probabilities resulting from testing the null hypothesis of no recombination are given: 
Likelihood (Lk) and the proportion of simulations with an Lk :5 the estimated one (P Lk) 
(McVean, Awadalla, and Fearnhead 2002). The estimates of the population recombination 
rate per locus (p) are also given. 
Dataset p Lk P Lk 
Red.deer-PrP 1.020 -4957.82 0.484 
Wapiti-PrP 1.020 -5582.71 0.256 
Red.deer-PBGD 0.000 -206.91 0.409 
Wapiti-PBGD 3.061 -133.90 0.353 
5.2.5 	Estimation of the Mutation Rate and the Effective 
Population Size 
The mutation rate (u) of the two target loci (Section 2.23) was estimated (Table 26) to 
determine if differences in the mutation rates affecting the target regions could improve the 
understanding of the variability patterns identified. The mutation rates were also used to 
determine the effective population size of the studied species. Using published data on the 
fossil record (Drake et al. 1988; Solounias et al. 1995), 19 MYA was used as the divergence 
time between Bovidae and Cervidae and used to estimate the mutation rate per site per year. 
The per generation p was calculated assuming a six years generation time for both C. 
elaphus and C. canadensis (Pemberton, J. M., 2006. Personal communication). Estimation of 
Ne  is also important as it can affect the patterns of genetic diversity: if the effective 
population size (Ne) is small then the effect of genetic drift on the genetics of the population 
will be large and vice versa. 
The mutation rate per site per year ranged from 1.32x10 9 in the wapiti PRNP to 
1 .88x 1 O in the wapiti PBGD gene. The mutation rates obtained for the two target genes 
were very similar between the two target species (Table 26). These values are very close to 
the average mammalian genome mutation rate per base pair per year, which has been 
estimated to be 2.2x10 9  through the analysis of 5,669 mammalian genes (Kumar and 
Subramanian 2002). No published estimates of the mutation rate of loci from the two studied 
cervid were identified. 
When only one locus was considered, either PRNP or PBGD, the values of Ne 
obtained for both species were similar; however, the values determined for the two genes 
were considerably different (Table 26): PRNP gave values of Ne 2.9 and 4.6 times larger than 
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PBGD for red deer and wapiti, respectively. These differences could be the result of the 
action of strong purifying selection on the PBGD gene and the very limited number of 
variants available for analysis. A larger number of loci should have been investigated for an 
accurate estimation of Ne; however, this was not possible as part of this thesis due to time 
constraints. No estimates Of Ne were found in the literature for similar ruminant populations. 
Table 26 - Mutation Rate and Effective Population Size 
The mutation rate was estimated using silent (non-coding and synonymous) sites. A 
generation time of 6 years was used to calculate the effective population size. The effective 
population size was estimated using the formula Ne = 8141j. p was based on divergence from 
Capra hircus. N5 is the number of substitutions between a sequence from the studied 
species and the outgroup sequence and (is the length of the sequences (Section 2.23). 
Pper 
Locus 	Species 	N5 	 e 	M 	 e 	N. 
generation 
Red deer 70.15 1370 1.35x10 9 8.10x10 9 0.0013 40,123 
PrP  
Wapiti 71.59 1425 1.32x10 9 7.92x10 9 0.0013 41,035 
Red deer 96.76 1364 1.87x10 9 1.12x10 8 0.0006 13,393 
PBGD 
Wapiti 98.34 1377 1.88x10 9 1.13x10 0.0004 8 1 849 
5.3 Discussion 
A number of population genetics studies have been carried out on mammalian species to 
investigate the possible action of TSEs in shaping the evolutionary history of the PrP locus. 
This study targeted the cervid PrP gene to better understand the evolutionary forces acting on 
it and the possible influence of CWD. 
The data obtained seem to suggest the occurrence of one or more bottlenecks 
followed by population expansion during the evolutionary history of wapiti. The analysis of 
C. Canadensis PrP gene identified low levels of genetic diversity in both coding and non-
coding regions coupled with the presence of few main haplotypes (two haplotypes 
represented 85% of the alleles). This supports a possible bottleneck scenario. The samples 
from the two wapiti populations (E-8 and E-9) were pooled and analysed together, as the 
analysis of both PrP and PBGD data using permutation tests did not give significant results, 
thus indicating a lack of genetic subdivision. 
The ir (1.Ox 10) estimated for PrP in the two cervid species was similar to the one 
detected for PRNP in North American cattle (1.25 x 03) which was shown to be under strong 
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purifying selection (Seabury et al. 2004). These values were high compared to the one 
obtained for the human PRNP gene; however, in the latter species the PRNP gene is believed 
to have experienced a complex evolutionary history, possibly dominated by positive 
selection, which is believed to have been driven by functional and TSE related forces and 
could explain the low levels of pairwise nucleotide diversity (Soldevila et al. 2006). A low 
value of 0w  (0.00 12) was also estimated; a value which was lower than the one obtained for 
PRNP in other ruminants (Section 5.2.1) and provided further support for the occurrence of a 
bottleneck. 
When a population goes through a bottleneck, genetic variation is reduced and as the 
population recovers from the bottleneck, the number of low frequency variants increases. 
Five of the SNPs identified within the target region of the wapiti PrP gene had frequencies of 
less than 0.05, which may fit a model of population expansion after a possible bottleneck. 
However, a number of SNPs were found at quite high frequencies (>0.3) (Table 9) but these 
could simply have been present in the animals that survived the bottleneck thus increasing in 
frequency when the population started expanding again. Support for the bottleneck model 
also came from the LD analysis of the data, which showed high levels of LD throughout the 
PRNP target region and a lack of association between LD decay and increase in distance 
between sites. A population expansion scenario following a bottleneck was also supported by 
lower than expected haplotype diversity (H-test) for the wapiti PRNP target region. An 
analysis of the population recombination rate did not support the presence of recombination 
within this region, and the low levels of p also provided support for the presence of LD 
within the region. However, the absence of recombination within the PrP gene could also be 
related to the physical structure of this locus. Certain long interspersed nuclear elements 
(LINEs) have been shown to be strongly underrepresented in human recombination hotspots 
(Myers et al. 2005). In the sheep PRNP gene, the target area is flanked by two repetitive 
elements; L1NE2a and BovB (LiNE-like element). In addition to this, a number of LINE 
elements are spread throughout the sheep PrP gene (Lee et al. 1998). Although the BovB 
element is known to be specific to true ruminants, and an Artiodactyl specific LINE! is 
present within the 3'UTR, the presence and distribution of LINE elements within the C. 
elaphus and C. Canadensis PRNP are unknown. However, a distribution similar to the ovine 
one in cervid PRNP is likely, and it could provide an explanation for the recombination 
levels identified in the studied region. The presence and distribution of LINE elements 
within the PBGD gene is also unknown. Studies in several species, have determined that as a 
result of selection at linked sites, genetic variability is reduced in regions of low 
recombination (Nachman 2002), which could partly explain the very low levels of genetic 
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variability identified in the two target regions. 
Recombination and mutation rate are known to be correlated, the absence of 
recombination from the studied regions and the low diversity, could suggest the location of 
the two studied loci within a cold mutational region: in humans, mutation rates have been 
shown to vary widely across different regions of the genome, which results in mutational hot 
and cold regions; regions with high and low mutation rate, respectively (Matassi, Sharp, and 
Gautier 1999; Smith, Webster, and Ellegren 2002). However, there is currently no evidence 
of the presence of these regions in cervids. In humans, regional mutation rates are believed to 
affect the spatial organization of genes, with genes involved in essential cellular processes 
being preferentially located in cold regions, due to the possible detrimental effects that their 
variation could have (Chuang and Li 2004). The possibility that regional mutation rates 
affect the spatial organization of genes is also supported by studies in yeast (Pal and Hurst 
2003). If this was also true in cervids, the localization of the PBGD gene in a cold region 
would be expected due to its role as a housekeeping gene while for PrP it would strengthen 
the hypothesis of it performing an essential cellular function (Seabury et al. 2004). However, 
although the mutation rates identified are lower than the average mammalian rate, no other 
published estimates were found for cervids making any conclusion supported only by the 
currently available data objectionable. 
A bottleneck is expected to create a skew in the allele-frequency spectrum which 
should be detected by neutrality tests. However, none of the tests implemented in this study 
gave significant results thus suggesting that the data do not differ significantly from the one 
expected under a model of neutral evolution. Despite not being significant, the values 
obtained for the Fu and Li's D*  and F*  were moderately negative (Table 21). The lack of 
significance could be the result of the low number of genetic variants available for analysis, 
which reduces the power of the neutrality tests. 
The analysis of CWD+1 and CWD 1 animals did not provide any evidence for 
disease specific patterns of genetic variability, as none of the neutrality tests gave significant 
results. The absence of any evidence for disease specific selection could be the result of the 
low levels of disease prevalence in the two target populations: E-8 = 1.2% (95% CI, 0.4 - 
2.1%) and E-9 = 1.7% (95% Cl, 0.9-2.5%). 
An analysis of the history of C. canadensis does suggest the presence of at least two 
bottlenecks and subsequent population expansions. Since it evolved, North American wapiti 
has undergone two major restrictions in population size. The first one occurred when it 
colonised North America (Alaska) between 0.26 and 0.15 million years b.p. (Guthrie 1966) 
while the most recent one culminated at the beginning of the 20 th century. During the latter 
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population contraction, which started with the arrival of the European settlers in North 
America, it has been estimated that due to hunting and ranching activities, the number of 
wapiti dropped from 10 million to between 50,000 and 100,000 (Polziehn et al. 2000). Of 
the survivors, around 40,000 were located in the Yellowstone National Park, which were 
widely reintroduced throughout North America where they mixed with whatever native stock 
survived (Gyllensten et al. 1983). These contractions in population size are in agreement 
with some of the results obtained in the study. Low levels of diversity in wapiti have also 
been described through microsatellite studies (Talbot, Haigh, and Plante 1996; Wilson et al. 
1997; Polziehn et al. 2000) (Roed and Midthjell 1999), protein electrophoresis (Cameron 
and Vyse 1978; Emerson and Tate 1993; Glenn and Smith 1993), random amplified 
polymorphic DNA analysis (Comincini et al. 1996) and by restriction analysis of mtDNA 
(Cronin 1992; Murray, McClymont, and Strobeck 1995). As mentioned above, the 
population of the Yellowstone National Park did not experience the second population 
contraction and as a result of this, the genetic diversity of this population was conserved. 
However, low levels of genetic variability have also been described in this population, which 
may suggest that low levels of diversity were also present prior to the last bottleneck 
(Polziehn et al. 2000). These low levels of variation could be the result of a founder effect 
experienced when wapiti first colonised North America. 
Reduced genetic variability has also been detected in other large mammals that 
colonised North America at the same time as wapiti and experienced similar demographic 
events. Two examples are moose and brown bear (Ursus arctos) (Cronin 1992; Matsuhashi 
et al. 2001). In agreement with this, low levels of genetic variability have been identified in 
the PrP ORF of three subspecies of moose (Huson and Happ 2006). 
A bottleneck would have a genome-wide effect on the variability patterns of wapiti, 
although loci specific patterns due to stochastic variation can also occur. To determine the 
possible presence of a bottleneck, PRNP data were compared to those obtained from the 
housekeeping gene porphobilinogen deaminase. As for the PrP target region, low levels of 
genetic variability were identified together with low haplotype diversity, high LD and a 
prevalence of low frequency SNPs. In contrast to the PRNP results, a value of 3.061 was 
obtained for p. However, the likelihood permutation test (LPT) provided very low support 
for the presence of recombination and this value could be the result of the very low number 
of SNPs and the smaller sample number analysed (Chapter 3). These data match those 
obtained for the PrP genes thus supporting a possible post bottleneck population expansion 
scenario for wapiti. 
In addition to the possible effects of demography, strong functional constraint on the 
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two target regions could have contributed to the low levels of genetic variability identified in 
wapiti. The presence of purifying selection would be expected to be acting on the PrP locus 
on the basis of evolutionaiy studies carried out on ruminant PRNP (Krakauer, Zanotto, and 
Page! 1998; Seabury et al. 2004; Slate 2005) and its hypothesised key role in cellular 
metabolism (Section 1.7). Strong functional constraint was also expected in the PBGD gene 
since by being a housekeeping gene it is expected to be essential for the survival of the 
organism; thus making variation at this type of locus often hannful for the organism. 
For this thesis, European red deer and wapiti have been considered as two separate 
species, Cervus elaphu.s and Cervus canadensis, respectively. However, there is still 
disagreement on whether they should be considered as two independent species. A number 
of haplotype divergence statistics estimated for the two cervid species identified significant 
levels of genetic subdivision between the two groups of samples, however a test statistic 
using information on within and between species diversity identified low levels of genetic 
divergence; which may suggest that although the two species have diverged since the 
emergence of wapiti around 0.6 million years b.p., the level of divergence is not actually 
very large. 
Lower levels of LD, together with haplotype diversity higher than in wapiti were 
identified in the red deer PRNP target region; this could be the result of the history of this 
island population. The red deer samples analysed in this study were obtained from the 'North 
block' of the Isle of Rum. After extirpation in the 18th century, red deer were reintroduced to 
the Isle of Rum from at least four different UK populations. These source populations were 
probably quite variable due to the intense human translocation that the red deer has been 
historically subjected to (Harti, Zachos, and Nadlinger 2003; Nussey et al. 2006). As for 
wapiti, the presence of recombination in the target region was not supported and in addition 
to this, despite higher expected values, on the basis of the population history, the level of 
genetic variability was similar to the one detected for wapiti. Neutrality testing did not 
provide evidence for departure from a model of neutral evolution and as for the wapiti gene, 
purifying selection is apparently acting on the PrP gene. 
Previous studies of LD in ruminant PRNP showed that in sheep LD is greatest at 
sites in the 3'UTR of exon III. This was used as evidence in support of possible balancing 
selection acting on the 3'UTR in relation to the regulation of gene expression (Slate 2005). It 
is not possible to make a direct comparison between the LD patterns found in sheep and the 
results obtained for C. elaphus and C. canadensis, as the sheep study looked at 
approximately 3.4kb of the 3'UTR while the current study only analysed 0.7kb of the 
untranslated region. A comparison of the 0.7kb region covered by both studies shows that 
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wapiti seems to have an LD pattern similar to the one found in sheep. However, there is no 
evidence for balancing selection acting on the PrP locus of the two cervid species and higher 
levels of LD are present throughout the area analysed rather than just in the 3 'UTR suggests 
a pattern different from the ovine one. In addition to this, studies in humans, dogs and pigs 
have demonstrated that the pattern and extent of the LD is often population-specific (Sawyer 
et al. 2005), thus making a direct comparison between these studies difficult. 
The extent of LD in mammalian genomes has been studied most thoroughly in 
humans, where the genome appears to be organised into blocks of high LD, separated by 
regions of low LD or recombination hotspots (Maniatis et al. 2002). LD appears to extend 
for physical distances of up to 100 kb in several populations, and up to several megabases in 
isolated populations (Ardlie, Kruglyak, and Seielstad 2002; Myers et al. 2005) More than 
25,000 recombination hotspots have been identified in the human genome; an average 
hotspot density across the genome of approximately one every 50 kb (Myers et al. 2005). A 
number of LD studies have also been carried out for livestock populations due to their 
agricultural importance. The extent of LD in livestock was expected to be higher than in 
humans, since the forces producing LD (admixture, selection and small effective population 
sizes) are more extreme in these populations. Indeed, high levels of LD have been found to 
extend for many centimorgans in cattle, pigs, horses, goats and sheep (McRae et al. 2002; 
Nsengimana et al. 2004; Tozaki et al. 2005; Khatkar et al. 2006). The study of C. 
Canadensis and C. elaphus was expected to provide information on the LD patterns in 
ruminant species not affected by intensive selective breeding regimes. The current data are 
however insufficient to draw any conclusions on the LD patterns of non-livestock 
populations. 
The analysis of the red deer porphobilinogen deaminase target region provided 
results very similar to the one obtained for wapiti: extremely low levels of genetic variability 
and haplotype diversity (Rh-PBGD. 1 represented 84% of the alleles), high levels of LD, no 
recombination and a prevalence of low frequency variants. In wapiti, these data matched the 
one obtained for PRNP thus supporting a population expansion scenario. As for C. 
Canadensis, strong functional constraint is also expected to play a significant role in shaping 
the variability patterns of the housekeeping gene. Despite the lower levels of LD and higher 
haplotype diversity identified in red deer PRNP, the data obtained for the PrP and PBGD 
genes do not exclude the possibility of a bottleneck in C. elaphus as age and intensity of such 
a bottleneck would modulate the characteristics of its genetic signature. 
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5.4 Conclusions 
Many of the studies that have investigated the genetic variability of genomic loci and the 
evolutionary forces shaping them have concentrated on species with well-characterized 
genomes (e.g. Drosophila species and humans) or on livestock species; thus resulting in a 
lack of information related to the genetic variation and selection in wild populations. Many 
of these studies aimed at determining the existence of an association between particular 
genetic variants and traits of interest, often agriculturally important traits, or disease; the 
latter particularly applies to many of the PrP studies. Knowledge of the genetic variability of 
a gene involved in a particular trait of interest is also desirable in relation to the management 
and conservation of genetic variation and to the improvement of breeding schemes. 
However, intensive breeding regimes and the resulting reduction in diversity can make the 
analysis and identification of specific evolutionary forces very challenging. Genetic 
uniformity in intensively bred species has been shown by a number of studies, which 
identified low levels of genetic variability (Cheong et al. 2006; Hayes et al. 2006; Li et al. 
2006a) and high LD (McRae et al. 2002; Nsengimana et al. 2004; Tozaki et al. 2005; 
Khatkar et al. 2006) in livestock species. For this reason, the study of non-model wild 
species or populations may provide useful information which could be then related to the 
understanding and management of agriculturally important traits in livestock populations. In 
addition to this, understanding DNA sequence diversity can also provide an insight into the 
history and evolution of the analysed species. 
The current study, in addition to assessing the possible presence of CWD-related 
selection in wapiti PR/VP, also dealt with the current lack of knowledge of the genetic 
variability of autosomal loci in non-model populations and provided data for the analysis and 
interpretation of the evolutionary history of the target species. 
The analysis of both the PrP and PBGD target regions of wapiti suggested the 
occurrence of one or more bottlenecks followed by population expansion during the 
evolutionary history of this species. This scenario is supported by the history of C. 
canadensis, which is known to have undergone at least two major restrictions in population 
size since it colonised North America between 0.26 and 0.15 years b.p. (Guthrie 1966). The 
data obtained from the two loci in red deer do not provide clear evidence for a specific 
evolutionary or demographic scenario and this is probably the result of the complex history 
of this population; however, the data showed many similarities with the results obtained for 
wapiti and a bottleneck scenario cannot be excluded. These data indicate that low genetic 
variability is obviously not limited to farmed populations and that due to demographic events 
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and in some cases, human intervention, the genetic variability of some species can be driven 
down. 
The data from these two cervid species show high levels of conservation for the two 
target loci, which appear to be under purifying selection. This result was expected for the 
PBGD gene due to its role as a housekeeping gene. In the case of PrP, although a number of 
studies have suggested a major role for purifying selection in the evolution of ruminant 
PRNP (Krakauer, Zanotto, and Pagel 1998; Seabury et al. 2004; Slate 2005), the possible 
presence of species-specific patterns driven by protein function or in the case of wapiti by 
CWD, could not be excluded prior to this study. The analysis carried out for this thesis 
provides no evidence for CWD-related variability patterns and although this could be related 
to the low levels of disease prevalence in the two target populations, the presence of 
purifying selection supports the theory of a key role of PrP in cellular metabolism. The 
possible presence of disease-specific selection appears even less likely after the genotyping 
analysis described in Chapter 4 suggested a lack of CWD resistance associated with variation 
at codon 132. The possible significance of purifying selection in the PrP gene is further 
analysed in Chapter 6 where the possible presence of positively selected sites is investigated. 
The study also provided evidence for the lack of recombination within the two target 
loci; this factor could contribute to the low levels of genetic variability identified and could 
result from the physical structure of the studied genes. LINEs have been shown to be 
strongly underrepresented in human recombination hotspots; although no information is 
available on the distribution of these elements within the cervid PrP and PBGD genes, a 
number of LiNEs are known to be present in the sheep PRNP gene. If a similar genetic 
elements are also present in the cervid gene, this could at least explain the low levels of 
recombination identified in the PRNP gene. Recombination has been shown to be correlated 
with mutation rate and reduced mutation is expected in regions of low or no recombination. 
The data obtained could suggest the location of the two loci in genomic regions which in 
humans have been termed cold mutational regions, which are believed to affect the spatial 
organisation of genes (Matassi, Sharp, and Gautier 1999; Smith, Webster, and Ellegren 
2002). Although below the mammalian average, the mutation rates identified for the two loci 
do not appear to be exceptionally low; this together with lack of evidence for the presence of 
hot and cold mutational regions in cervids, make any conclusion highly speculative. 
However, the presence of PRNP in a cold mutational region would strengthen the belief of a 
key role of the PrP protein in cellular metabolism. Despite their importance for the 
understanding of genetic variation and of the forces shaping it, not many estimates of the 
effective population size and mutation rate have been published for wild populations; the 
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estimates obtained in this study, although only based on data from two genomic loci, provide 
an additional tool for the understanding of cervid genetic variability. 
Despite being useful by increasing the limited volume of data currently available for 
wild ruminant species, the data obtained in this study do not provide enough information to 
suggest specific patterns of genetic variability and selection which could exist in free-
ranging ruminant populations. 
The present study utilised direct sequencing for the identification of genetic variation 
within the target loci. In contrast to this, many of the studies currently published on the 
genetic diversity of populations have utilized microsatellites as markers of genetic variability 
within species. This was highlighted by a study which reviewed diversity studies in farmed 
animals (e.g. cattle, sheep, goat, etc.). It revealed that for example 89% of the diversity 
studies carried out for sheep and 91% of the studies targeting goat utilised microsatellites as 
markers (Baumung, Simianer, and Hoffmann 2004). However, the variability of 
microsatellite is often not biologically relevant and it is often difficult to compare data 
produced by different studies. Conversely, the variation identified through direct sequencing 
of SNPs, in addition to being biologically relevant, is also more accurate than microsatellites 
in its interpretation (Vignal et al. 2002). As for microsatellites, the studies utilizing SNPs as 
markers of genetic diversity have focussed on model species or on genes believed to be 
involved in agriculturally important traits of livestock populations (Section 1.30), thus 
providing further evidence for a lack of data relating to the patterns of genetic variability of 
wild non-model species and the adaptive forces shaping them. 
The current study, although foccussed mainly on the PRNP gene, due to its 
involvement in TSEs, also provided useful data which could be used to better understand the 
patterns of genetic variability and selection in mammalian loci. 
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Selected Sites in the Chapter VI: Positively 
Mammalian PrP 
6.1 	Introduction 
Significantly higher nonsynonymous than synonymous substitutions is an unequivocal 
indicator of positive natural selection at the molecular level. A number of tests have been 
developed which analyse the ratio (w) between synonymous (silent, d) and nonsynonymous 
(amino acid-changing, dN) substitutions within a protein coding region and determine the 
presence of selection: when w > 1, nonsynonymous mutations have a higher fixation rate 
than synonymous mutations thus indicating the presence of positive selection (Goldman and 
Yang 1994). This method has successfully identified a number of positively selected genes: 
abalone sperm lysine (Yang, Swanson, and Vacquier 2000), reproductive proteins in 
Drosophila (Tsaur and Wu 1997; Ting et al. 1998) and sex-related genes in Chlamydomona.s 
(Ferris et al. 1997) are only few examples. A more comprehensive list of genes in which 
positive selection has been detected using d/d5 can be found in Yang and Bielawski 2000 
(Yang and Bielawski 2000). A study carried out in 1996 proposed that about 0.47% of the 
3,595 gene groups in the DDBJ, EMBL, and GenBank DNA sequence databases at the time 
may have experienced positive selection at one or more amino acid sites. However, those 
tests averaged d/d5  over the whole sequence of the analysed gene; thus making this estimate 
very conservative (Endo, Ikeo, and Gojobori 1996), due to the fact that different sites in a 
protein have different structural and functional roles and for this reason are expected to be 
under different selective pressures. In many cases, only few amino acid positions are under 
positive selection, while the rest of the protein is dominated by purifying selection. In these 
cases, the high number of sites under purifying selection would result in co values smaller 
than one, despite the presence of positively selected sites (Nielsen and Yang 1998; Yang and 
Nielsen 2000). Likelihood-based methods for the detection of natural selection at single 
amino acid sites have now been developed. These methods enable the identification of 
critical amino acids under diversifying selection without knowledge of protein function. 
(Nielsen and Yang 1998; Suzuki and Gojobori 1999) (Section 2.24). Positively selected sites 
have been identified in a number of proteins through the implementation of these methods 
and a list of these studies can be found in Yang et al. 2005 (Yang, Wong, and Nielsen 2005). 
Different patterns of selection have been identified in a number of mammalian 
species (Mead et al. 2003; Seabury et al. 2004; Slate 2005; Soldevila et al. 2006). Despite 
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this, in the majority of species investigated, including the two cervid species in this thesis 
(Chapter 5), the PrP protein appears to be under purifying selection (Krakauer, Zanotto, and 
Pagel 1998; Seabuty et al. 2004; Slate 2005) (Section 1.12). To date, no study has been 
carried out to investigate the possible presence of positively selected sites within the PrP 
protein and for this reason the existence of sites under positive selection cannot be excluded. 
The identification of such sites could provide insight into regions of the protein which could 
be important for protein function and disease. The work carried out as part of this thesis 
investigated the possible presence of positively selected sites within the mammalian prion 
protein. 
6.2 Results 
Site specific models (Section 2.24) were applied to two datasets of mammalian PrP 
sequences (Figure 6), in order to investigate the presence of positive selection within PR/VP 
and identify the positively selected amino acids of the PrP protein. From this point forward, 
the Artiodactyla dataset will be abbreviated to ART and the Mammalia dataset to MAM. 
6.2.1 	Best-Fit Nucleotide Sustitution Model 
The online application FindModel was used to identify the best fitting nucleotide substitution 
model for the two datasets, thus enabling the subsequent generation of good quality trees. 
The output obtained for the two datasets is presented in Table 27. In both cases the General 
Time Reversible (GTR) model with gamma distribution (Rodriguez et al. 1990) was selected 
as the best fitting model. The lnL scores of the best fitting models were -2466.030 for ART 
and -4829.188 for MAM. 
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Table 27 - FindModel Output 
The log likelihoods of the twelve substitution models tested are given. The selected model is 
highlighted in light yellow. 
Substitution Model Artiodactyla (lnL) Mammalia (lnL) 
Jukes-Cantor (JC) -2593.120 -5389.713 
Jukes-Cantor plus Gamma (JC+G) -2548.850 -5038.708 
Felsenstein 1981 (F81) -2582.089 -5376.122 
Felsenstein 1981 plus Gamma (F81+G) -2538.404 -5027.565 
Kimura 2-parameter (K80) -2531.323 -5229.441 
Kimura 2-parameter plus Gamma (K80+G) -2483.709 -4856.784 
Hasegawa-Kishino-Yano (HKY) -2520.856 -5213.939 
Hasegawa-Kishino-Yano plus Gamma (HKY+G) -2472.848 -4837.501 
Tamura-Nei (TrN) -251 9.258 -5202.498 
Tamura-Nei plus Gamma (TrN+G) -2472.354 -4834.235 
General Time Reversible (GTR) -251 3.771 -5199.494 
General Time Reversible plus Gamma (GTR+G) -2466.030 -4829.188 
The GTR model is a DNA substitution model aimed at estimating the average number of 
substitutions per site; it assigns a different probability to each pair of nucleotide 
substitutions. This model assumes a symmetric substitution matrix, which means that the 
model is time reversible and that the probability of the data is independent of the placement 
of the root on the tree (Lanave et al. 1984; Rodriguez et al. 1990). The gamma correction 
accounts for site rate heterogeneity: the rate of nucleotide substitution varies across sites 
according to a gamma distribution (Uzzell and Corbin 1971). 
6.2.2 	Generation of Phylogenetic Trees 
The GTR+G model was then used in MrBayes (Section 2.24) to infer the phylogeny of the 
sequences under study. Two simultaneous, completely independent analyses were run for 
each dataset, starting from different random trees (Section 2.24). At the end of the analysis 
of both datasets, the standard deviation of split frequencies was less than 0.01, which is 
considered a satisfactory level of topological convergence. Good levels of convergence were 
also supported by PSRF and by the pattern obtained through the plotting of generations 
versus their log likelihood values; at the stationary phase PSRF is expected to have a value 
of one for each estimated parameter while the piots should look like white noise. When the 
analysis was stopped the PSRF of all the parameters estimated had a value of 1.0 and no 
obvious pattern was seen in the plots (Figure 25), thus indicating high levels of similarity 
between the trees obtained through the two independent runs carried out for each dataset. 
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Figure 25 - Generation vs. Log Likelihood 
The generation number was plotted against the log likelihood values obtained at each 
generation. The data obtained for both of the runs (pink = RUN 1 and black = RUN 2) from 
the analysis of both datasets (ART = A; MAM = B) are shown. The likelihood values for the 
"burn-in" generations were not displayed. The lack of any obvious trend in the graph 
supports the fact that both runs had reached stationarity when the analysis was stopped. 
The values obtained for the two runs were very similar and for this reason many of the data 
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The analysis was run for 5x106 generations, with Markov chain sampling every 100 
steps, resulting in 50,000 sampled trees. Four discrete categories were used to approximate 
the gamma distribution. Acceptable levels of mixing between the cold and the heated chains 
were obtained (Table 28); thus indicating a robust approximation of the posterior probability 
distribution of all the parameters estimated by MC 3 . 
Table 28 - Chain Swap Information 
Matrix of the acceptance rates between chains generated at the end of the MC 3 run for the 
two runs of ART (A and B) and MAM (C and D) datasets. Upper diagonal: Proportion of 
successful state exchanges between chains. Lower diagonal: Number of attempted state 










The output phylogenetic trees produced by MrBayes are shown in (Figure 26); these two 
trees were used in PAML for the detection of positively selected sites. 
C) 
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Figure 26 - Phylogram of the PrP Gene ORF within mammals and artiodactyls 
Bayesian reconstruction of PrP gene ORE phylogeny within the order artiodactyla and the 
class Mammalia. For the Mammalia dataset (A), a total of 28 sequences were used and the 
Tammar wallaby sequence was utilised as an outgroup. For the Artiodactyla dataset (B) 24 
sequences were used; the human PrP gene sequence was included as an outgroup. The 
posterior probability of the clades is specified by the numbers next to the nodes. 





1 .0 Thomson's gazelle 
1.0 L Waterbuck 
0.911: Nyala 
U.rDomestic goat 
0.9211 L  Scimitar-horned oryx 
0.871r Alpine musk deer 
O.919r Caribou 
i.o'ljRed deer 






Gray mouse lemur 
1 1.0 Rhesus monkey 
0.99 
	Francois's black leaf monkey 




0.97 	Gray dwarf hamster 
Hispid cotton rat 
1.0 Tawny-bellied cotton rat 
1.0 	
Mongolian jird 
















4 European bison 
 Gaur 
Water buffalo 
















0.701 Red deer 
0.97 L Fallow deer 
Thomson's gazelle 
- Waterbuck 0.99 
0.1 
157 
6.2.3 	Detecting the Presence of Positively Selected Sites 
The presence and distribution of selective pressure within PRNP was assessed through the 
implementation of six models of codon evolution (MO, Mia M2a, M3, M7 and M8) using 
PAML (Section 2.24). The models are implemented in a maximum likelihood framework 
and each model represents a different evolutionary scenario. A description of the different 
models is given in Section 2.24. The likelihood values and the parameter estimated for the 
two dataset are summarised in Table 29. 
The co estimates of the one-ratio model MO, which assumes uniform selective 
pressure among sites, indicated high levels of purifying selection (WT = 0.119 and WMI = 
0.081) throughout the protein. This model is very conservative and provides an average of 
the selective pressures in all the amino acid sites of the prion protein. As a result of this, it is 
possible that the known presence of highly conserved regions within the PrP protein results 
in the low levels of dAplds and conceals the possible existence of positively selected sites. 
The model which provides the best representation of the data being analysed was identified 
through a number of likelihood ratio tests (Section 2.24). Variation of the selective pressure 
between the amino acids of the PrP protein was supported by the rejection of the null 
hypothesis of uniform selective pressure among sites (MO) in favour of a model of variable 
selective pressure among sites (M3): P < 0.0001 for both datasets (X 2 = 35.4 and 187.77 for 
ART and MAM, respectively - d.f. = 4). M3, or the discrete model, allows for variation in 
the selective pressure among sites but only three site classes are permitted: for ART, co 0 = 
0.000, 0)1 = 0.090, CO2 = 0.565 (Table 29). This model suggests the absence of positively 
selected sites (co> 1) and that 53% of the amino acid positions are under extreme purifying 
selection: co = 0 (Table 29). 
The presence of positive selection was then tested by comparing models Mia 
(Nearly-neutral model) and M2a (Positive selection model). Both models assume variable 
selective pressure among sites (0 <coo  < 1) but M2a also allows for positively selected sites 
(co > 1). In both models w 1 is fixed at 1.000 (Table 29). No difference in the likelihood 
scores was detected between these two models for both datasets. Equality of likelihood 
scores was also seen for models M7 (Beta model) and M8 (Beta & co model) in the 
Artiodactyla dataset; these two models assume a beta distribution of the selective pressure 
among loci with M8 also allowing for the existence of positive selection (co> 1). These data, 
together with a value of zero for the pj  parameter, which represents the proportion of codon 
sites with co > 1 in M8, seem to indicate that none of the sites of the PrP gene have been 
under positive selection during the evolution of Artiodactyla. This is also supported by the 
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fact that none of the three cv classes assumed by M3, the best fitting model (Table 29), have 
values larger than 1. 
Different results were seen for the Mammalia dataset: the M7 model was rejected in 
favour of M8 (P = 0.01 - = 9.198 - d.f. = 2), which was the best fitting model. In addition 
to this, the presence of a small number of sites under diversifying selection was indicated by 
a positive value for thep i parameter (p' = 0.006 - cv = 1.720) and byp 2 = 0.010 ((0 = 1.376) 
in M8 and M3, respectively (Table 29). A comparison of M3 and M8 indicated that M8 fits 
the data better than M3 by minimising the value of AIC: 92 15.942 (M8) and 92 18.536 (M3). 
The shapes of the beta distribution obtained for the two datasets using models M7 and M8 
were similar. The shape of the beta distribution is given by the values of p and q (Table 29). 
Such shapes suggest a high proportion of highly conserved sites. 
The low estimates of cv (cv < 1) obtained for the two datasets are similar to the one 
available in the literature for ruminant PrP; cv = 0.156 (Slate 2005). The two cervid 
populations analysed in previous sections also give similar estimates of cv: 0.183 and 0.502 
for wapiti and deer, respectively. The study by Slate in 2005 also provided estimates of cv for 
a number of ruminant species; with the exception of sheep and goat, low levels of cv were 
found in all the species analysed: cattle (cv = 0.53), wapiti = (cv = 0.34), mule deer (CO = 0.06) 
and white-tailed deer (cv = 0.29). These low levels of cv could be consistent with high levels 
of purifying selection acting on the PrP gene to maintain the primary sequence of the protein 
and its function. 
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Table 29 - Log-likelihood Values () and Model Parameter Estimates 
The table summarises the results obtained for the ART (A) and MAM (B) datasets using the 
codeml program implemented in PAML. The symbol P(numbe,)  represents the proportion of 
sites within PrP protein which are expected to have a specific value of w: in table A, under 
M3 53.2% of the PrP sites (po = 0.532) is expected to have a w of zero (wo = 0.000). In M7 
and M8, p and q represent the shape of the beta distribution. 
Model e Estimates of Parameters 
MO(oneraflo ) 2366.147 w=0.119 
M1a(neayfleu t,.al) -2350.264 
Po = 0.904 (Pi = 0.096) 
= 0.052 w1 = 1.000 
M2a(pos j vese I ecuQn ) -2350.264 Po 
= 0.904 Pi = 0.058 (P2 = 0.038) 
W0 =0.052 W1 =1.000 w2 1.000 
M3(dlscrete ) -2348.447 
Po = 0.532 Pi = 0.293 (p2 = 0.175) 
W0 = 0.000 w1 = 0.090 W2 = 0.565 
M7(be ) -2348.505 p0.165 q=1.125 
M8(beta & w) -2348.505 
po=1.000 (pi=O.000) 
p0.165 q= 1.125 W = 1.000 
Model e Estimates of Parameters 
MO(oneratj o) 4698. 153 W = 0.081 
Mla(flea ,jyfleu I) 4642.946 Po 
= 0.931 (p1 = 0.069) 
W0 0.054 Wil.000 
M2a(p00 1uve00 ,ecuQfl ) 4642.946 
p0 = 0.931 Pi = 0.069 (P2 = 0.000) 
W0 = 0.054W1 = 1.000 w2= 2.492 
M3(dlscrete ) 4604.268 Po 
= 0.744 P' = 0.246 (p2 = 0.010) 
W0 = 0.015 Wi = 0.261 c 	= 1.376 
Ml(beta ) 4608.570 p = 0.230 q = 2.152 
MS(beta & w) -4603.971 
Po = 0.994 (Th = 0.006) 




6.2.4 	Identification of the Positively Selected Sites 
The results of M8 and M3 for the MAM dataset indicated the presence of a small number of 
sites under diversifying selection. Using the naive empirical Bayes (NEB) and the Bayes 
empirical Bayes (BEB) methods (Section 2.24), PAML calculated the posterior probabilities 
for each site of the PrP gene to identify the sites under positive selection. As alignment gaps 
were removed by PAML before the analysis, the posterior probability for the following 
codons were not calculated: 2, 3, 33, 54, 55, 56, 57, 58, 59, 92, 98, 103, 228, 229, 230 and 
246. A graphical representation of the location of these codons in the PrP ORF is given in 
Figure 27. 
Figure 27 - Codons Excluded from the Likelihood Analysis 
The position of the codons excluded from the maximum likelihood analysis due to the lack of 
models for indels in PAML are shown. The wapiti open reading frame is used. 
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Codon 100 was the only position with a posterior probability for the category w> 1 which 
was higher than 0.95; both model 8 and model 3 identified this position as being under 
positive selection. Figure 29 shows the results of the NEB for model 3, posterior 
probabilities of 0.999 and 0.857 were obtained for codons 100 and 223. respectively. Model 
8 gave values of 0.998 (NEB) and 0.975 (BEB) for codon 100 and 0.321 and 0.596 for codon 
223 (BEB). A graphical representation of the posterior probabilities obtained for NEB from 
model 8 is also given in Figure 29. All the other positions had very low posterior 
probabilities for the w> I site category. Codon 100 is located in the central part of the PrP 
protein, between the disordered N-terminus and the structured C-terminus (Figure 28). 
Throughout the class Mammalia (132 species were analysed), three different amino acids 
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have been found at codon 100: serine, asparagine and glycine. In two of the species 
analysed, codon 100 was deleted: Nannospalax ehrenbergi (Palestine mole rat) and 
Macrotus ca/fornicus (California leaf-nosed bat). Codon 100 has also been found to be 
polymorphic in cattle: G I OOS (Zhang et al. 2004). 
Figure 28 - Codon 100 
Codon 100 (red arrow) was found to be under positive selection by M8 (w = 1.720 PNEB 
0.998 and PBEB = 0.975) and M3 (w = 1.376 PNEB = 0.998). This position encodes serine (S) 
in deer and wapiti. It is located in the central part of the PrP protein, between the disordered 
N-terminus and the structured C-terminus. 
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Figure 29 - Posterior probabilities of Site Classes along the PrP Gene 
A) Posterior probabilities obtained for the codons of the PrP gene using NEB under Model 8. 
This model assumes a beta distribution of w ratios among sites and allows the existence of 
positively selected sites. It was identified as the model that best fitted the data of the MAM 
dataset. The ten w ratio categories obtained for this model were combined into two 
categories to simplify the graphical representation: w < 1 and w = 1.720. B) Posterior 
probabilities obtained for the codons of the PrP gene using NEB under Model 3. M3 
assumes three categories of w but they were combined into: w < 1 and w = 1.376. The 
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6.3 Discussion 
The analysis of the PRNP open reading frame using site specific models indicated that most 
of the amino acid sites of the PrP protein are under strong purifying selection. The analysis 
of the ART datasets provides no evidence for positively selected sites. In contrast to this, the 
MAM dataset seems to indicate the presence of a small number of sites under positive 
selection; 1% of the sites according to M3 and 0.6% of the sites according to M8, the best 
fitting model (Table 29). 
The posterior probabilities calculated for the different sites within the protein 
identified codon 100 as being positively selected: the posterior probabilities for this codon 
were higher than 0.95 for both M3 (0.999 using NEB) and M8 (0.998 using NEB and 0.975 
using BEB). The difference between these two methods is that BEB takes the sampling 
errors of the estimated parameters into account, thus making the posterior probabilities more 
reliable (Nielsen and Yang 1998; Yang et al. 2000; Anisimova, Bielawski, and Yang 2002). 
Position 223 also had a relatively high posterior probability under models 3 (0.857); 
however, under the best fitting model the posterior probability of this site dropped to 0.321 
and 0.596 using NEB and BEB, respectively. To date, a number of studies have identified 
evidence for strong purifying selection acting on the PrP gene in a number of mammalian 
species. An analysis of selective pressure variability within the ruminant phylogeny, using 
codon-based likelihood models that allowed d/d5 to vary between lineages, showed that 
PRNP is subject to purifying selection in ruminants (Slate 2005). Population genetics 
analysis also identified strong purifying selection in the Bovinae PRNP (Seabury et al. 2004) 
and using a conservative method for the analysis of d vlds, evidence of overall purifying 
selection has also been identified in the PRNP of Cercopithecidae, Hominidae, Cebidae, 
Artiodactyla and Rodentia (Krakauer, Zanotto and Pagel 1998). However, species specific 
evolutionary patterns cannot be excluded and have indeed been detected in a number of 
mammalian and ruminant species (Mead et al. 2003; Slate 2005; Soldevila et al. 2006) and 
the presence of positive selecton in the human PRNP, although still uncertain, has been 
proposed (Soldevila et al. 2005; Soldevila et al. 2006). 
Although the function of the prion protein is still unknown, it is expected to have a 
key role in cellular metabolism (Seabury et al. 2004), which fits well with the high levels of 
functional constraint identified by the various molecular evolution studies. Prnp ° '° mice do 
not display obvious developmental or anatomical defects and have a normal lifespan; 
however, more careful analyses revealed a number of abnormalities (Section 1.7). It has been 
suggested that due to its key cellular role, a backup system that compensate for the lack of 
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PrPC may exist (Caughey and Baron 2006); one of the recently discovered PrP paralogs, 
Shadoo, has been proposed as being potentially involved in such a system (Watts, 
Balachandran, and Westaway 2006). To date, a number of possible functions ranging from 
participation in cell adhesion, synapse formation and neuronal survival have been proposed 
for PrPC  (Section 1.7). 
The current data suggest that codon 100 is probably the only positively selected site 
in the mammalian PrP protein. However, although the method used is much better than past 
tests for the detection of positive selection (Goldman and Yang 1994) and has been shown to 
be able to effectively detect the presence of selection and identify specific sites under 
selection (Section 2.24), this approach is still conservative as it implies that the same level of 
selection is present throughout the studied phylogeny (Nielsen and Yang 1998). As a result 
of this, the possible presence of positively selected sites within individual species or 
taxonomic groups due to specific functional or disease related selective pressures cannot be 
excluded. The lack of detection of positively selected sites within the ART dataset could be 
due to the high levels of similarity between the PRNP sequences of Artiodactyl species: high 
levels of similarity between the analysed sequences has been shown to have a detrimental 
effect on both the power and accuracy of Bayes predictions and on the performance of the 
likelihood models (Anisimova, Bielawski, and Yang 2002). 
Codon 100 is located in the central part of the PrP protein, between the disordered 
N-terminus and the structured C-terminus (Figure 28), in an area defined as the stop transfer 
effector (STE) region (cervid residues 99-114). The STE region is a hydrophilic sequence 
that contributes to the regulation of PrP topology (Falcone et al. 1999). It contains the 
information for interrupting protein translocation at the adjoining hydrophobic domain 
(Lingappa et al. 1978; Blobel et al. 1979) [transmembrane (TMB) region, cervid codons 
115-139)], which creates the membrane-spanning region of the PrP protein and results in the 
transmembrane topological forms of PrP. The prion protein is synthesized in three 
topological forms at the endoplasmic reticulum (ER): secp rp NtmPrP and  CtfllPrP  While most 
PrP molecules are completely translocated within the lumen of the endoplasmatic reticulum 
(seCprp) less than 10% of the PrP molecules assume a transmembrane orientation and span 
the ER membrane at the hydrophobic TMB domain, either with the C-terminus ("PrP) or 
the N-terminus (CPrP)  on the cytoplasmic side. 
It has been proposed that CtmPrP  could have a pathogenic role in prion diseases: 
mutations located in both the STE and TMB regions, which increased the number of CtfflP rP 
have been shown to result in the development of neurodegenerative disease in mice; one of 
these mutations was the human GSS-causing mutation Al 17V (Hegde et al. 1998; Hegde, 
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Voigt, and Lingappa 1998a; Hegde and Lingappa 1999). Three SNPs (P102L, P105T and 
P105L) (Stahl et al. 1987; Kitamoto et al. 1993; Mead 2006) with possible pathogenic or 
modulatory roles have been identified in human PRNP and one of the two major 
determinants of prion disease incubation time in mice, codon 108 (L1O8F) (Westaway et al. 
1987) is also located in this region (The amino acid numbering used in the original 
publications was used; see Section 3.3 for more information and for the corresponding cervid 
positions). Removal of the STE region has also been shown to prevent PrP sc formation 
(Muramoto et al. 1996). Despite this, mutations in other regions of the molecule have no 
effect on the amounts of CtIflPrP  suggesting that this topological form of PrP does not play a 
central role in the pathogenesis of all prion diseases (Stewart and Harris 2001; Stewart and 
Harris 2003). However, it is still possible that increased levels of CtmPrP  through variation in 
the primary structure of the STE and TMB regions could be responsible for a subset of 
inherited prion diseases (Stewart and Harris 2001). 
Regardless of its actual involvement in disease development, CtmPrP  and the ratios of 
the different topological forms are probably involved in the normal cellular function of PrP. 
This is supported by the high levels of conservation seen in both the STE and TMB region. 
TMB has not only been shown to be conserved between mammalian species but also 
between species of different vertebrate classes; thus suggesting a central role for this region 
in PrP function. In addition to high levels of conservation in the TMB region, inter-class 
conservation of the main structural features of PrP has also been described, thus suggesting a 
possible evolutionary conserved role of vertebrate PrPs (Schatzl etal. 1995; Oidtmann etal. 
2003; Rivera-Milla etal. 2006). 
The mutations in the STE domain may act by disrupting or enhancing its interaction 
with components of the translocon; however, the details of the underlying molecular 
mechanism are still unknown (Yost et al. 1990; Kim, Rahbar, and Hegde 2001). The 
importance of the STE region for the regulation of PrP topology has also been demonstrated 
by studies which showed that mutants that lacked codons 106 to 114, were unable to 
generate Ntmprp  and CtIflPrP  (Lopez etal. 1990; Yost etal. 1990). 
Throughout the class Mammalia, three different amino acids have been found at 
codon 100: serine, asparagine and glycine. These three amino acids are all neutral in charge, 
polar and hydrophilic. In two of the species analysed, codon 100 was deleted: Nannospalax 
ehrenbergi (Palestine mole rat) and Macrotus ca!fornicus (California leaf-nosed bat). No 
information is available on the functionality of PrP in these two species and the effects, if 
any, that the deletion of codon 100 has on PrP topogenesis or on its structure and function. 
Codon 100, together with codon 103, appears to be the most variable of the STE-TMB 
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region. However, the hydrophilic nature of the STE domain is not affected by these amino 
acid changes, once again emphasising the importance of hydrophilicity for the role of this 
region. 
6.4 Conclusions 
The PrP protein appears to be under strong purif'ing selection throughout the mammalian 
evolution; thus suggesting a key cellular role for this protein. The study identified codon 100 
as the only positively selected site within PrP. This codon, which is located at the start of the 
stop transfer effector region has been shown to be considerably more variable than the 
surrounding codons. The STE region is believed to be involved in the regulation of PrP 
topology and has also been proposed as a central factor in some prion diseases. Although the 
adaptive pressures driving this selective pattern remain elusive, and the different amino acids 
found at position 100 have very similar characteristics, one could speculate that variation at 
this position is favoured in relation to the interactions of the STE region with the translocon 
andlor other translocation accessory factors (Hegde et al. 1998; Hegde, Voigt, and Lingappa 
1998a) that are believed to be crucial for the function of this domain. 
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Chapter VII: Final Discussion 
Due to the identification of an association between polymorphisms of the prion protein gene 
and susceptibility to scrapie (Section 1.13), breeding programmes have been put in place to 
increase natural resistance to the disease (Atkinson 2001; Le Dur et al. 2005). However, 
selection for specific alleles may have detrimental effects on economically important traits. 
In breeds where the resistant alleles are only found at low frequencies, selection could result 
in a bottleneck that would significantly reduce genetic variability and which could also affect 
agriculturally important characteristics of these populations and their ability to resist 
pathogens. The latter scenario became apparent with the identification of a new scrapie strain 
affecting resistant animals (e.g. Nor98) (Benestad et al. 2003). A number of studies have 
investigated the possible economic impact of these breeding programmes but no significant 
effects have been detected for agriculturally important traits (Vitezica et al. 2006; Sweeney, 
Hanrahan, and O'Doherty 2007) although some breed-related effects may exist (Alexander et 
al. 2005). This suggests that the susceptibility alleles are probably not associated with higher 
fitness in the absence of disease (Slate 2005). 
Scrapie significantly reduces the life expectancy of affected sheep and for this 
reason reduces the number of offspring contributed to the next generation. Due to this, if the 
only effect of disease-related PrP alleles was to confer susceptibility to scrapie, natural 
selection would be expected to lower the frequency of these alleles (Woolhouse et al. 2001) 
and possibly eliminate them in regions of high scrapie incidence. Although reductions in the 
frequency of susceptible alleles have been reported during scrapie outbreaks (Woolhouse et 
al. 1998), scrapie-susceptible alleles are present at relatively high frequencies in domestic 
sheep (Hunter et al. 1997b) and PrP variation in sheep has been suggested to persist thanks 
to balancing selection; a selective process not seen in the PrP locus of other ruminants. The 
exact form of balancing selection acting on the PRNP locus and the forces behind this 
selective process remain elusive. It is possible that LD between the sheep PRNP and a gene 
influencing fitness rather than scrapie may have resulted in the signature of balancing 
selection. Regardless of the forces driving selection, breeding plans are expected to disrupt 
this selective process, thus possibly resulting in reduced fitness and pathogen resistance 
(Slate 2005). 
The identification of a selective process that differs from the one believed to 
dominate the evolution of PRNP in ruminants (i.e. purifying selection) (Seabury et al. 2004; 
Slate 2005) and possibly in all mammals (Krakauer, Zanotto, and Pagel 1998), suggests the 
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presence of species-specific evolutionary processes acting on the PRNP locus. This is also 
supported by a number of studies investigating the selective forces acting on the human 
PRNP gene, which describe a complex history of selection dominated mainly by positive 
selection, although temporally and spatially localized balancing selection (Hardy et al. 2006) 
and/or weak purifying selection cannot be excluded (Kreitman and Di Rienzo 2004; 
Soldevila et al. 2006; Zan et al. 2006b). The analysis of the human gene also indicated the 
ability of TSEs to drive selection at PRNP (Mead et al. 2003). To date, all the evolutionary 
studies which have analysed the selective forces acting on ruminant PrP genes have focussed 
on livestock species. However, genetic variability patterns obtained from these intensively 
bred species are often difficult to interpret. 
The aim of this thesis was to study the selective forces acting on the cervid PIU%JP 
gene to gain insight into how this locus varies in populations not affected by intensive 
breeding regimes and to test the ability of CWD to drive selection. On the basis of strong 
evidence for Kuru-related balancing selection at codon 129 of the human PrP gene (Mead et 
al. 2003), and due to the fact that C. canadensis is the only other known mammalian species 
showing variation at this position (wapiti codon 132) and the association of the latter with 
CWD modulation (O'Rourke et al. 1999); it was hypothesised that ancient CWD epidemics 
may have occurred in wapiti and consequently selected for the maintenance of this genetic 
variant. A similar scenario has also been suggested for ovine alleles (Baylis and McIntyre 
2004). 
The current study suggests that the PRNP genes of the two studied cervid species (C. 
elaphus and C. canadensis) are under purifying selection (Chapter 5), thus providing 
evidence for the central role of this selective process throughout the mammalian 
evolutionary history of this locus. In contrast, no evidence was found of either directional or 
balancing selection (Section 5.2.3); although the low number of genetic variants available for 
analysis could have significantly reduced the power of the implemented neutrality tests. High 
levels of conservation support the theory of a key role of PrP in cellular metabolism. 
This study also provided evidence that CWD is currently not affecting the variability 
patterns of the C. canadensis PRNP gene. This is supported by the apparent absence of 
CWD-related variability patterns during the analysis of the molecular evolution of this locus 
(Chapter 5) and also by the lack of CWD resistance associated with variation at codon 132 
(Chapter 4). The latter result was surprising as it challenged the results of a previous 
genotyping study, which showed that wapiti homozygous for methionine at codon 132 were 
over-represented in farmed and free-ranging CWD + 1 animals; thus suggesting that 
heterozygosity at codon 132 may have a protective role, although incomplete, against CWD 
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(O'Rourke et al. 1999). Those data were readily accepted on the basis that variation at the 
corresponding human position (codon 129) plays a major role in susceptibility to, and 
phenotypic expression of, human prion diseases (Mead 2006). Despite this, the work 
described in this thesis does not challenge the idea that variation at codon 132 modulates 
CWD incubation times, which is supported by a number of experimental challenges of 
wapiti. Despite this, how individual alleles and genotypes affect disease incubation is still 
unclear; although heterozygosity or more simply the 132L allele seem to result in increased 
incubation times (Kreeger et al. 2005; Hamir et al. 2006). The identification of a CWD, 1 
ML 132  animal in this study, which was less than 2 years old when diagnosed suggested that 
heterozygosity is not always associated with prolonged incubation times and that other 
factors must play a role in the modulation of CWD incubation times; these could include the 
action of different strains, the dose of the agent, the route of infection, additional PRJ%JP 
polymorphisms located outside the studied region and also additional genomic loci. 
Although the action of some of these factors has been described in other TSEs, no evidence 
is currently available for CWD. No unusual genotypes or haplotypes were associated with 
the studied sample and two similar animals were identified by O'Rourke et al. in 1999. The 
current study also confirmed that like in captive wapiti (Spraker et al. 2004b), all codon 132 
genotypes are susceptible to disease in free-ranging animals. 
The lack of genetic patterns associated with CWD could be due to the low 
prevalence of CWD in wild populations or to the fact that the increase in incubation time 
resulting from codon 132 genetics may not be enough to significantly affect the number of 
offspring contributed to the next generation. When present in farmed cervids CWD usually 
affects a high proportion of the animals within the affected population (Williams and Young 
1992; Miller, Wild, and Williams 1998) and for this reason, the analysis of the codon 132 
genotypic patterns of the survivors of a CWD outbreak in farmed animals may provide a 
better insight on the ability of CWD to drive selection; as high disease incidence coupled 
with delayed disease onset associated with specific genetic variants may provide the 
opportunity for selection. Although they cannot be excluded, ancient CWD epidemics which 
shaped genetic variation of the C. canadensis locus are not supported by this study. This 
could thus suggest that CWD is a relatively new agent; which, as estimated through 
surveillance data and epidemic modelling, originated in the 1960s in Colorado (Miller et al. 
2000). It is important to remember that disease-related variants may also play a role in 
protein function during the absence of disease and that for this reason other selective forces 
may be affecting their frequency. The current lack of knowledge on the functional role of the 
PrP protein makes the interpretation of these data very challenging. Variation at residue 129 
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of the human PrP protein is believed to affect the kinetics of PrPC  oligomerization; however, 
disruption or modification of PrPC  interactions with different molecules and/or PrP 
trafficking and sorting have also been proposed (Jones, Surewicz, and Surewicz 2006a). 
Codon 132 is only one of many positions within the mammalian PrP gene which 
have been shown to be polymorphic. Amino acid changes can result in structural changes 
(Section 3.3) that could then potentially affect the function of the protein and its role in TSE 
mechanisms. Not only the position of variant sites per Se, but also the nature of the variant 
amino acids can be very important in determining the effects of variation. 
Three novel cervid nonsynonymous mutations were identified during the study: 
K25R and TI91A in C. canadensis and P168S in C. elaphus. Codon 25 is also located in a 
region of the PrP protein believed to interact with other molecules: it is the first residue of a 
5 amino acid glycosaminoglycans binding motif (KKRPK). The binding of PrPC  to GAGs is 
believed to be important in the hypothesised cell—cell adhesion and signalling function of the 
PrP protein (Pan et al. 2002b; Yin et al. 2006), although a possible involvement in disease 
mechanisms has also been suggested (Wong et al. 2000). Variation at codon 168 and codon 
191 are of particular interest due to the association of SNPs at these positions with disease 
resistance and development in other mammalian species: the SNP L168 allele has been 
associated with increased resistance to the BSE agent (Goldmann et al. 2006a) (Section 
3.2.2.5) while heterozygosity at codon 188 in the human PrP gene (cervid codon 191) has 
been linked to CID development (Windi et al. 1999; Collins et al. 2000; Finckh et al. 2000) 
(Section 3.2.2.6). While in the case of codon 168 the properties and characteristics of the 
variant amino acid rather than variation per se seem to be the main factors controlling the 
biological effect of variation, in the case of codon 188 in humans, the crucial factor seem to 
be location as all human mutations identified to date at this position have been associated 
with disease development. Wapiti sample which carried the T191A mutation, was CWD 
but the possibility of the animal developing CWD if it had not been culled, cannot be 
excluded, especially if the fact that in humans the threonine to alanine change resulted in 
disease only when the patient reached an age close to its life expectancy is considered 
(Collins et al. 2000). 
The understanding of genetic data is hindered by a lack of confirmed molecular 
models of PrP sc  structure and formation and the fact that the function of the PrPC  is still 
unknown. The variants described in the previous section are ideal examples of the 
complexity behind variation at the PrP locus and its effects on protein function and disease. 
Although the function of the prion protein is still unknown, it is expected to have a key role 
in cellular metabolism (Seabury et al. 2004), which fits well with the high levels of 
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functional constraint identified by most molecular evolution studies and the high levels of 
interspecies sequence conservation. To date, a number of possible functions have been 
proposed for PrPC ;  however, none of them has been confirmed. These include involvement 
in cell adhesion, cellular signalling (Schneider et al. 2003; Santuccione et al. 2005), synapse 
formation (Kanaani et al. 2005), neuronal survival (Chen et al. 2003; Solforosi et al. 2004) 
and copper metabolism (Vassallo and Herms 2003; Taylor et al. 2005). It has been suggested 
that due to its key cellular role, a backup system that could compensate for defective PrPC 
may exist (Caughey and Baron 2006). At present, the main candidate is Shadoo, a GPI-
anchored glycoprotein encoded by one of the PRNP paralogs, which is believed to be present 
in all vertebrates (Premzl et al. 2003) and like PrP is believed to be expressed in most tissues 
(Premzl and Gamulin 2007). With the exception of the hippocampus and the cerebellum, 
Shadoo appears to be expressed in neurons which lack PrP; thus suggesting a possible PrP-
like activity of Shadoo (Watts, Balachandran, and Westaway 2006). In vitro conversion 
studies as well as transgenic animal models could provide a better insight into how these 
novel cervid variants may affect the biology of their carriers and if they could play a role in 
TSE disease. 
Within a highly conserved protein which appears to be under purifying selection, a 
number of amino acid sites may still be under positive selection (Nielsen and Yang 1998; 
Suzuki and Gojobori 1999) (Section 2.24). The identification of these amino acid sites can 
provide an insight into the role of different regions of a protein and aid the study of protein 
function. A search for positively selected sites within the mammalian prion protein (Chapter 
6) identified codon 100 as being under positive selection. This codon is located at the start of 
the stop transfer effector region, a highly conserved section of the protein believed to be 
involved in the regulation of PrP topology and that has also been proposed as a central factor 
in some prion diseases (Yost et al. 1990; Hegde and Lingappa 1999). The adaptive pressures 
driving positive selection at this site are unknown and although position 100 has been shown 
to be considerably more variable than the surrounding codons, the different amino acids 
encoded at this site have very similar characteristics. Despite this, variation at this position 
could be favoured as part of the interactions of the STE region with the translocon and/or 
other translocation accessory factors that are believed to be crucial for the function of this 
domain (Hegde et al. 1998; Hegde, Voigt, and Lingappa 1998b). 
The work carried out for this thesis focussed mainly on the PRNP gene due to its 
involvement in TSEs; however, an additional locus, which was used as control during the 
population genetics study, was also investigated. The combination of the data obtained for 
these two loci provides useful information on the fine-scale genetic diversity of autosomal 
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mammalian genes in wild populations. To date, most of the studies that have investigated the 
genetic variability of genomic loci and the evolutionary forces shaping them have 
concentrated on species with well-characterized genomes (e.g. Drosophila species and 
humans) or on livestock species; thus resulting in a lack of information related to the genetic 
variation and selection in wild populations. Knowledge of the genetic variability of a gene 
involved in a particular trait or believed to be associated with disease is desirable; however, 
intensive breeding regimes and the resulting reduction in diversity can make the analysis and 
identification of specific evolutionary forces very challenging. The study of non-model wild 
species or populations may provide useful information which could be then related to the 
understanding and management of agriculturally important traits in livestock populations. 
Low levels of genetic variability were identified for the two target loci in both cervid 
species and purifying selection is believed to be one of the possible causes of the low levels 
of genetic diversity in both genes. The population genetics analysis of both the PrP and the 
PBGD genes seem to support a population expansion scenario following a bottleneck in C. 
canadensis. However, the neutrality tests failed to detect the skew in the allele-frequency 
spectrum, which would be expected under such demographic scenario. Lack of significance 
may have occurred due to the low number of genetic variants available for analysis, which is 
known to reduce the power of the neutrality tests. Nevertheless, fossil data and historic 
human documents support the occurrence of at least two bottlenecks and subsequent 
population expansions during the history of C. canadensis. The first one is believed to have 
occurred between 0.26 and 0.15 years b.p. when this species first colonised North America 
(Alaska) (Guthrie 1966); while the second one started with the arrival of the European 
settlers in North America and culminated at the beginning of the 20th century. During the 
latter, approximately 99% of the wapiti population of North America was wiped out. The 
species managed to recover thanks to the protection of these animals within the Yellowstone 
National Park; animals which were then widely reintroduced throughout North America 
(Gyllensten et al. 1983). Reduced genetic variability has also been detected in other large 
mammals that colonised North America at the same time of wapiti and that experienced 
similar demographic events (Cronin 1992; Matsuhashi et al. 2001). On the other hand, the 
data obtained from the two loci in red deer do not provide clear evidence for a specific 
evolutionary or demographic scenario and this is probably the result of the complex history 
of this population. 
The mutation rate of the two target loci and the effective population size of the 
studied populations were also estimated (Table 26); as they can both have significant effects 
on the variability patterns of the target regions. Despite their importance for the 
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understanding of genetic variation and of the forces shaping it, no published estimates of p or 
Ne were available for the two studied cervid species or for similar cervid populations. The 
mutation rates obtained for the two target genes were very similar between the two target 
species and these values were very close to the average mammalian genome mutation rate 
per base pair per year (Kumar and Subramanian 2002). This suggested that the low genetic 
variability identified in the two cervid species is not simply the result of a reduced mutation 
rate. Significant variation was detected between the estimates of Ne from the two target 
genes and a larger number of loci should have been investigated for a more accurate 
estimation. The estimates obtained in this study, although only based on data from two 
genomic foci, provided an additional valuable tool for the understanding of cervid genetic 
variability and the selective forces shaping it. 
The population genetics study indicated that low genetic variability is obviously not 
limited to farmed populations and showed how demographic events and in some cases, 
human intervention, can significantly affect patterns of genetic variability. 
Due to the public and political attention received by BSE and related diseases, the 
PrP gene has been widely studied in a number of mammalian species. Although a genetic 
component has been identified for most TSEs, PrP amino acid differences are not the sole 
genetic factor modulating disease phenotype and with the improvement of sequencing 
technologies, larger sections of the regulatory regions of PRNP are being investigated and 
variants associated with disease have been identified (McCormack et al. 2002; Sander et al. 
2004; Juling et al. 2006; Vollmert et al. 2006). However, the exact role of these variants is 
unknown and it is possible that they could be simply linked to other loci or genetic variants 
involved in or affected by disease. The existence of genomic regions, other than PRNP, 
associated with TSE disease has been suggested (Baron 2002; Moreno et al. 2003) and to 
fully appreciate the genetic component of these diseases, an understanding of the way in 
which these additional loci vary and affect disease will be essential. This should provide a 
more complete understanding of genetic susceptibility to TSEs, disease mechanisms and 
selective forces driven by disease. 
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Appendix 1. Solutions and Reagents 
Agarose Gel 
Multi Purpose agarose (ROCHE, Switzerland) was diluted in either 100 or 300m1 of dH 20 to the 
desired fmal concentration, depending on the selected casting tray. Unless mentioned, 0.8% gels were 
used. 
Ampicillin 
Half a gram of ampicillin powder (ROCHE, Switzerland) was dissolved into lOmI of dH 20. 500j.tl 
aliquots were stored at -20°C in 1.5m1 microcentrifuge tubes. 
Ampicillin Agar Plates 
A 1L solution of LB agar (Gibco BRL ®, USA) was prepared using 32g of LB agar and dH 20. The 
final solution was split into three 330ml aliquots, autoclaved for 15 minutes at 12 1°C and then stored 
at room temperature. When needed, the agar was melted in microwave and ampicillin (ROCHE, 
Switzerland) was added to the melted agar (approximately 55°C) to a final concentration of ltl/ml. 
For blue-white selection, 0.5mM IPTG (Promega, USA) and 80ig/ml X-gal (VWR International, UK) 
were also added. The solution was then poured into Petri dishes (Barloworld Scientific, UK), allowed 
to cool on the bench and then stored at +4°C. 
Ethidium bromide 
One 10mg ethidium bromide tablet (Sigma-Aldrich, USA) was dissolved into imI of dH 20 and made 
up to 2ml with dH20. 
Gel loading buffer 5x 
Ficoll 400 (30g) (VWR International, UK) was mixed with lml of 10% SDS, 8tl of 0.5M EDTA (pH 
8.0) and 0.25g of Orange G (Sigma-Aldrich, USA). 
Luria-Bertani (LB) Broth 
A 1 L solution of LB broth base (Gibco BRL ®, USA) was produced using 20g of LB broth base and 
dH20. The final solution was then split into lOOmI aliquots which were first autoclaved for 15 minutes 
at 12 1°C and then stored at room temperature. If required, ampicillin (ROCHE, Switzerland) was 
added to a final concentration of 1tlIml. 
Miniprep Solution A 
D-glucose (50mM) (VWR International, UK) was mixed with 25mM of tris base (pH 7.5) and 10mM 
EDTA (pH 8). A lOOmI aliquot was autoclaved before the addition of glucose. After the addition of 
glucose, the solution was stored at 4°C. 
Miniprep Solution B 
A lOmI solution containing 0.2M NaOH and 1% SDS was prepared fresh for each preparation. 
Miniprep Solution C 
60m1 of 5M KAc was mixed with 11.5m1 of glacial acetic acid and 28.5ml of dH 20. 
PCR Clean UP Mix 
A 0.4g volume of activated charcoal (particle size 100-400 mesh) (Sigma-Aldrich, USA) was mixed 
with 50m1 of dH 20 and vortexed. 
0.5M EDTA (pH 8) 
EDTA (93.05g) (VWR International, UK) was dissolved into 400m1 of dH 20. The pH of the final 
solution was adjusted to 8.0 using NaOH. 
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IM Sodium acetate (NaAC) (pH 5.2) 
NaAc (82.03g) (VWR International, UK) was dissolved into 800m1 of dH 20. The pH of the fmal 
solution was adjusted to 5.2, using glacial acetic acid, and the volume was made up to 1L with dH 20. 
Aliquots of lOOml were autoclaved at 12 1°C for 15mm. 
lx TBE Buffer 
A 1:10 solution of lox TBE buffer was prepared using dH 2O. 
10% Acrylamide Sequencing Gel 
An 18g volume of urea (VWR International, UK) was mixed with Sml of lox TBE buffer, 5m1 of 
Long Ranger® Gel Solution (CAMBREX, USA) and 26m1 of dH 20. The final solution was stored at 
4°C. Before use the solution was thawed and mixed with 250il of 10% ammonium persulfate 
(AMRESCO®, USA) and 35il of TEMED (Flowgen, UK). 
10% Ammonium persulfate (APS) 
A 10% solution of ammonium persulfate (AMRESCO®, USA) was prepared using 0.lg of APS and 
5m1 of dH20. The final solution was stored at 4°C in foil. 
10% Sodium dodecyl sulphate (SOS) 
A 10% solution of sodium dodecyl sulphate (VWR International, UK) was prepared using 20g of SDS 
powder and dH 20. The solution had fmal volume of 200ml. 
lOx TBE buffer 
A volume of 108g of tris base (ROCHE, Switzerland) was diluted in water together with 55g of 
orthoboric acid (VWR International, UK) and 40ml of 0.5M EDTA (pH 8.0). The volume of the 
solution was made up to 1L with dH 20. The pH of the final solution was adjusted to -8.3 with HCl. 
50% Glycerol 
A 1:1 solution of glycerol (Fisher Scientific, UK) was prepared using dH 20. 
75% ethanol 
A 3:1 solution of ethanol and dH 20 was prepared 
75% Isopropanol 
A 3:1 solution of isopropanol (propan-2-ol) and dH 20 was prepared 
177 
Appendix 2. Cervid PRNP Consensus Sequences 
Alignment of the PR/VP consensus sequences of the 2kb target region obtained for red deer and Colorado wapiti. The IUPAC code for ambiguous 
nucleotides was used to describe the variable sites. The ORF starts at nucleotide 576 and terminates at nucleotide 1343. The red deer sequence was used 
for the numbering of the nucleotide positions and SNPs throughout the thesis. 
10 	20 	30 	40 	50 	60 	70 	80 	90 	100 	110 	120 
Wapiti 	TGAGGTGTGGCCAATATTCAGAAAATTATTTAATGATC TCAGCACCTACCTTGGGG C ACCCAAC TGGACATTAGAATCAATTCCATAGGGTCCATGCCAGGGTTYGGAAGGTTCC 
Red. deer TGAGGATGTGGCCAATATTCAGAAAATTATTTAATGATCTCAGCACCTACC :GGGG C 





250 	260 	270 	280 	290 	300 	310 	320 	330 	340 	350 	360 
Wapiti 
Red. deer 
370 	380 	390 	400 	410 	420 	430 	440 	450 	460 	470 	480 
Wapiti 
Red. deer 
490 	500 	510 	520 	530 	540 	550 	560 	570 	580 	590 	600 
Wapiti 
Red. deer 
610 	620 	630 	640 	650 	660 	670 	680 	690 	700 	710 	720 
Wapiti :'GGAACACTGGGGGGAGCCGTACCCGGGACAGGGAAGTCC'GGAG 
Red . deer 	 2GGAACACTGGGGGGAGCCGTACCCGGGACAGGGAAGTCC TGGG 
00 
730 	740 	750 	760 	770 	780 	790 	800 	
810 	820 	830 	840 
Wapiti 
Red. deer GCAACCGCTATCCACCTCAGGGAGGGGGTGGCTGGGGTCAGCCCCATGGAGGTGGCTGGGGCCAACCTCATGGAGGTGGCTGGGGTCAGCCCCATGGTGGTGGCTGGGGACAGCCACATG 
850 	860 	870 	880 	890 	900 	910 	920 	930 	
940 	950 	960 
Wapiti 
Red. deer GTGGTGGAGGCTGGGGTCAAGGTGGTRCCCACAGTCAGTGGAACAAGCCCAGTAAACCAAAAACCAACATGAAGCATGTGGCAGGAGCTGCTGCAGCTGGAGCAGTGGTAGGGGGCCTCG 
970 	980 	990 	1000 	1010 	1020 	1030 	1040 	
1050 	1060 	1070 	1080 
Wapiti 
Red . deer 
1090 	1100 	1110 	1120 	1130 	1140 	1150 	1160 	1170 	
1180 	1190 	1200 
Wapiti 
Red. deer 
1210 	1220 	1230 	1240 	1250 	1260 	1270 	1280 	1290 	


















1690 	1700 	1710 	1720 	1730 	1740 	1750 	1760 	1770 	1780 	1790 	1800 
Wapiti 	AACAAAACTGGAAATCCTTAGTTCATAGACCCAGACTCYAjCCTGGTTGAGAGCATGTGTCCTGTGTCTGCAGAGAACTGTAAAGGATATTCTGCATTTTGCAGGTTACATTTGCAGGTGA 
Red . deer AACAAAACTGGAAATCCTTAGTTCATAGACCCAGACTCTACCTGGTTGAGAGCATGTGTCCTGTGTCTGCAGAGAACTGTAAAGGATATTCTGCATTTTGCAGG TTACATTTGCAGGTGA  
'.0 
1810 	1820 	1830 	1840 	1850 	1860 	1870 	1880 	1890 	
1900 	1910 	1920 
Wapiti 
Rod, deer 






.1.... I.... I.... 	'''.1.. 
Wapiti 	ACCTCTAGACCTGGPGCAAkTCTG 
Red. deer ACCTCTAGCACTGGAGC.AAATCTG 
00 
C 
Appendix 3. Cervid PBGD Gene Consensus Sequences 
Alignment of the PBGD gene consensus sequences of the target region obtained for Rum deer and Colorado wapiti. The IUPAC code for ambiguous 
nucleotides was used to describe the variable sites. Exon IX = nucleotides 23 to 136; Exon X = nucleotides 384 to 422; Exon XI = nucleotides 544 to 
663; Exon XII = nucleotides 888 to 941; Exon XIII = nucleotides 1077 to 1163; Exon XIV = nucleotides 1248 to 1418. The Red deer sequence was 
used for the numbering of the nucleotide positions and SNPs throughout the thesis. 












370 	380 	390 	400 	410 	420 	430 	440 	450 	460 	470 	480 
Wapiti 
Red. deer 
490 	500 	510 	520 	530 	540 	550 	560 	570 	580 	590 	600 
Wapiti 
Red. deer GTCCCTTAGCTCTATTGGCTGGGAAAAGATTGGCACTGGTATCTTAGGCTATTTTCCCATCAGGGGGCTCTGGGTGTGGAAGTTCGAGCCAAAGACCAGGACATCTTGGATCTGGTGGGT 




730 	740 	750 	760 	770 	780 	790 	800 	




850 	860 	870 	880 	890 	900 	910 	920 	930 	
940 	950 	960 
Wapiti 	CAGGGTGGTGhTAAGGGTCTTAAGCTAACAGGCAGAACTTGTTGCAGGAAGGAGGCrrGCAGTGTGCCAGTGGCAGTGCATACAACTATTAAGGATGGGCAAGTAAGCAGGGGAAGATGGG 
Red. deer 
970 	980 	990 	1000 	1010 	1020 	1030 	1040 	1050 	
1060 	1070 	1080 
Wapiti 
Red. deer TGGGAGGGCAGGGAAGGGACTCTGGCGTTTCCCCTGTGTATCCACCAGCATGAAGAAcACAGGTTTCTAAGTAGTTCTCTCTGACAGTCTACTGAGGCACCCATTTTCTTTCCCAGTTGT 




1210 	1220 	1230 	1240 	1250 	1260 	1270 	1280 	1290 	1300 	
1310 	1320 
Wapiti 
Red. deer AGCTTCCCTTTCGTTCTCACCAAACCCAACCCTTCTTCCCTACCCAGCATGAAGATGGCCCTGAGGATGATCCACAGCTGGTGGGCA TC
ACTGCCCGCAACILTTCCACGACAACCCCAGC  
1330 	1340 	1350 	1360 	1370 	1380 	1390 	1400 	1410 	1420 	1430 	
1440 
Wapiti 
Red. dear TGGCTGCTGAGAACCTGGGCATCAGTCTGGCCACCTTGTTGCTGAACAAAGGCGCCAAGAACATCTTGGATGTTGCACGGCAGCTCAATGAAGCCCACTAATTGGCCTGTGGGGCACAGG  




1570 	1580 	1590 	1600 	1610 	1620 	1630 	1640 	1650 	1660 	1670 	1680 
Wapiti 
Red. deer 





1810 	1820 	1830 	1840 
Wapiti 	CCAGGGAACGCCAAGA.AAGACCCATCCTTTTTTTTTTTTT  
Red. deer CCAGGGACGCCAAGhAAGACCCCCTTTTTTTtTr? 
00 
Appendix 4. Ruminant PRNP Sequences 
PRNP sequences of the seven ruminant species analysed as part of this thesis. When more than one sample was analysed, the consensus sequence is 
given. The IUPAC code for ambiguous nucleotides was used to describe the variable sites. The ORF starts at nucleotide II and terminates at nucleotide 
807. 
10 	 20 	 30 	 40 	 50 	 60 	 70 	 80 	 90 	100 	
110 
Tragelaphus. angasii 
Bi.son . bonasus 
Boa. grunn.ians 
Boa . frontaLis ATGGTGAAAAGCCACATAGGCAGT:.GGATCCTGGTTCTCTTTGT 
Gazalla. thorns onii 	
CTGcAAGAAGCGAecAAPJCCTGGAGG 
Kobus. ellipsipzyinrlus 	 ATGGTGAAAGCCACATAGGCAGTTGGATCCTGGTTCTCTTTGTGGCCATGTGGTCGTCC 'ICTGCAAGAAGCGACCAAAACCTGGAGG 
Rangifer. tarandus 
120 	130 	140 	150 	160 	170 	180 	190 	200 	210 	220 
Tragelaphus. angasii 
Bison . bonasus 
Bos. grunn.iens 
Boa. frontalis 	 .GGC GGGGTCAGCCCCArGGAGGTGGCTGGG 
Gazella. thorns onii 	AGGTGGAACACCGGGGGCAGCCGATACCCAGGACAGGGAGTCCTGGAGGCAACCGCTATCCCTC 	 'GGC :GGGGTCAGCCCCkGGGG2GGCTGGG 
Kobus. ellipsipryrnnus 
Rangife.r. tarandus 
230 	240 	250 	260 	270 	280 	290 	300 	310 	320 	330 
Tragelaphus . angasii GYCAG 	 CCTCA:GGAGG GGC GGGGTCAGCCCCA:GGTGGTGGTTGGGGACAGCCGCATGGTGGTGGAGGCTGGGGTCAAGGTGGT 
Bison. bonasus 	 GCCAGCCTCATGGAGGTGGCTGGGGCCARCCTCATGGAGG GGC GGGGCAGCCCCAIGGTGGTGGCTGGGGACAGCCACATGGTGGTGGAGGCTGGGGTCAAGGTGGT 
Bos. grunni ens GCCAGCCTCATGGAGGTGGCTGGGGCCAACCTCATGGAGG. GGC GGGGCAGCCCCATGGTGGTGGCTGGGGACAGCCACATGGTGGTGGAGGCTGGGGTCAA'rT 
Boa. frontalis 	 GCCAA 	 CCTCATGGAGGTGGCTGGGG:CAGCCCCATGGTGG'rGGCTGGGGACAGCCACATGG GGTGGAGGCTGGGG'CAAGGTGGT 
Gaze.Lla. thornsonii 
Kobus. ellipsiprymnus GCCAGCCTCATGGAGGTGGCTGGGGTCAGCCCCATGGAGGTGGCTGGGGTCAGCCCCA7'GG-GGTGGCTGGGGACAGCCCCATGGTGGTGGAGGCTGGGGTCAAGGTGGT 
Rangifar. tarandus 	GCCAA 
00 
340 	350 	360 	370 	380 	390 	400 	410 	420 	430 	440 
Tragelaphus. angaaii 
Bison . bonasus 
Boa. grunnians ACCCACGGTCATGGAACAAACCCAGTAAGCCAAAAACCAACATGAAGCATG 	 TGCTGCAGC TGGAGCAG GG AGGGGGCCTTGGTGGCTACATGC GGG 
Boa. frontalis ACCCACGGTCAATGGAACA7CCCAGTAAGCCAAAAACCAACATGAGCA G GGCAGGPGCTGCTGCAGCTGGGCAG GG AGGGGGCCGGTGGCTACATGCTGGG 
Gazolla. thomsonii ACCCACAGTCGTGGAACAAGCCCAGTAAGCCAAAAACCAACATGCA G .GGCAGGGCTGCTGCAGCTGGPGCAG GG AGGGGGCCr TGGTGGCTACATGCTGGG 
Xobus. ellipsiprywnus 
Rangifer. tarandua ACCCACAGTCAGTGGAACAAGCCCAGTAAACCAAAAACCAACATGAAGCATGTGGCAGGAGCTGCTGCCGCTGGAACAGTGGTAGGGGGCCTCGG TGGCTACATG
CTGGG 
450 	460 	470 	480 	490 	500 	510 	520 	530 	540 	550 
Tragelaphus. angasii 
Bison. bonasus AAGTGCCATGAGCAGGCCTCTTATACATTTTGGCAGTGACTATGAGGACCGTTACTATCGTGAAAACATGCACCGTTACCCCAACCAAGTGTACTACAGGCCAG TGGATC 
Boa. grunni ens 
Boa . frontal is 
Gazella. thomsonii 
Kobua . eli ipsipzymnua AAGTGCCATGAGCAGGCCTCTTATACATTTTGGCAATGACTATGAGGACCGTTACTATCGTGAAAACATGTACCGTTACCCCAACCAAGTGTACTACAGACCAG TGGATC 
Ran gifer. tarazzdus AAGTGCCATGhGCAGGCCTCTTATACATTTTGGCAACGACTATGAGGACCGTTACTATCGTGAAAACATGTACCGTTACCCCAACCAAGTGTACTACAGGCCAGTGGATC 
560 	570 	580 	590 	600 	610 	620 	630 	640 	650 	660 
AGTATAGTAACCAGAACAACTTTGTGCATGACTGTGTCAACATCACAGTCAAGCAGCACACAGTCACCACCACCACCAAGGGGGAGAACTTCACCGAAACTGACATCAAG Tragelaphus . angasii 
Bison . bonasus 
Boa . grunni ens 
Boa. frontalia 
Gazella. thomsoni i 
Xobus. ellipsipzymnus GGTATAGTAACCAGAACAACTTTGTGCATGACTGTGTCAACATCACAGTCAAGCAACACACAGTCACCACCACCACCAAGGGGGAGAACTTCACCGAAACTGACATCAAG 
Rangif.r. tarandua AGTATAATAACCAGGACACCTTTGTGCATGACTGTGTCAACATCACAGTCAAGCAACACACAGTCACCACCACCACCAAGGGGGAGAACTTCACCGAAACTGACATTAAG 
670 	680 	690 	700 	710 	720 	730 	740 	750 	760 	770 
Tragelaphus . angasii 
Bison . bonasus 
Boa . grunni ens 
Boa. frontalis ATGATGGAGCGAGTGGTGGAGCAAATGTGCATCACCCAGTACCAGAGAGAATCCCAGGCTTATTACCAACGAGGGGCAAGTGTGATCCTCTTCTCTTCCCCTCCTGTGAT 





780 	790 	800 	810 	820 	830 	840 	850 	860 	870 	880 
Tragelaphus. angasii CCTCCTCATCTCTTTCCTCATTTTTCTCATAGTAGGATAGGGGCCCTTCCrGTT'rrTTATCTTCTTTCT rTGCCAGGTTGGG 
Bison . bonasus 	 CCTCCTCATCTCTTTCCTCATTTTTCTCATAGTAGGATAG 
Boa. grunni ens CCTCCTCATCTCTTTCCTCATTTTTCTCATAGTAGGATAG 
Boa. frontalis 	 CCTCCTCTCTCTTTCCTCATTTTTCTCATAGTAGGATAGGGGCAACCTTCC2GTT'I2CTTATCTTCTTC 
Gazella. thomsonii 
Kobus. ellipsipzymnus CTTCCTCATATCTTTCCTCATTTTTCTCATAGTAGGATAGGGGCAACCTTCCTGTTTTTTATCTTCTTTCTTT 
Rangifer. tarandus 	CCTCCTCATCTCTTTCCTCATTTTTCTCATAGTAGGTAG 
Tragelaphus. angasli. 
Bison. bonasus 
Boa. grunn.i ens 
Boa. frontalis 
Gazella. thow.sonhi CC 
Kobus. ellipsiprymnus 
Ran gifer. tarandus 
00 
Appendix 5. Capra hircus Consensus Sequences 
A) Alignment of the consensus sequences of the Cervus elphus and Capra hircus PRNP target regions. The ORF starts at nucleotide 575 and terminates 
at nucleotide 1343. B) Alignment of the consensus sequences of the Cervus elphus and Capra hircus PBGD target regions. Exon IX = nucleotides 23 to 
136; Exon X = nucleotides 384 to 422; Exon XI = nucleotides 544 to 663, Exon Xli = nucleotides 894 to 947; Exon XIII = nucleotides 1083 to 1169; 
Exon XIV = nucleotides 1256 to 1426. The IUPAC code for ambiguous nucleotides was used to describe the variable sites. 
A) 
10 	20 	30 	40 	50 	60 	70 	80 	90 	100 	110 
Capra_hircus 	 TCAGCACCTACCTTGGGGTCTTCC AACTGGACATTAGAATCACTTCCATAGGGTCCILTGCCAGGGTTCA  
Corvus_el aphus 
120 	130 	140 	150 	160 	170 	180 	190 	200 	210 	220 
Capra_hircus 	 TTAG.AGTTCAAAG 
Cerv'us_olaphus 
230 	240 	250 	260 	270 	280 	290 	300 	310 	320 	330 
Capra_hircus 	YT TGGTAAACCTACCAGATATTTATAGTTTCTTCCAATTTATGATATAGTGTACCAATCAGAGGTTATTTTTATCATAAGCAATGTTGCTGGCATTCTATATTTATCAA 
Corvus_al aphus 
340 	350 	360 	370 	380 	390 	400 	410 	420 	430 	440 
Caprahircus 	GTTACTAGGAAA TGGCCAGGAATTATTTTAAGGTCAACTTTGTCCTTAGAGGAGAAGAGTTGTGTTACTRCTTTACCTATAATTACTTTCATTGTATAATG 
Cervus_olaphus 
450 	460 	470 	480 	490 	500 	510 	520 	530 	540 	550 
Caprahircus 	TGAAGAACATTTATGACCTAGAATGTTTATAGCTGATGCCASTGCTATGCAGTCATTCATTATGCTGCAGACTTTAAGTGATTTTTACGTGGGCATATGATGCTGACACC 
Cervu s_el aphus 
00 
560 	570 	580 	590 	600 	610 	620 	630 	640 	
650 	660 
Capra h.ircus 	CTCTTTATTTTGCAGAGAAGTCATCATGGTGAAAAGCCACATAGGCAGTTGGATCCTGGTTCTCTTTGTGGCCATGTGGAGTGACGTGGGCCTCTGCAAGAAGCGACCAA 
Carvua_elaphus 









890 	900 	910 	920 	930 	940 	950 	960 	970 	980 	990 
Capra_hircus 
Cervus_elaphus GGTAGGGGGCCTCGGTGGCTACATGCTGGGAAGTGCYATGAGCA 
1000 	1010 	1020 	1030 	1040 	1050 	1060 	1070 	1080 	1090 	1100 
Capra_hircus 
Carvus_elaphus 
1110 	1120 	1130 	1140 	1150 	1160 	1170 	1180 	1190 	1200 	1210 
Capra_hirCus 	AACAACTTTGTGCATGACTGTGTCAACATCACAGTCAAGCAACACACAGTCACCACCACCACCAAGGGGGAGAACTTCACCGAAACTGACATCAAGATAATGGAGCRAGT 
Cervus_elaphus 
1220 	1230 	1240 	1250 	1260 	1270 	1280 	1290 	1300 	1310 	1320 
Capra_hircus 	GGTGGAGCAAATGTGCATCACCCAGTACCAGAGAGAATCCCAGGCTTATTACCAAAGGGGGGCAAGTGTGATCCTCTTTTCTYCCCCTCCTGTGATCCTCCTCATCTCTT 
Cervus_elaphus TGTGGAGCAAATGTGCATCACCCAGTACCAGGAGAATCC SAGGCTTATThCCAAAGAGGGGCAAGTGTGATCCTCTTCTCC TCCCCTCCTGTGTCCTCCTCATCTCTT 
1330 	1340 	1350 	1360 	1370 	1380 	1390 	1400 	1410 	1420 	1430 
Capra_hircus 
Cerv-us_elaphus TCCTCATTTTTCTCATAGTAGGATAGGGGCAACCTTCCTGTTTTCATTATCTTCTTAATCTTTACCAGGTTGGGGGAGGGAGTATCTACCTGCAGCCCTGTAGTGGTGGT 
1440 	1450 	1460 	1470 	1480 	1490 	1500 	1510 	1520 	1530 	1540 












1770 	1780 	1790 	1800 	1810 	1820 	1830 	1840 	1850 	1860 	1870 
Capra_hircus 
Cervus_elaphus AAAGGATATTCTGCATTTTGCAGGTTACATTTGCAGGTGILCACAGCCAGCTATTGCATCAAGAATGGATATTCATGCAACCTTTGACTTATGTRCAGAGGACATTTTCAC 
1880 	1890 	1900 	1910 	1920 	1930 	1940 	1950 	1960 	1970 	1980 
Capra_hircus AAGKAATGAACATA 
Cervuselaphus AhGGAATGAACATAACAAAATACAAAAGGCTTCTGAGACTGGAAAATTCCAACATATGGGAGAGGTGCCCTTGGTGGCAGCCTTCTATTTTGTATG TTTAAAGCKCCTTC 
1990 	2000 	2010 	2020 	2030 	2040 	2050 	2060 	2070 	2080 	2090 
Capra_hircus AAGTGPLTATTCCTTTCTTTAGTAACATAAAGTATAGATAATTAAGGTACCTTAATTAAACTACCTTCTAGACACTGAGAGCAA 
Cer-vu s_el aphus AAGTGGATTCCTTTCTTTAGTA3IXATAAPGTATAGA1AATTM.GTACCTTA TTAAACTACCTTCTAGACACTGAGAGCAAATCTG 
2100 	2110 




10 	20 	30 	40 	50 	60 	70 	80 	90 	100 	110 
Capra_hircus 	GGTCCTTAGTGTCTCTCCACAGCGGGGAAACCTCAACACACGGCTGCGTAAGCTGGATGAGCTGCAGGAGTTCAGTGCCATCATCCTGGCCGCAGCTGGCCTGCAGCGCA 
Cervus_elaphus GGTCCTTAGTGTCTCTCCACAGCGGGGAAACCTCAACACGCGGCTGCAGAAGTTGGAYGAGCTGCAGGAGTTCAGTGCCATCATCCTGGCTGCAGCTGGCCTGCAGCGCA 
120 	130 	140 	150 	160 	170 	180 	190 	200 	210 	220 




230 	240 	250 	260 	270 	280 	290 	300 	310 	320 	330 
Capra_hircus 	CAAGCTGGAAATGAGACCCAGGTTAGCAAGGT 
Cervus_elaphus CAAGCTGGAAATGAGTCCCAGGT 
340 	350 	360 	370 	380 	390 	400 	410 	420 	430 	440 
Capra_hircus 
Corvus_elaphus 
450 	460 	470 	480 	490 	500 	510 	520 	530 	540 	550 
Capra_hircus 	GCCATGTATTGT 
Cervus_elaphus 
560 	570 	580 	590 	600 	610 	620 	630 	640 	650 	660 
Capra_hircus 	TGGGTGTGGAAGTTCGAGCCAAAGACCAGG.TATCTTGGATTTGG GGG G G :TGCACGATCCTGAGACTCTACTTCGCTGTATTGCTGAACGATCCTTCCTGGGCAC 
Cervus_elaphus TGGGTGTGGAAGTTCGAGCCAAAGACCAGGACATCTTGGATCTGG GGG G GCTGCACGATCCTGAGACLCTACTTCGCTGCATTGCTGAACGATCCTTCCTGGGCAC 
670 	680 	690 	700 	710 	720 	730 	740 	750 	760 	770 
Capra_hircus 	CTGGTAGGACCTGTGCTCCTGYGGAGGGGTGGATATTAGGAGGGAAGGGGAArTTCTCC TGCTGTGTATTTAGTCCTAACTCATTCTTTTAAGAATGGACAGGAC 
Cervus_elaphus 
780 	790 	800 	810 	820 	830 	840 	850 	860 	870 	880 
Capra_hircus 	CCAGGTCTGGGCCCCTGCCTCATTTTCCGTTATATCCTCTTGGAGGGGTCTGTCTGTCTCTGTGGGCCTT'AGGG GG;G AAGGGTCTTAAGCTAACAGGGA 
Corvus elaphus AGGTCTGGGCCCCTGCCTCATTTTCCATTATGTCCT TAGCGGGGGICTGT GTATCTGTGGGCTCGGTTACAGGG. GG GA.AAGGGTCTTAACTAACAGGGA 
890 	900 	910 	920 	930 	940 	950 	960 	970 	980 	990 
Caprahircus 	GAACTTGTTGCAGGAAGGAGGCTGCAGTGTGCCAGTGGCAGTGCATACGCTATTAGGA GGGCAAGTAAGCAGGGGGAGAGGA'GGGAGGGCAGGGAAGGAACTCTG 
Cervus_olaphus 
1000 	1010 	1020 	1030 	1040 	1050 	1060 	1070 	1080 	1090 	1100 
Capra_hircus 	GCATTTCCCCTGTGTATCCACCAGCATGAAAGCACAGGTTTCTAAGCAGTTCTCTT ACAGTTTACTGAGGCAGCCATTTTCTTTCCCAGCTGTACCTGCTGGhGGA 
Cervus_elaphus 
1110 	1120 	1130 	1140 	1150 	1160 	1170 	1180 	1190 	1200 	1210 
Caprahircus 
Cervus_elaphus GTCTGGAGTCTGAATGGCGCAGAGACCATGCAGGkCACCATGCAGACCACCATCCACGTCCCTGTCCAGGTGCCAGGGCTGGAGGGAGGGCA CACC'rTTATGTTAGC 
1220 	1230 	1240 	1250 	1260 	1270 	1280 	1290 	1300 	1310 	1320 
Caprahircus 
Cervua_elaphus TTCCCTTTCGTTCTCACCAAACCCAACCCTTCTTCCCTA CCCAGCATGAAGATGGCCCTGAGGATGATCCACAGCTGG-GGGCATCACTGCCCGCAACATTCCACGACA  
1330 	1340 	1350 	1360 	1370 	1380 	1390 	1400 	1410 	1420 	1430 
Capra_hircus 	ACCCCAGCTGGCTGCTGAGAACCTGGGCATCAGCCTGGCCACCTTGTTGCTGAACAAAGGAGCCAAGAACATCTTGGATGTTGCACGGCAGCTCAATGAAGCCCACTAAT 
C.rvus_e.laphua ACCCCAGCTGGCTGCTGAGAACCTGGGCATCAGTCTGGCCACCTTGTTGCTGAACAAAGGCGCCAAGAACATCTTGGATGTTGCACGGCAGCTCAATGRAGCCCACTAAT 
1440 	1450 	1460 	1470 	1480 	1490 	1500 	1510 	1520 	1530 	1540 
Capra_hircus 
Cervuselaphus TGGCCTGTGGGGCACAGGTGCCTGCCTTGCTGGTGCCTGGTGCCTACACCCTAGCCCTCTGCTACCTGAGGAGTGKCTACCCCCACAGGATTGAACTGCAGGGGCAGAGA 
1550 	1560 	1570 	1580 	1590 	1600 	1610 	1620 	1630 	1640 	1650 
Capra_hircus 	CTTCCAGCTTGTCTCACCGAGGGGCCTTGCCTCCCCAGTAGGTGGGGGCTTCCTCTCTA A TCTTAATATAAGCCACAGCCTTTGAATGTAACCAGT 
Cervus_alaphus CTT 	 GTCTCACCGTGGGGCCTTGCCTCCCCARTAGGTGGGGGCTTCCTCTYTAG&GAAAAAAAATCTTAATAA GCCACAGCCTTTGAATGTAACCAGT 
1660 	1670 	1680 	1690 	1700 	1710 	1720 	1730 	1740 	1750 	1760 
Capra_hircus 	TCTACTAATAAACCAAATTTAAAGGTGGTTTTTGTTTTTGGTGGAGCTGCAGAAAAGGAAACACAAACTCAAAACTCTTTATTTATGCCTGATCTCTGAGGCTAGGACCC 
Cervus_e1apius TCTACTAATA.ACCAAATTTGAAGGTGGTATTTGTTTTTGGTGGGGCTGCAGAAAAGGkCA AAACTCAAAACCCTTTATTTATGCCTGkTCTCAGAGGCTAGGACCC 
1770 	1780 	1790 	1800 	1810 	1820 	1830 	1840 	1850 	1860 	1870 
Caprahircus 
Corvus alaphus TTTCAAAGTTCTCCTGAAAAACGCC TGTCAATAGTTCCCATTTTCT GACAGAATCAAGTGTCTCCCAGGGCGCCAAGAAAGACCCATCCTTTTTTTTTTTTTAA 
1880 	1890 	1900 	1910 	1920 	1930 	1940 	1950 	1960 	1970 	1980 
Caprahircus 	CCATCATCTTAATAATCTACAATTTGTCGCTCCAGTTAACAGTAAAGCCTTATATCGGTTCCCCTCCCCCACTACCTTCAGGTATCTACAGAGTCGACTCTACAAC 
Cez-v-us.laphus AGACCCAI'CATCTTAATAAGCTACAATTTGCCGCTCCAGTTAACAGTAAAGCCTTATATCGGTTCCCCTCTCCCACTACCTTTCG TATCT AGAGTCGkCTCTACAAC 
1990 	2000 	2010 	2020 	2030 	2040 	2050 	2060 	2070 	2080 	2090 
Caprahircus 	CCTTTCGCAAAATGAAGACACCTCACTTTTCTTTAGGAAAAA. CAACCCTTTAATAAAATTAGTCCATCTGAAACTCCCCCCATACCTAAAGTACTAGTTTTGG?TGG 
Corvus_el aphus CCTTTCGCAAAATGAAGACACCTCACTTTTCTTTAGGAAAAAAACAACCCTTTAATAAAATTAGTCCATCTGIkAACTCCCCCCAATACCTAAAGTACTAGTTTTGAATGC 
2100 	2110 	2120 	2130 	2140 	2150 	2160 
Capra_hircus 	GTTAGCTGCAATTCCAGTTCCGAAGCCAAAGGCGGCTCAGTCCAGkCGGGTTAACGGACTTGTGCTGG 
Corvus olaphus GTTAGCTGCAAAAYTCCAGTTCCGAAGCCAAAGGCGGCTCAGTCCAGhCGGGGTTAACGGACTTGTGCTGG 
Appendix 6. Cervus canadensis PRNP Pseudogene 
A) Alignment of the PBGD pseudogene (GenBank, EU032318) with the PBGD functional gene. The hyphens indicate missing nucleotides in the 
pseudogene. The missing sections correspond to the introns. Exon IX = nucleotides 23 to 136; Exon X = nucleotides 384 to 422; Exon XI = nucleotides 
544 to 663; Exon XII = nucleotides 888 to 941; Exon XIII = nucleotides 1077 to 1163; Exon XIV = nucleotides 1248 to 1418. The dots correspond to a 
sequence match between the pseudogene and the functional gene. Nucleotide changes between the functional gene and the pseudogene are indicated: a 
cytosine to thymine transition at the first base of codon 238 (nucleotide = 604), a cytosine to thyrnine transition at the third base of codon 260 
(nucleotide = 896), a cytosine to thymine transition at the first base of codon 343 (nucleotide = 1362) and a cytosine to adenine transversion at the third 
base of codon 346 (nucleotide = 1373) (Section 3.2.7). B) Alignment of the amino acid sequences obtained from the translation of the pseudogene and 
the functional gene. The dots correspond to a sequence match between the pseudogene and the functional gene. Amino acid differences between the 
functional gene and the pseudogene are indicated: codon 263 V to M, codon 264 p to L, codon 270 T to A; codon 321 R to H and codon 325 R to Q (the 




10 	20 	30 	40 	50 	60 	70 	80 	90 	100 	110 
Pseudogene 	 CTGCAGGAGTTCAGTGCCATCATCCTGGCTGCAGCTGGCCTGCAGCGCA 
Coding Gene GGTCCTTAGTGTCCTCCACAGCGGGGAAACCTCAACACGCGGCTGCAGAAGTTGGATGAG ................................................. 
120 	130 	140 	150 	160 	170 	180 	190 	200 	210 	220 
Pseudogene rGGGCTGGCkGAACCGGGTGGGGCAG 
Coding Gene .......................... GTAGGGCCTGTCCCTCTCCCCTCTCTAGTTATCTTCATCTCTTTCCTGCCTGTATTCTTTCTGAPTACCCACCTCTAGCCAGTG 




340 	350 	360 	370 	380 	390 	400 	410 	420 	430 	440 
Pse udogene 	 ATCCTGCACCCTGAGGAGTGCATG'1ATGCTGTGGGTCAG 
Coding Gene GCTTCTGGGCACCCCIACCTCCACCCTTCTGACTGTCTCTTCTGCCCCCACAG ....................................... GTATGCTTGACCAGCGAA 
450 	460 	470 	480 	490 	500 	510 	520 	530 	540 	550 
Pseudogene 	
GGGGCTC 
Coding Gene GCCATGTATTGTTGTCCCCTTTTGTTTTCAACCAAGTACTGTCCCTTAGCTCTATTGGCTGGGAAAAGATTGGCACTGGTATCTTAGGCTATTTTCCCATCAG ....... 
560 	570 	580 	590 	600 	610 	620 	630 	640 	650 	660 
Pseudogene 
CodingGene 	.... ................................................. C ........................................................ 
670 	680 	690 	700 	710 	720 	730 	740 	750 	760 	770 
Pseudogene CTG 
Coding Gene . . . 
780 	790 	800 	810 	820 	830 	840 	850 	860 	870 	880 
Ps e udoge ne 
Coding Gene AGGTCTGGGCCCCTGCCTCATTTTCCATTATGTCCTTAGCGGGGGTCTGTGTATCTGTGGGCTCTGGTTACAGGGTGGTGATAAGGGTCTTAAGCTAACAGGGAGAACTT 
890 	900 	910 	920 	930 	940 	950 	960 	970 	980 	990 
Pseudogene 	 GAAGGGGTTGCAGTATGCTAGTGGCAGTGCATACAGCTATTAAGGATGGGC?.A 
Coding Gene GTTGCAG ........ C ..... . G . . C ................ A ................. GTAAGCAGGGGAAGATGGGTGGGAGGGCAGGGAAGGG.CTCTGGCGTTT 
1000 	1010 	1020 	1030 	1040 	1050 	1060 	1070 	1080 	1090 	1100 
Pseudogene 	 TTGTACCTGACTGGAGGAGTCTGG 
Coding Gene CCCCTGTG!r.TCCACCAGCATGAAGAACACAGGTTTCTAAGTAGTTCTCTCTGACAGTCTACTGGGCACCCATTTTCTTTCCCA ........................ 
1110 	1120 	1130 	1140 	1150 	1160 	1170 	1180 	1190 	1200 	1210 
Pseudogene AGTCTGAATGGCGCAGhGACCATGCAGGACACCATGCAGACCACCATCCACGTCCCTGTCCAG 
Coding Gene 	............................................................... GTGCCAGGGCTGGAGGGAGGGGGCACACCTTTATGTTAGCTTCCCTT 
1220 	1230 	1240 	1250 	1260 	1270 	1280 	1290 	1300 	1310 	1320 
Pseudogene 	 CATGAAG;LTGGCCCTGAGGATGATCCACAGCTGG-GGGCATCACTGCCCACAACATTCCACAACAACCCCAGC  
Coding Gene 	TCGT'rC'rCACCAAACCCAACCCTTCTTCCCTACCCAG ................................................. G ........... G........... 
1330 	1340 	1350 	1360 	1370 	1380 	1390 	1400 	1410 	1420 	1430 
Pseudogene TGGCTGCTGGAkCCTGGGCATCAGTCTGGCCACCTTGTTGTTGCAGGAGCCGAACTC' 2TT 
Coding Gene 	.........................................C ..........C .................. GTTGCACGGCAGCTCATGAAGCCCACTATTGGCCTGT 
1440 	1450 	1460 	1470 	1480 	1490 	1500 	1510 	1520 	1530 	1540 
Pseudogene 
Coding Gene GGGGCACAGGTGCCTGCYTTGCTGGTGCCTGGTGCCTACACCCTAGCCCTCYGCTACCTGAGGAGTGACTACCCCCACAGGATTGAACTGCAGGGGCAGAGACTTGTCTC 
1550 	1560 	1570 	1580 	1590 	1600 	1610 	1620 	1630 	1640 	1650 
Pseudogene 
Coding Gene ACCGTGGGGCCTTGCCTCCCCAGTAGGTGGGGGCTTCCTCTCTAGAGAAAAAAAATCTTAATAAGCCACAGCCTTTGAATGTAACCAGTTCTACTAATAAACCAAATTTG 
1660 	1670 	1680 	1690 	1700 	1710 	1720 	1730 	1740 	1750 	1760 
Pseudogene 
Coding Gene 
1770 	1780 	1790 	1800 	1810 	1820 	1830 	1840 	1850 	1860 	1870 
Pseudogene 
Coding Gene CTGTCAATAGTTCCCATTTTCTGACAGAATSAAGTGTCTCCCAGGGAACGCCAAGAAAGACCCATCCTTTTTTTTTTTTTAAAGACCCATCATCTTAATAAGCTACAATT 
1880 	1890 	1900 	1910 	1920 	1930 	1940 	1950 	1960 	1970 	1980 
Pseudogene 
Coding Gene TGCCGCTCCAGTTAACAGTAAKGCCTTATATCGGTTCCCCTCTCCCACTACCTTTCGTATCTAGAGTCGACTCTACAACCCTTTCGCAAAATGAAGACACCTCACTTTTC 
1990 	2000 	2010 	2020 	2030 	2040 	2050 	2060 	2070 	2080 	2090 
Pseudogene 
Coding Gene TTTAGGAAAAAAMCAACCCTTTAKTAAAATTAGTCCATCTGAAACTCCCCCCAATACCTAAAGTACTAGTTTTGAATGCGTTAGCTGCAAAATTCCAGTTCCGAAGCCAA 
2100 	2110 	2120 	2130 
Pseudogene 
Coding Gene AGGCGGCTCAGTCCAGACGGGGATrAACGGACTTGTGCTGGTATC 
180 	190 	200 	210 	220 	230 	240 	250 	260 	270 
Pseudogerie 	 QAL .'VRAXDQDILDLVGVLHDPETLLRCIAERSE1R}iLL CSCNAVHTM1WQLYLT 
FunctionalGene 	............ ..... ...... ............ ..... 	............. 	...................... 	......... T ......... 
280 	290 	300 	310 	320 	330 	340 	350 
Pseudogene 	 JIL 
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